{"resourceType":"MedicationRequest","id":"002eb5b8-2964-effd-3b09-f132017dae04","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/86d672c8-3119-04be-9d14-73c7cfb4a6e6"},"authoredOn":"1989-05-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"004cfb00-598b-523d-80fb-708ef79e4f1f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d2ae830c-8bcb-a075-e40f-3bb991ed1af5"},"authoredOn":"1985-10-25T16:23:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"006834bd-5024-a75e-671e-8e04a5f74ae9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8e5093cb-f1f1-c605-4db3-30b5d56522da"},"authoredOn":"1988-04-25T05:21:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"007d3870-182e-cf93-0968-917e18751ecc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-04T12:40:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"00800b48-cfb3-30f3-e4ca-d50bb1304670","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f4a22cac-6696-e2f7-b657-0a59653600bb"},"authoredOn":"1986-02-02T08:53:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"012563c3-289b-48d8-2295-427823378a81","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-26T17:57:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"01541952-c893-5155-4709-f4043df30056","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c073e339-1e53-4199-70ca-ff6808c4e031"},"authoredOn":"1971-06-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"01dd1395-5fe1-88ff-b408-1ee5e97c6bc6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-16T06:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"022304d0-b606-f973-1c07-19e20ce41920","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/7085da97-a15a-c54b-1abf-ddbf78628aa9"},"authoredOn":"2008-11-18T00:16:46-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999995597","display":"Dr. Shiloh191 Larson43"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"0258b691-452f-b840-4a76-f6cab1b95f57","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-24T03:33:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"025cc4d9-ec6b-33a3-74fc-2f7fb0d9df23","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b3263a6d-676e-8d60-58d4-cbfc13426184"},"authoredOn":"1990-01-11T16:35:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"02bae135-41d2-ec5b-b7dc-becfc50087a7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ed9be604-d6d4-a97a-fc25-b544112c3f75"},"authoredOn":"1983-04-23T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"02c66fbe-6ea7-366d-0196-47ef03f4a59e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0e156cf1-19e3-34f5-34da-cfe1871b2807"},"authoredOn":"1986-04-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"02cb4d97-e72c-6d5d-760d-9d5567628325","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d231c71b-a1ab-36d7-d5ad-6fac8d426cf7"},"authoredOn":"1988-04-18T22:35:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"02d3cddc-b36c-9d22-be1e-fdf27d518bc0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/459a44f4-ac15-e44e-7b27-11421b183888"},"authoredOn":"1988-05-01T11:39:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"02dc56e6-8d3f-ed5e-51f8-cf9cbdc10625","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d1d1009e-0dbf-3993-5d56-1283a211e07f"},"authoredOn":"1987-03-08T23:50:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0302505b-1e64-f994-6e8c-76d44c15b7ff","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7709085c-11c8-0f0d-adc1-bb64b252ab92"},"authoredOn":"1988-10-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"030915f7-3ceb-1e11-577a-30f3de316a9f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0bcee599-781e-767a-4c29-8cc966da8ee5"},"authoredOn":"1980-03-08T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"03153d39-9e31-b6bf-535e-d7e5782943d8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/54ae78f2-61c4-bbe1-1ad3-22f8441ed02f"},"authoredOn":"1990-08-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"032af586-8840-6a9a-c6bb-d8f9c0d7684e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e76f8c48-ef59-57b8-9980-122e72a22e14"},"authoredOn":"1984-11-01T21:47:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"03456469-d26d-fd55-ce44-e50cc3f77e35","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/66d980fb-db39-bd3f-d328-51ca0ad9cb4b"},"authoredOn":"1984-12-01T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"035d398f-632f-285f-856f-fc6cdcbefea9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/81b7a0cb-e01e-9522-7d80-7a3f0a5e4e51"},"authoredOn":"1971-09-18T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"036cacd3-4408-f76a-04d6-7063b721f97a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-23T19:16:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"037ee81d-fb01-0b05-5948-5c44bd185c8e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/078be185-0e8e-5f5c-a7dc-d779ae805f8d"},"authoredOn":"1978-06-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"038bdd79-8d84-3ccf-bae8-5937a83a2ea9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/53ee38fc-c961-fee0-2ecf-c60c6b31482c"},"authoredOn":"1974-06-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"03ac06ad-55e2-91e3-c6bc-e51ff8ed2b60","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f97534ef-1347-336d-5f4f-29b5977d96c6"},"authoredOn":"1988-02-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"03b92e62-5809-de99-0f58-9822d93bafbb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/5bde2d4d-3068-9054-b1fb-a1e6a0a2d6b0"},"authoredOn":"1985-07-18T20:35:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"03e0a64d-9302-4de8-75d7-2ae6adae5087","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/63217c04-c3d8-6144-9c78-3b2e97994a45"},"authoredOn":"1979-09-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"03f0ec12-fbce-86a3-afc9-6bc828de162d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/2e98806c-2e10-ff1d-407b-8578c53a7115"},"authoredOn":"1995-09-25T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999924092","display":"Dr. Asha251 Grimes165"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"03f97b5e-fe89-4726-70cd-ea3da8d95203","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/057feaaf-bf31-e9bc-98a5-726cbfa47ccd"},"authoredOn":"1982-06-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"043d1a72-e883-233c-daaf-2f41ddee75c3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/82754954-f2ae-6f74-65c0-1b8e7610ce26"},"authoredOn":"1975-07-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"046d72bf-8b4f-9ac4-bc2b-be3834906ec6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-12T17:30:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0471b696-36e8-e392-b040-1fddb71b7d32","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b746d3e2-ceff-de6b-ab56-3924fdda2ddc"},"authoredOn":"1986-12-31T03:19:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0493db3e-d683-7b35-4377-2a57b55a914b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/591f9ac2-737f-0213-fe6f-e70ea5c2cca7"},"authoredOn":"2014-02-24T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0498635d-f89d-b418-cece-18c665a938c0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b57e3916-d0a2-a18a-47e9-6246cdba56b7"},"authoredOn":"1989-03-30T08:29:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"04a1fccd-2464-a2f5-e96c-1d98418dd611","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e159615b-680f-2aa9-5a4a-3b7cbc101dea"},"authoredOn":"1985-08-31T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"04c87891-02b8-b670-80bd-69210b2c723a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/b101308a-0066-f30b-148d-d770cfb26443"},"authoredOn":"2017-09-05T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"04ccf183-d534-cf1a-8615-c5a796fcbb16","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/3de94d96-3eea-755c-55b0-0225382491ef"},"authoredOn":"2009-07-21T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"04e5ef3a-1ebd-df80-537e-aabc1543550e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c073e339-1e53-4199-70ca-ff6808c4e031"},"authoredOn":"1971-06-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"05bedb1f-62f3-6534-1786-8304c865dd38","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5a329497-54c3-0828-00cd-d3509c1781bc"},"authoredOn":"1988-08-12T18:02:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"05c81a37-be0c-4eb2-2472-cdff914afd71","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/299f643b-18ed-7b1a-4dcb-0800339efe96"},"authoredOn":"1987-07-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"05dc81aa-694b-6052-57d8-f3a055210d21","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-06T20:42:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"05e3b9b0-228d-b119-8c82-6a0f4887ec5c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d7da3067-3825-83bc-add1-b47ff571fd6f"},"authoredOn":"1982-08-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"05ecea93-e983-464c-15f7-9403e12f2b3a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/e2999d35-0ef1-bab7-d9c2-f9efffbdb997"},"authoredOn":"1989-08-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0618a9ed-00a3-22d5-0927-a682579fb281","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-24T23:41:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0621e5d6-d87b-75ad-59a6-5e1b5bc2a094","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e42773a6-c516-f4d5-74a1-24ca39898bcd"},"authoredOn":"1990-07-28T09:41:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"062503e3-ae93-853c-67a8-510240d35d7e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/98e1f05a-1b22-3a15-fced-1da98785dae2"},"authoredOn":"1987-07-31T14:57:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"06557973-6d28-927c-f316-7f00a0278095","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/796524f7-116d-9ec7-b1c2-6032f14fa6f1"},"authoredOn":"1986-04-25T14:56:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"06567742-9af3-baad-dda0-404441beb2bf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fd134a80-0f80-0208-6b5d-22f0e908dfd4"},"authoredOn":"1988-06-17T15:16:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"069e4e9e-d028-4c42-e0fa-4aee047d8953","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e3734411-56b1-01ba-4cf7-0e2dea96f9d9"},"authoredOn":"1971-06-26T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"06a1f003-8e0c-f4e9-cacb-7c88b81ec1db","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ba08536b-d01d-c2fd-c175-f7b6bdd940b6"},"authoredOn":"1990-12-30T05:28:11-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"06ab01c9-9e9e-6dd7-8052-7cd144b843bf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1664463","display":"24 HR tacrolimus 1 MG Extended Release Oral Tablet"}],"text":"24 HR tacrolimus 1 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ce5b42c6-7200-94ff-bbf2-a3b8fb9eff83"},"authoredOn":"1991-10-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"06ff6ab1-2768-3206-296b-88864a107770","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/90360b5a-5d3a-54af-e0ff-92c55d2fed51"},"authoredOn":"1978-07-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"07246193-b89f-51f7-4d53-762339c6740c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9ffa0a3e-4fa7-00c9-37d9-205cc80c8dce"},"authoredOn":"1990-08-03T15:42:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0743e360-827d-c242-7001-2a421511cb02","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-25T15:54:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"07517a2d-f8dd-7fc8-61ec-c47ddc16a09a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a84267fc-6587-5241-ce18-9b47c38556c1"},"authoredOn":"1970-06-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0788cfd6-dd68-fc1a-427a-a47d19efdcf2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/23b5af3e-8308-47f6-c9ba-3adcc9a50a0d"},"authoredOn":"1980-12-06T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"07aa18a6-d97a-977a-659e-71c162cd3ab2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/24d7309f-4ae9-0a26-c624-3fb0aed1e7db"},"authoredOn":"1985-04-13T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"07c35bcb-fd9b-ace9-bde3-e79a05ed9952","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/423414aa-7d6f-1911-3bd7-88fea9b5965c"},"authoredOn":"1990-06-05T10:50:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"07c3dfb1-f3d3-7f77-f3ef-49a978c78eda","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4b7070eb-5fb6-fb76-8d68-2e539cff23ce"},"authoredOn":"1990-10-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"07cc14e4-75d1-7edf-1856-53662fb566b2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/89808e43-605d-7674-493c-63c0317de7f9"},"authoredOn":"1987-03-17T16:32:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"083602a5-d443-e448-5676-89ff3d6bf5d7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3b496422-7540-9674-dc68-916cc47b22eb"},"authoredOn":"1990-05-19T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"08367863-a2e8-9ac2-ecba-886aefe268df","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/530969d8-c3ea-6fa2-b0f1-c62cc3c20092"},"authoredOn":"1987-06-20T06:29:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0846d2f5-5099-8f3f-5ba9-11a6ea2b626d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/53624cba-8225-e619-1b34-0e7da3b25038"},"authoredOn":"2008-11-16T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0882936c-9869-e784-dc2f-b87b75b5a839","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e76f8c48-ef59-57b8-9980-122e72a22e14"},"authoredOn":"1984-11-04T02:35:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0883099b-e649-13eb-4d7c-5741b5afe372","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2040d534-c687-67ee-e332-b2f697d326e7"},"authoredOn":"1982-01-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0885267b-909c-9553-6e16-4517ef6f2ed4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-01T20:01:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"08899ab8-c81c-cd08-a78c-c0d42cbdc111","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/449567ce-af37-d9f6-f98a-a23570d471e6"},"authoredOn":"2009-04-13T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999924092","display":"Dr. Asha251 Grimes165"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"08c0c128-637f-df03-19f9-54b360a3594d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/300de0de-0063-0fc0-67b2-a35ba7836c11"},"authoredOn":"1987-09-06T17:16:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"08f2ced0-b16a-be3a-6fec-b760d9b2f9c6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/68a0b5ef-7444-2fc1-af11-838f55e2a812"},"authoredOn":"2011-12-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0921d132-8cd7-4ba3-07b3-85b86c26df82","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e95986ec-c5ff-22ad-5404-8eea7388c999"},"authoredOn":"1987-01-24T06:30:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"093d2978-56d1-7d57-c1c1-ef675c50bc3e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b2a1eaf7-b50c-9bee-09ff-f00978af271f"},"authoredOn":"1989-10-29T01:46:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"095ac34b-aad1-7cf8-654a-6e77324499ab","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/9c9ed5c8-8335-4944-fe96-b08bae11cba3"},"authoredOn":"1999-10-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0965f00c-76db-6ee6-0412-d4c26699c4e8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7f7bb6c2-d504-33fc-4bbc-69426f2d1ec8"},"authoredOn":"1981-10-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"09756af6-4635-6320-f314-47863daaa8d9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/08cf0db9-d32f-5e67-4830-35efe7964434"},"authoredOn":"1978-06-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"09a0cc99-90da-20a9-78d5-11918310c6f9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-02T22:19:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"09ae8513-a0e0-8ede-37ff-a92ff07a57bb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313782","display":"Acetaminophen 325 MG Oral Tablet"}],"text":"Acetaminophen 325 MG Oral Tablet"},"subject":{"reference":"Patient/a4a401d1-a46a-eb4a-8a38-760d5d79d6ec"},"encounter":{"reference":"Encounter/6fb5b5e1-fa10-3a43-af90-9aadf74d47e4"},"authoredOn":"2015-11-02T15:05:27-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999909499","display":"Dr. Jamal145 Casper496"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"09b194b9-2988-e7e3-c311-edd1d3e15abc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/b99cd839-341d-deed-813b-17678e2269c4"},"authoredOn":"2018-03-27T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999995597","display":"Dr. Shiloh191 Larson43"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"09bc6276-54f0-9dfb-28e0-fb06e0180a67","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313782","display":"Acetaminophen 325 MG Oral Tablet"}],"text":"Acetaminophen 325 MG Oral Tablet"},"subject":{"reference":"Patient/a4a401d1-a46a-eb4a-8a38-760d5d79d6ec"},"encounter":{"reference":"Encounter/b420a78f-c824-8488-59c5-2e398c2f3381"},"authoredOn":"2015-01-13T15:07:45-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999999698","display":"Dr. Bobbye345 Wuckert783"},"reasonReference":[{"reference":"Condition/5908fcc4-c1e7-fb83-756a-34ffd2120e0b","display":"Acute bronchitis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"09cbc94a-4518-6477-5a47-449b81c1f8c0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1f72358c-6996-ff2b-9435-e9fab3722f5d"},"authoredOn":"1984-10-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0a298cb9-4752-a8be-ab28-1320e4fd2ebe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7ffeff66-2f87-bd97-5651-d3a82909df3a"},"authoredOn":"1971-02-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0a2d0af0-9a09-c8c0-febc-8ec5e1b14305","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/025ac45e-1977-4ee9-f881-b6d5e31e5434"},"authoredOn":"1971-09-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0a3ab3f3-7dfd-6175-0d13-810c44793d5f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/511eb1ed-0d22-7db7-a6a4-1370ee5a96f5"},"authoredOn":"1989-01-14T05:13:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0a5bf9a9-e69d-4542-ccce-6b045fbdc5ae","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c3d45d96-3eda-fe67-4a34-e97e647b9eb7"},"authoredOn":"1989-09-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0a8acc50-4eab-c803-32cb-5114ef0fc955","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/230cd571-0e61-26b9-3699-0e916520f87b"},"authoredOn":"1971-10-30T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0a8cd317-3ff8-05b7-78f7-b481913436a2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313782","display":"Acetaminophen 325 MG Oral Tablet"}],"text":"Acetaminophen 325 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/784d458c-b79d-2e6f-1065-c742a0bdb3b8"},"authoredOn":"2016-04-29T14:51:45-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999890897","display":"Dr. David908 Lindgren255"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"0a93d211-1738-4cce-9cb5-9853d61a8dda","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e2da4236-cd7b-02b3-c81c-8f974e3efbb9"},"authoredOn":"1988-05-07T18:05:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0ab9f36d-02a1-d931-2ce4-06e4a3b7a338","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/98e1f05a-1b22-3a15-fced-1da98785dae2"},"authoredOn":"1987-08-01T17:23:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0af9822f-9949-00a6-6514-35bd874d6117","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/299f643b-18ed-7b1a-4dcb-0800339efe96"},"authoredOn":"1987-07-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0b3202fe-740a-4839-7169-7bcd7a088346","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/9971e564-305e-3222-7104-ca971312fbf6"},"authoredOn":"2019-03-25T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0b48d4d0-3099-a7aa-2bb8-1f59bd0d2041","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/5bde2d4d-3068-9054-b1fb-a1e6a0a2d6b0"},"authoredOn":"1985-07-17T17:51:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0b6e58bb-3649-6748-2491-204f53fce699","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-06T05:08:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0b97342c-488b-7889-50ee-18afbc814fdf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/53ee38fc-c961-fee0-2ecf-c60c6b31482c"},"authoredOn":"1974-06-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0bb91f48-fe44-a6eb-54b8-9c8edcfea118","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/60ca5cc6-52f0-771b-8497-a25142968814"},"authoredOn":"1987-08-13T07:06:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0be28b4e-3aab-5025-a553-25bf8a947535","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/950049e3-b310-87e7-3184-e72d185d1813"},"authoredOn":"1979-06-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0c010c32-954d-3ada-f897-3a2aeddf52e8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-07T10:42:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0c44c544-4585-5713-f5ca-9a305a35d7a7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/17f1d5a2-38c4-44ab-da1b-ada4b82ba0b9"},"authoredOn":"1989-03-25T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0c48baf7-d820-680f-e5c0-6684ccef89dc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/82e589e4-20e2-4bd6-bda4-721f89de16cf"},"authoredOn":"1978-09-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0c573830-9dea-8b99-2d95-6547da7ad12c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/df8e4024-b32f-6339-9a35-d49a34b7565b"},"authoredOn":"2020-01-18T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0c738ac5-8058-e29d-42e9-a3e6d2889c27","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-29T14:20:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0c880bb1-269f-140c-636e-4b01f215932f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-20T13:14:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0cb581a9-fab5-196a-f7f8-af7999fa1cd2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad9ac519-9724-fb5e-b17b-312065a2e14b"},"authoredOn":"1981-08-08T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0d1ade6d-7bb7-dcae-43fb-bd7090f2b26b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/ad5388d1-8388-b7ba-dbd9-405587643943"},"authoredOn":"2009-01-26T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0dc1dbd8-0e83-fd87-c293-f918e99fc375","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/8c5e631c-ae61-23c6-6af3-c22ccb1ada7d"},"authoredOn":"1986-07-20T00:28:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0df5bbeb-1db8-5fa4-61e9-012a79dcbeb2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/68cd511a-269c-b687-a52a-a6784ff731a4"},"authoredOn":"1980-10-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0dfdeaa7-2c19-6da5-bae7-9ab192f1a0e7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1e0b70d1-174a-2f1b-ce4e-ccfd86b27936"},"authoredOn":"1986-12-20T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0dff0ebc-ffc3-5d12-5ce2-e125fc8b8d19","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2106a670-2372-dc48-d617-7f1f00a6d745"},"authoredOn":"1981-01-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0e09b5d1-2c52-e08c-8ceb-3844d51c38c0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1e9a6ded-eb1d-11aa-4688-4b3db8fe97c4"},"authoredOn":"1990-03-03T12:02:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0e3758db-c6aa-cf7c-393f-18c89a85a456","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b57e3916-d0a2-a18a-47e9-6246cdba56b7"},"authoredOn":"1989-03-29T04:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0e57bf91-4c36-974c-399d-9a83aee7cfb4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-05T03:33:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0e9d1173-28cf-eb5a-227e-fe9a7a306b8a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/0d3f79d5-ee2c-af5f-18bb-0cde9480457f"},"authoredOn":"2014-08-19T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"0eae064a-db5e-3286-cc27-80cd149ecda2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2bc49551-6496-1edf-e9cd-fbae62cdb67e"},"authoredOn":"1980-06-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0eda04c3-5791-621d-49e9-d8e252b28e9f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d7da3067-3825-83bc-add1-b47ff571fd6f"},"authoredOn":"1982-08-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0f2134eb-44f2-56eb-039b-1b2f0dd630dd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d47ad367-cb57-0e0c-474b-cf84164dff8d"},"authoredOn":"1984-04-21T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0f515256-f059-f3f3-0502-605b641237a1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/f504f2ea-e611-451d-599e-de4ac92c173e"},"authoredOn":"2017-03-13T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0f698a59-f452-0d5a-b495-1b1514de088a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/96e536ad-1bb4-ab41-8ce0-50b58a52002e"},"authoredOn":"1988-12-29T01:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0f7c3616-a553-cc4f-d1fc-f313b0f9c713","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"243670","display":"Aspirin 81 MG Oral Tablet"}],"text":"Aspirin 81 MG Oral Tablet"},"subject":{"reference":"Patient/3af3708d-41f1-cd80-f3dd-ec5ac76072bf"},"encounter":{"reference":"Encounter/d65bc28a-49dd-d3d1-9cf6-e36e35405807"},"authoredOn":"1967-12-21T11:43:52-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999907691","display":"Dr. Karisa693 D'Amore443"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"0f884c37-2bf4-094f-1688-75bcc4be253b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/203b3f8f-7ade-7e0d-8d84-b403f6b885b7"},"authoredOn":"1999-12-06T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0f8cc940-083d-d6ea-ba79-25700ec3c79c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/40d7d2d6-7f4e-776a-b704-cd0b8de45cd0"},"authoredOn":"1971-09-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"0fb77e0a-ec0a-1258-1d0e-db6f8b150fd8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4b7070eb-5fb6-fb76-8d68-2e539cff23ce"},"authoredOn":"1990-10-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0fd00a05-95a4-f4cb-4bc0-7ecadcc5c606","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2f9dedb5-c083-afdf-cc2f-075f75cbf92b"},"authoredOn":"1990-09-08T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"0fef38bb-c77c-f648-c850-fe7701bc3bb3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/798187ef-ec6d-e274-5e54-4e060b90e10d"},"authoredOn":"2015-08-25T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"100b272b-e1ae-e828-4a74-29e512e76d1a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-11-05T06:52:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"103b9a58-2e95-d7d0-5724-fbd560b89265","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8c00cd33-936e-7ba2-367e-34f009daabc3"},"authoredOn":"1986-01-23T22:23:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"10652650-c519-0f27-b108-dc43e16c20b3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/511eb1ed-0d22-7db7-a6a4-1370ee5a96f5"},"authoredOn":"1989-01-14T05:13:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"109bccaf-0cb4-fefe-c695-d68b98cd80be","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ec24c38e-9b44-d273-2a88-b98502770e14"},"authoredOn":"1984-08-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"113ead4c-4ff3-87c4-9b52-338e9fc41d8c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f47bd74b-4e96-5a46-59dc-3847d3247326"},"authoredOn":"1985-03-30T07:45:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"116be94a-84f1-93b8-ddc6-2dd6582413ab","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7bf633c-a68f-a530-fc60-6150abc1cf18"},"authoredOn":"1988-10-27T02:12:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"117c103e-9b21-8877-75af-d217f29d6e7c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4b04d7cb-e317-00ef-e838-b52db9ae4fde"},"authoredOn":"1990-06-17T23:37:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"11ba4baa-b5c2-3f68-2c3f-8867779021ee","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311995","display":"NITROFURANTOIN, MACROCRYSTALS 50 MG Oral Capsule"}],"text":"NITROFURANTOIN, MACROCRYSTALS 50 MG Oral Capsule"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b24dad6b-91ae-b538-51a3-438865308142"},"authoredOn":"1986-06-25T19:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/d2be1b9a-1465-4ee9-c053-402bf7676e27","display":"Escherichia coli urinary tract infection"}]}
{"resourceType":"MedicationRequest","id":"11cf52a5-6456-e301-fa55-8fa034f1021c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ede395be-fdb0-5173-21cf-f2b0c1411cfa"},"authoredOn":"1985-10-13T04:32:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"11eeb5e4-2f43-5138-1f2a-e580750a61c8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/16f6456d-f143-4f90-fa65-6ab0e7d2297a"},"authoredOn":"1988-01-09T07:55:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1214b571-9ce8-6716-ced3-80075f27bfce","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/591f9ac2-737f-0213-fe6f-e70ea5c2cca7"},"authoredOn":"2014-02-24T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"12857e6e-264d-b72a-4f41-f5b8593e2981","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-12T19:24:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"129bba79-7151-1121-e0cf-7b6535bc6827","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c841374b-dde4-6602-fc0c-1c136e854c6f"},"authoredOn":"1983-08-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"12b26943-e2f3-1ddc-4a3b-41a3cc89299a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/09dd8c25-1319-a5a5-f663-a729badbe70b"},"authoredOn":"1982-05-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"12bb8f56-e82f-19a7-1861-4a74530f61f1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2a6b2529-6b90-c748-e1c7-75f753832701"},"authoredOn":"1989-06-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"12bbdc6f-c2e5-3c4c-0e11-8c7b98084847","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c723127a-06b1-7f38-4e12-7965d42f241e"},"authoredOn":"1985-10-10T02:19:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"132e028b-f8eb-c371-3e28-5ce3de62a47a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8ffcc256-9010-0f7b-31df-89fcde87b81d"},"authoredOn":"1989-09-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"134e062e-0bed-5ef8-2c68-156830a97e35","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-22T00:15:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"136fc7db-3346-72fe-0b65-bdb369c86c66","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7bf633c-a68f-a530-fc60-6150abc1cf18"},"authoredOn":"1988-10-28T04:05:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"13b270a6-2376-1861-c855-9e1a84aaa484","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ab9f22bc-bfc8-f44a-eeae-9a99f1e48d94"},"authoredOn":"1986-05-02T14:34:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"13cd4d92-0d14-4393-93b8-4b235f3f0e0c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/aa41e98a-d08c-cf88-7074-ccf5c7b3e264"},"authoredOn":"1990-05-04T15:46:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"140d5cbb-866c-05cf-31c7-995ab71dd3db","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5586bcb2-665c-db3d-4a63-8b8675dc1174"},"authoredOn":"1988-06-08T06:51:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"143ff00c-0a32-4195-36a8-aa363b9c18a1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9346b9b5-0f25-ea58-2a46-3e229ffff50c"},"authoredOn":"1985-12-29T22:43:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"14a160bc-403b-b923-632f-3e9be61e5096","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/248210ad-87ae-66a8-a756-393f140752a7"},"authoredOn":"1995-05-22T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"14a6bbc1-698d-1510-0b25-34f5002b5357","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f34c95b-347f-3f84-587b-7de093dde963"},"authoredOn":"1992-10-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"14b3b2a7-e423-212e-45c1-0529808dadcf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ccb53676-230b-952a-02d0-c34b3f698974"},"authoredOn":"1987-02-26T22:55:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"14ebd4b9-17b6-1fed-eabb-8f128684902c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/1a84e7cc-f363-1faf-679b-a66e3328a382"},"authoredOn":"2014-12-20T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1503442a-ec4b-697c-7eab-3f98d1b4543d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/80e4ba0a-e774-6fc9-13d7-10e2718cff89"},"authoredOn":"1986-08-29T18:19:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"151be4dc-4431-1cab-967c-066544b3f85f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/8916f0b4-d8e4-7c57-fdf4-c0839b6aa85f"},"authoredOn":"1981-07-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"15270838-d9d4-f940-e3c9-2421a84c35df","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/203b3f8f-7ade-7e0d-8d84-b403f6b885b7"},"authoredOn":"1999-12-06T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"153681e0-266f-939d-a5ab-cd05bcba40c1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a0adc537-3d32-4e00-6628-dcef0fda9693"},"authoredOn":"1988-10-29T09:43:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"15644fd2-de78-eeb2-66f6-36bf3f403f09","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e76f8c48-ef59-57b8-9980-122e72a22e14"},"authoredOn":"1984-11-02T22:30:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"15ca4f3b-c312-7104-e8ed-0dab84fbc5fb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6901015b-cfe8-637d-b4fb-f506541164e5"},"authoredOn":"1985-10-16T07:57:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"15fb0b28-8a47-2693-4490-bfac489a9168","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/16721467-00f3-06a3-77d2-1959f0e81392"},"authoredOn":"1998-11-30T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"1636fe1a-59d7-e29f-175f-324d699af8a0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-26T11:00:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"166bd9f9-6894-624a-290b-de17ba1b9b0d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/9971e564-305e-3222-7104-ca971312fbf6"},"authoredOn":"2019-03-25T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"16cd1157-589b-6a35-c0ca-c3a54f7e0b7f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"997488","display":"Fexofenadine hydrochloride 30 MG Oral Tablet"}],"text":"Fexofenadine hydrochloride 30 MG Oral Tablet"},"subject":{"reference":"Patient/cbc86e51-9eca-3855-76ec-c058f72c5761"},"encounter":{"reference":"Encounter/068032dd-088c-4108-4da9-25b25847f4e3"},"authoredOn":"1996-12-27T05:00:32-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999999698","display":"Dr. Bobbye345 Wuckert783"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"16dac344-fd4f-2d23-725e-5ea7e382943b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/be25dfd3-79f2-4f46-a828-c2d2ded162b5"},"authoredOn":"2000-12-11T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"16f1de48-887c-6843-d686-4fc9c3a066e2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/ddcb8f80-e583-adc8-f0b0-cf8fcc4afdbc"},"authoredOn":"2015-02-18T13:45:24-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999933390","display":"Dr. Cherrie404 Conn188"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"17469fb4-de3b-5324-6488-2179f67a1b83","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/28bf21c8-d703-9f22-f940-e29b87f195eb"},"authoredOn":"1989-02-26T02:23:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"175152cf-d247-5f85-9b22-314db9755b74","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-14T12:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"17862256-3c31-e068-b1a4-682311f8930c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a53543ff-b352-53ec-24d5-0b9093dea284"},"authoredOn":"1987-09-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"17865788-a0a1-d045-4be8-4afe90c33a39","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-25T00:56:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"178ddde9-3837-8636-996d-262ade6907b9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/49994b4b-b57f-de31-353c-ec4484873e7a"},"authoredOn":"1984-07-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"17d54b97-1e1a-2fe1-458e-bede3aa61a5f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8d82f0e1-7a79-35f6-c48f-4dd5356f547f"},"authoredOn":"1971-09-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"17e63177-10b4-a507-6de9-2e615da9a13e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bd941365-1ff9-6533-4ba3-cbf512304924"},"authoredOn":"1988-04-22T02:13:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"180de22e-a7ea-d194-19e8-7035a83664bb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-21T18:45:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1812cba0-d5ac-dc87-e7b1-0d059b0e5891","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/baa186ba-d9ca-4621-f71d-d448cdec244e"},"authoredOn":"1984-11-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"1866b577-7ab2-7754-8dd2-556f047463bf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/7215c384-da46-883e-4873-10a0f5f9a749"},"authoredOn":"2019-09-17T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"187da603-dc9d-7878-de62-e6bdab4cb01f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-19T04:28:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"189b211f-9128-4baa-ca67-6f0223863519","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6c8cb8e6-92bd-9b8c-f419-326f39cd66de"},"authoredOn":"1989-12-24T00:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"18a183e4-5d23-c9e2-7a45-41805fd32f2f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-06T07:49:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"18a30141-0ea1-dffd-ba98-5316545e1c14","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-07T08:06:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"18cc96d3-9b37-e677-6074-db8b2f3ee4dc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b1884875-2ee5-9d7d-7a60-1eb1d95c1a97"},"authoredOn":"1973-06-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"18db8e17-4903-c2cf-1382-db298e6e54cf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fbb03a61-5505-7bab-7ddf-dc9be51675ee"},"authoredOn":"1990-01-08T13:05:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"18f5cc78-b197-0fe9-d1a3-04330edcba5f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/403e883a-5960-06a2-f1dd-c7e4b6ceb50e"},"authoredOn":"1986-03-08T16:42:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"191109ab-d159-21c5-f19e-2f12243e84f1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/8437529f-337b-aef9-6023-1501c10656ba"},"authoredOn":"2007-01-15T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"19562324-67d1-afd8-0d9d-603fc67fc2af","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311989","display":"Nitrofurantoin 5 MG/ML Oral Suspension"}],"text":"Nitrofurantoin 5 MG/ML Oral Suspension"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/aea4a38b-9860-8edb-cef8-79e5da15e7f4"},"authoredOn":"2018-01-31T13:45:24-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"},"reasonReference":[{"reference":"Condition/9f2e1f92-3b7e-cb46-db86-19117bd600aa","display":"Escherichia coli urinary tract infection"}]}
{"resourceType":"MedicationRequest","id":"19874ff4-a443-dcb4-3d47-1fa39c9c373e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/08cf0db9-d32f-5e67-4830-35efe7964434"},"authoredOn":"1978-06-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"198a8ba8-8e02-d885-ac8c-bd2331f13d29","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/fe4a05bb-895b-a8bd-9b57-24a9cd6a446f"},"authoredOn":"1988-08-13T16:23:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"198fd721-f30f-8fc0-6d31-6a1c192ea662","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7f2b0a7f-0a78-556c-a92f-e08d72e64ad1"},"authoredOn":"1985-09-15T02:12:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"19c83272-5fd0-c01f-2683-c2fb99250812","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/530969d8-c3ea-6fa2-b0f1-c62cc3c20092"},"authoredOn":"1987-06-23T17:34:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"19c84372-fa2c-f1cd-95d7-b822e9fc96d5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-07T08:06:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1a479f86-8508-cd6a-3919-6a73335488e7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-16T16:51:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1aa38c6d-e3d0-5043-7c92-007b8a125b46","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-09T13:57:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1aadd6a4-b1a7-2d8f-0d86-9fce23297a12","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2967841e-b3c4-910c-b380-110165162cb1"},"authoredOn":"1986-04-19T08:45:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1abe56b4-f2e8-2151-b8ec-e48799f75023","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/5bde2d4d-3068-9054-b1fb-a1e6a0a2d6b0"},"authoredOn":"1985-07-15T13:06:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1ac89bbc-a621-44d3-6a78-514e2d3619a5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9481d91f-9cbc-78b7-c28b-56827a6c20f3"},"authoredOn":"1978-12-16T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1ad138d8-0565-d190-66b5-2e8fc00c3893","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d2e411f8-1b9e-374f-6c9d-fe1f54f7d745"},"authoredOn":"1984-08-18T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1aee7e64-a26e-1fcd-6ae6-293f0546f970","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-20T13:14:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1afaed9a-24b1-c9ae-5ed4-a8943f75a76d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f3353813-7dfe-2040-fc67-947bea2e6ac8"},"authoredOn":"1984-12-15T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1b1aa1f6-ff08-d409-3c27-c5a3a2e4c7cc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-20T22:56:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1b99f75b-71ba-0c07-68ee-fd565a78063e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a954dd3c-d3a0-7dfe-7a81-75c29c9f6454"},"authoredOn":"1986-09-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1ba1a259-b68c-520e-74a7-7e906be05cc5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ae93c4b0-c416-61f3-1a7c-760ac8a8edaa"},"authoredOn":"1986-01-11T09:30:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1bcdaba5-a233-07c6-98f5-c08f876d5acf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-10-31T02:44:30-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"1bf7a828-23b8-8fb8-ea09-939f317c2a58","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-19T00:52:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1c026e06-6336-f7d4-ecf0-d88681ac0379","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e06a5917-9f46-3891-e40a-8917335e408a"},"authoredOn":"1990-09-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1c163337-0637-c41f-547d-d39463e83c94","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9759a722-e802-3e6d-f3ee-96910894e65e"},"authoredOn":"1988-04-24T23:38:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1c36a0f3-6039-bdae-3542-100adacc9220","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-19T18:00:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1c5d6802-721a-2227-c37d-fdeb35d65c2d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/928b8e3d-0f9a-766c-98fb-c304d60f5a97"},"authoredOn":"2008-09-02T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923995","display":"Dr. Johnson679 Schmidt332"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"1c632a56-a8f2-7a79-eae3-23bd5c1d61b3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/86d672c8-3119-04be-9d14-73c7cfb4a6e6"},"authoredOn":"1989-05-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1c6da341-56d4-074c-207c-27f09b7c7253","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/8d865606-a904-6ce1-55ca-e2615a727c1d"},"authoredOn":"1988-10-03T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"1c890d97-9f6d-fd1a-6a2b-06aef98d3c95","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f7b801a-e10c-6a6c-d6a9-e3438e997a92"},"authoredOn":"1988-12-25T23:15:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1c99d54b-0717-2b90-4104-244f905ef549","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/09dd8c25-1319-a5a5-f663-a729badbe70b"},"authoredOn":"1982-05-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1cda2d67-9583-0c40-4275-107fd9585aca","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3c30a378-c63a-0e5f-b9e8-27670646f6f5"},"authoredOn":"1988-12-10T09:25:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1d00c0a0-4867-4789-d622-4f867835659e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7bf633c-a68f-a530-fc60-6150abc1cf18"},"authoredOn":"1988-10-29T07:49:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1d4c83ba-b207-c5cf-7b21-318ca3162cda","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ed720c15-610a-e299-df4f-a57c4b9df1bb"},"authoredOn":"1989-07-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1d55b34c-5cc9-cb32-675a-c7001e07d827","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5af68361-26b5-dc5f-aa78-62ff8134a7d0"},"authoredOn":"1990-01-20T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"1d64fba1-c3fe-1bbb-ba1c-405ade90820f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ca521ae3-4861-0fb5-52e9-6c528b874072"},"authoredOn":"1988-03-27T23:19:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1d71705a-cf52-7c24-cf76-fde906fabf5a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ab9f22bc-bfc8-f44a-eeae-9a99f1e48d94"},"authoredOn":"1986-05-03T18:35:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1d8136c5-fe67-8538-c9e3-0ec99856f413","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/cbcea78a-b03b-76a4-ced4-3a3a9785be47"},"authoredOn":"1989-10-09T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"1d96fcce-5655-0d7b-3988-60a2842a6af4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/6dbcda3a-0d7e-8561-a96c-036fc3ed5743"},"authoredOn":"2021-09-28T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"1d9e8a39-5a8f-28c2-4203-99b9166fadf3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-12T07:28:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1e6860bf-6210-b29e-6d7f-5b38fbd12644","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/99979aae-9a70-2276-8246-bc2a41da4e9c"},"authoredOn":"1988-04-15T19:13:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1e9033a6-3295-6ffb-9ad3-ac96a77452d0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1856546","display":"Kyleena 19.5 MG Intrauterine System"}],"text":"Kyleena 19.5 MG Intrauterine System"},"subject":{"reference":"Patient/7bc002fa-dc52-17d6-1563-fd8901826f7d"},"encounter":{"reference":"Encounter/0e90acf6-e234-c2a4-1484-34267c227a66"},"authoredOn":"2020-01-25T03:40:44-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999998195","display":"Dr. Nicholle822 Fisher429"}}
{"resourceType":"MedicationRequest","id":"1eb05a9d-c4c6-bdcb-72a6-9da1fe38a1df","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-28T19:50:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1ec3f769-83de-7500-5f0d-78dc7e53eeb1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/12ff474d-b388-59a9-fc3d-c2357e37f9d6"},"authoredOn":"1986-05-10T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1ed5629a-ed83-2aa5-9943-7d44222c241f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-25T05:55:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1f5b0c40-90e4-dff0-2189-b0a2f045be0b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/47e766c3-e95f-e790-c112-831c88f201eb"},"authoredOn":"1990-08-29T05:44:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1f6e81a3-8401-df45-bee6-ec070b9b09d3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a4798c34-c8b0-79d4-3776-ec557c11b469"},"authoredOn":"1974-07-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1f77f1fa-412d-75a4-fdd1-47cf1762c8bc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7346de45-6ce9-20cf-9537-68e70d1331fd"},"authoredOn":"1990-06-11T17:39:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1f7a398c-9cea-074a-721c-7633e6785d09","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4a533f70-7dd2-aeeb-7a18-17e02cd63f16"},"authoredOn":"1987-03-23T23:19:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"1ff61443-09a6-1b5b-40be-cfc868a7b2a0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/afe9d4d4-0d61-1955-9570-07f20af00712"},"authoredOn":"1970-12-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"203431f6-c29a-64b9-bf6a-0f799ef941fc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-15T14:51:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2062116a-d5c7-20c2-cfcd-2f0c58b8a92d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1af01740-4655-142c-7206-73e3af93c81d"},"authoredOn":"1989-11-04T07:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"20693b50-eec4-59f8-7087-930c506a73a3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ab9f22bc-bfc8-f44a-eeae-9a99f1e48d94"},"authoredOn":"1986-05-04T19:13:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"20cd0890-c36f-3bed-a771-8d14ccd1961d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1c21a20c-788e-1052-d488-3c9ff2b31b98"},"authoredOn":"1971-07-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"20d36703-0abd-24e1-7eae-78c8248747f5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/388c00f2-a51f-3c21-0bfb-a09ced1cd95a"},"authoredOn":"1985-03-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"20fc76c2-0ac5-8f8f-1f12-3bd014c8016d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/97c65cf1-9090-4826-cb5f-17f3cf30b265"},"authoredOn":"1989-10-21T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"211d49c5-ac1a-9569-524d-75bb3a4362c3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-22T16:07:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"213e5cdf-d139-dbba-00ec-71ed9c1d6542","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/0cbdade8-b2a7-5616-a5fb-e010571d9a9f"},"authoredOn":"2015-03-02T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2183b5de-81fa-d902-0b8b-4801e4636a9c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9fbe9ab9-9369-12c3-d5a2-b554eea42d01"},"authoredOn":"1984-12-09T03:46:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"21968596-3c21-6b0d-c412-e5ea577f89d3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4531fe24-4355-d727-8c9d-30640cb47437"},"authoredOn":"1985-09-18T04:18:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"22105dfe-565a-a277-e87b-b134506678a0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/d61edb04-bc0e-110a-e2ef-de9c5484b524"},"authoredOn":"2008-11-11T00:16:46-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923995","display":"Dr. Johnson679 Schmidt332"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"224b8993-99f3-98c9-4f4c-dde0ad2da1d3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/887af0a5-63d2-b23f-c5fa-1269205d288d"},"authoredOn":"1989-05-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2288f422-d835-7ddf-0800-f7bd2731ecbd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"748962","display":"Camila 28 Day Pack"}],"text":"Camila 28 Day Pack"},"subject":{"reference":"Patient/7bc002fa-dc52-17d6-1563-fd8901826f7d"},"encounter":{"reference":"Encounter/476211b8-49e2-7710-0c14-bb9ef2fb5567"},"authoredOn":"2019-01-30T03:40:44-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999998195","display":"Dr. Nicholle822 Fisher429"}}
{"resourceType":"MedicationRequest","id":"22bbe621-2fcc-62e4-e03e-4a1ff8800389","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d0baede2-7c1a-84a1-09e6-7febe84a097a"},"authoredOn":"1986-07-19T11:26:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"22c8e1e4-0eb1-9c35-87fe-34d087669a18","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/16960634-e916-1a41-6c5f-1db216ea2712"},"authoredOn":"1987-06-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"22f170d1-0132-d676-cf81-6e3ae48c3af8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-14T13:22:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"23268ac3-4233-d995-8067-98b86a4eb5c5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-06T07:00:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"23555d8b-042e-e9a0-5ebc-20d4832e918f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-08T09:58:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"23deece5-0c97-a45d-14bd-9302f5119c7c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/20407659-acd8-4385-03a8-94f13b238a1c"},"authoredOn":"1989-07-08T10:01:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2459ae76-7dd4-f898-b2e1-ae731ea96f06","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8690d98a-628b-94dc-e4ab-cc67244a04c7"},"authoredOn":"1971-04-24T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"24bde982-95a0-3f81-f8cc-04fead88b886","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/277f0d3e-261b-6767-dd20-b4f318dacb5c"},"authoredOn":"1986-02-27T08:04:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"24c0e2e5-faf3-cea8-1e2c-2d22ea2b3df7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/661e4d2c-1e95-6484-70a3-ee0b951228db"},"authoredOn":"1977-07-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"25156930-c05e-0cb1-53ae-180de0f8babe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7fa739f0-91a2-f1e3-86e6-f105d7b6fcda"},"authoredOn":"1986-11-25T03:21:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"253c9d35-95c9-591c-eee3-69af5ab7a534","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-21T15:19:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"25499c2d-6c80-7943-6608-a0851d7461c6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/874982d5-4bc9-fa70-888a-827c3b02e207"},"authoredOn":"1987-04-10T04:50:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"25506ea2-8174-828a-102a-905ef9851ee7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/17f1d5a2-38c4-44ab-da1b-ada4b82ba0b9"},"authoredOn":"1989-03-25T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"256bf38f-52f5-ede6-8ad5-1cc32bfdc2f9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"243670","display":"Aspirin 81 MG Oral Tablet"}],"text":"Aspirin 81 MG Oral Tablet"},"subject":{"reference":"Patient/3af3708d-41f1-cd80-f3dd-ec5ac76072bf"},"encounter":{"reference":"Encounter/069907eb-16f5-2c4d-b76f-beef954662b3"},"authoredOn":"1970-12-07T12:23:11-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999907691","display":"Dr. Karisa693 D'Amore443"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"259e8e0c-69a7-20e1-cbb6-d04fcff76ce4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c4a398a3-fb8f-b209-f4cc-c41340603476"},"authoredOn":"1989-06-07T04:40:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"25e013ab-a858-c78b-4890-7d80ee4eefcf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f138c75b-05dc-58ec-6842-14f1e0b29905"},"authoredOn":"1988-01-07T23:13:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"25ebd0f5-81f5-e294-9382-8e3591e9ad70","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-04T22:04:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2606f6f7-1788-d97c-ba61-f83b0177e1bc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/36f08727-b7ab-8965-9aad-652d330fe5ac"},"authoredOn":"1987-10-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"260a934c-4081-1952-d17f-269177f1d186","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-26T07:48:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2613a387-b4be-0b0c-3d66-f653eee6f33b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/36f08727-b7ab-8965-9aad-652d330fe5ac"},"authoredOn":"1987-10-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"261ca7af-739b-d7f0-fe0d-80109c181bd4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/6830f5d0-d918-6912-52f4-a3aa42446638"},"authoredOn":"2000-10-01T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2635f843-08ed-dec0-8694-47d252a6dea4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/17f1d5a2-38c4-44ab-da1b-ada4b82ba0b9"},"authoredOn":"1989-03-25T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2636d384-962e-5d04-2c32-718a55de6a6b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/60f7170c-e032-39b2-7cd0-8560dbc932de"},"authoredOn":"1987-02-11T06:07:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"264e1907-32ad-3896-0d94-0eb124ad286c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-10-29T01:27:49-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"267317b8-78b6-b6bb-809c-e7a506ead71c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/530969d8-c3ea-6fa2-b0f1-c62cc3c20092"},"authoredOn":"1987-06-21T09:44:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"26898d7a-b74b-55dd-2c3d-5f4c5517d4f3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1856546","display":"Kyleena 19.5 MG Intrauterine System"}],"text":"Kyleena 19.5 MG Intrauterine System"},"subject":{"reference":"Patient/7bc002fa-dc52-17d6-1563-fd8901826f7d"},"encounter":{"reference":"Encounter/6f9facf2-99fd-34a4-21d2-88d1738eb247"},"authoredOn":"2018-01-30T09:55:40-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999998195","display":"Dr. Nicholle822 Fisher429"}}
{"resourceType":"MedicationRequest","id":"268b3537-c711-fca4-b502-ab6e813f0f4b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8594ce9c-239b-a11a-fadc-664940386b91"},"authoredOn":"1981-01-03T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2699e6ce-da72-c995-af07-6393a4cd9cc5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/baa186ba-d9ca-4621-f71d-d448cdec244e"},"authoredOn":"1984-11-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"26fcdeb7-76eb-bf0c-4f5f-0347ac0d1c28","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/81b7a0cb-e01e-9522-7d80-7a3f0a5e4e51"},"authoredOn":"1971-09-18T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2717c1c9-d03e-7965-3fc9-9d28a398d899","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ae74ef60-7505-64d4-d6ac-06bd69979e88"},"authoredOn":"1986-07-28T22:11:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"272a9d58-9536-367c-1c3d-1d355661956e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c64bcfc3-e46a-402c-db9a-f1f266f8d083"},"authoredOn":"1989-06-13T10:22:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2746a1a3-a4e0-604a-f868-e3980a331701","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/58a09024-2908-6cd5-1165-8110ebb4bebc"},"authoredOn":"2021-01-24T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"27592176-e866-69f4-4dbc-ad76384803a7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-06T01:54:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"278ee7ec-1f8d-d79c-722c-7ba7dc0877a5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-11T16:51:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2791c4a5-b3a7-b2c0-a3a0-064b157920c5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-06T07:49:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"279606ae-0900-c1d8-b10c-846d7c0017c8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/094eff01-4e5a-0f7b-3d35-ff06c046ef3a"},"authoredOn":"1982-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"279c429b-1448-3f6e-a34f-f4c3ccb11398","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1c21a20c-788e-1052-d488-3c9ff2b31b98"},"authoredOn":"1971-07-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"27ddb4cc-f19a-0cbc-ed9f-4d055410aee1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/95f1ab77-b752-0d8f-298e-804cab2f8456"},"authoredOn":"1982-05-01T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"280b7f9b-6ecb-5a80-5f9d-f63ebe3e605f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/fe4a05bb-895b-a8bd-9b57-24a9cd6a446f"},"authoredOn":"1988-08-11T09:30:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"281376e4-2184-dfe3-b786-caf35be51e1c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/874231ee-fe0b-e747-c0bf-0eb6b734e77f"},"authoredOn":"1987-05-03T19:28:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"28258997-cf67-76fa-4d4e-4d1d5781d1ed","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/f5cdbb47-c6c3-3133-9163-d68b7b343fdf"},"authoredOn":"2009-11-28T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"28261e63-5100-80a9-a388-3e061a106f29","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a53543ff-b352-53ec-24d5-0b9093dea284"},"authoredOn":"1987-09-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"28270b96-ebd8-1a64-9291-e32280fc450d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/464fa24e-a654-d19f-bf62-c78daa09708a"},"authoredOn":"2001-12-17T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2848d9cc-5c00-282c-8c81-c2aa0c3f9eda","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/874982d5-4bc9-fa70-888a-827c3b02e207"},"authoredOn":"1987-04-11T05:29:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2856d209-ee26-5db1-f532-6b859e9fb878","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/242a39c5-104f-d16f-1ef1-3f66a001805d"},"authoredOn":"1989-01-29T05:39:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"28735c09-0650-387b-f61d-07d14830b8a1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad9ac519-9724-fb5e-b17b-312065a2e14b"},"authoredOn":"1981-08-08T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"288f6485-cf7a-d237-67d1-954baf692ac3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9027d918-9232-f6f4-901c-40729d07d4dd"},"authoredOn":"1980-03-15T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"28f13456-4b47-0bd9-ff43-cddb3ff3c460","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e5f7690e-f502-6eeb-0370-5f193ca644bb"},"authoredOn":"1986-07-10T01:38:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"28f727d0-3a0b-28fd-03a0-bcc4679e0707","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2e8e22e0-3961-a80b-223b-0a01c5297618"},"authoredOn":"1983-01-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"292616f2-d980-9651-dd5c-dab07d48db8b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/90360b5a-5d3a-54af-e0ff-92c55d2fed51"},"authoredOn":"1978-07-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"293d65b3-2e19-6421-4cdd-094eff179c7f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-02T17:42:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"29672873-3dad-0362-4306-47d7dd41a08d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7d584e49-4f06-2a64-d497-1a98c7118c12"},"authoredOn":"1981-08-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"29aa204c-5c86-0fa9-fcd8-87d5bd024ec3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/73f0269c-bb03-766c-52e0-48cb714e9f24"},"authoredOn":"2021-04-05T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"29ad9048-c7cc-7b0d-85d9-031900458cf5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/ff8bd176-3b13-8757-3c03-81782918ecf5"},"authoredOn":"2019-03-13T14:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999933390","display":"Dr. Cherrie404 Conn188"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"29bd259e-7b65-8426-db72-f3ab57d4a593","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ba729faf-be3b-d130-a1da-b3fd7016e275"},"authoredOn":"1990-06-21T01:46:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"29cf56c3-4a81-9e83-3e56-e39fbf1297f9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311989","display":"Nitrofurantoin 5 MG/ML Oral Suspension"}],"text":"Nitrofurantoin 5 MG/ML Oral Suspension"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/59515b7e-3f42-7649-be31-d1c27c71aff8"},"authoredOn":"1986-06-18T19:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/d2be1b9a-1465-4ee9-c053-402bf7676e27","display":"Escherichia coli urinary tract infection"}]}
{"resourceType":"MedicationRequest","id":"29d1495b-03b0-cb2b-fab0-17aec1f96130","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-15T15:43:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2a0a042b-68d6-6665-dc42-b588909c4418","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/874982d5-4bc9-fa70-888a-827c3b02e207"},"authoredOn":"1987-04-13T08:46:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2a3204c1-39e4-6403-09ff-843fd958f5dc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-13T18:57:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2a377808-11f4-fcd0-6514-1ecb3067de67","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1970a439-6a26-78fd-529d-7e578fb88435"},"authoredOn":"1983-12-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2a4af9ec-fd57-9cf2-37b9-62715330a8c5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f9d7435f-48a2-bc1e-1096-af575d7107b4"},"authoredOn":"1988-08-03T09:01:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2a6b41ed-76d4-b290-7a0e-7f921805b15c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8d3e5f0c-a5de-25a7-4207-ba0d12e7f98f"},"authoredOn":"1970-11-28T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2a9919e4-ec10-4363-6740-cbf7c24d4a20","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/04c743c3-fd07-6b4e-a288-75f9c7a88d94"},"authoredOn":"1983-02-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2ac23a0f-fd1c-3a76-5791-f178ae3b4d5a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e76f8c48-ef59-57b8-9980-122e72a22e14"},"authoredOn":"1984-11-05T03:37:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2ad78bba-8ef4-b4bd-84b9-5ca2f8490818","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/10815fed-3432-54c1-b955-a80783d0ae79"},"authoredOn":"1982-01-02T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2b4c005f-911e-a6a8-bd1b-2da0c080a243","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ca5eddaf-8dfb-c06e-cf40-d6c670b428e6"},"authoredOn":"1987-01-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2b5c35ba-536a-651c-84b8-fd6d3a286943","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"831533","display":"Errin 28 Day Pack"}],"text":"Errin 28 Day Pack"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/3979095e-3f96-17f7-a87b-7871cb8bd4d3"},"authoredOn":"2018-07-19T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999995597","display":"Dr. Shiloh191 Larson43"}}
{"resourceType":"MedicationRequest","id":"2b7f36ed-4ef3-1546-b744-2b7adc194f87","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8b46fea0-8663-0f37-a62d-a582a1e652fe"},"authoredOn":"1984-06-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2b8e2223-e0ed-1b08-fd64-d01542f9260f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2e376b26-c4e5-96af-d1e7-ea4808adcf29"},"authoredOn":"1990-08-18T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2bbe6a43-635b-1140-2482-25963fde2bec","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-20T22:56:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2c043fbd-63c0-8ee1-a0f1-99c0dd1f3474","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b8fb3635-6ab0-79c6-7ed8-1aa08dcd6937"},"authoredOn":"1986-09-29T21:29:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2c102b68-c96d-7654-710d-aef0f05cecb1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d3cc6f84-efa9-9194-7728-72f699bb39bc"},"authoredOn":"1972-02-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2c3a8f8a-fe59-f814-140c-79c4ab692a4f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"312961","display":"Simvastatin 20 MG Oral Tablet"}],"text":"Simvastatin 20 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f34c95b-347f-3f84-587b-7de093dde963"},"authoredOn":"1992-10-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"}}
{"resourceType":"MedicationRequest","id":"2c65839e-cf1b-730c-abab-52fbc91cf63e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/95f1ab77-b752-0d8f-298e-804cab2f8456"},"authoredOn":"1982-05-01T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2c7790c2-3aff-91b4-51d3-385c9b9d7142","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/530969d8-c3ea-6fa2-b0f1-c62cc3c20092"},"authoredOn":"1987-06-20T06:29:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2c81db6e-27f2-484c-f5e5-e8a8ee315d0d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1d86dcd9-4294-9004-85a5-feed894dd177"},"authoredOn":"1990-05-07T18:34:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2ca6e42c-8e6e-de1f-56f4-afa2a3318262","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/11136e09-d595-d98f-f2d4-38fc3b04ff61"},"authoredOn":"1988-11-14T00:00:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2cba9525-2840-14bf-4a10-c00a8c47f0df","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6332b66d-e55d-551e-400f-b75bd7cd878d"},"authoredOn":"1987-07-28T13:51:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2cd854b8-c6f8-3680-cf74-4d6ce627d13a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/afd05543-70aa-5d66-1580-d8b99d0af89c"},"authoredOn":"1986-02-14T20:47:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2cf4c27d-57d9-6b32-0398-05b85d25e9e5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/6dffbbcf-a8a7-4e51-e90a-0f3bc83bb53c"},"authoredOn":"1987-07-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2cf927f9-f441-74ee-917d-15d923e6e0fc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/c5098980-3e94-5b4e-1f13-8f6406dbd0e7"},"authoredOn":"2019-01-13T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2d0bd174-77c0-95fe-0945-1cd35b880356","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/603711ca-c10b-24ee-ba2e-b9a6cc8f8704"},"authoredOn":"1980-09-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2d3ca367-2089-70ce-9432-d9cccaade7a1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2911d4fa-0c56-8875-bab5-3ed59f453842"},"authoredOn":"1977-11-19T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2d3e4ffd-aab9-0f69-2e5a-9787fbbdab7a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-25T12:37:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2dc42007-f4f1-b2ed-530f-dd45ca36713a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9b916350-fe45-5f1e-f7c4-341c03781726"},"authoredOn":"1976-09-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2dd8dc28-86c6-0af4-ca96-c05ff7d72267","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cd12c54f-c76b-4b21-ff97-4222abc69d89"},"authoredOn":"1969-05-31T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2df5fcf1-795e-f77c-313e-bacddb7b3310","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/932159b0-173a-6e05-9055-54b33efa3c36"},"authoredOn":"1989-11-07T10:49:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2ea21e4a-8efc-57ca-eb7f-003d5aaa0d84","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/359529a9-4805-e9c8-a976-29fbb971223e"},"authoredOn":"1989-04-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2ea8a93b-de1f-e938-ff97-3010f0a98b22","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f244706f-cb3e-94e5-ab97-8de748d78a47"},"authoredOn":"1983-08-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2ebad816-277e-7ff9-ebfa-eb49bd415ae5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0e156cf1-19e3-34f5-34da-cfe1871b2807"},"authoredOn":"1986-04-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2f50cd2f-d7a9-7b50-68bb-0865914cd446","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/03699278-1388-f7b2-544b-b02277d2ec5f"},"authoredOn":"1987-10-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2f742e32-0535-8f25-5f9a-6ded0ef4f833","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3d11d073-b05e-6349-90ab-d92ed5795f86"},"authoredOn":"1986-08-09T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"2f98a84a-b82b-c891-4943-ec82d1bfcbdc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1edab468-a695-f52a-cfaa-da186d2a25c7"},"authoredOn":"1990-07-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2fa88cca-984d-94c3-9d98-031a6a39603f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9fbe9ab9-9369-12c3-d5a2-b554eea42d01"},"authoredOn":"1984-12-10T07:21:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"2fc95711-7d6e-8971-5ceb-334e0d7193c7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ed720c15-610a-e299-df4f-a57c4b9df1bb"},"authoredOn":"1989-07-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"300974cc-a009-6b70-5943-906f13489d5b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-01T16:00:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"304b61c8-ba08-d74e-00ad-94e49a9b82a6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7ffeff66-2f87-bd97-5651-d3a82909df3a"},"authoredOn":"1971-02-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"306367a3-c82a-22ec-c47f-6c7fbe696194","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-21T07:11:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"30cf6610-68b4-e73a-e466-f1c9f14442db","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/68cd3316-2d99-793a-c6c8-c6d63a265035"},"authoredOn":"1971-07-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"30dac964-a43d-a8cc-7f72-27455acf176e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fad78901-0126-6b25-aaee-cd26de32a546"},"authoredOn":"1987-04-11T22:33:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"30ed17a0-b7e3-7280-a7df-8304ba3202db","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/eec4c259-4ad3-9ff2-f284-c1a185f93787"},"authoredOn":"1987-08-19T13:15:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"30fc0f23-e241-6a35-081d-dbc14e87ba41","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/eb96a570-8079-912c-1f48-a497a6470b26"},"authoredOn":"1992-10-26T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"31127489-becf-9db3-69c9-fff0681c4ac8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/0cbdade8-b2a7-5616-a5fb-e010571d9a9f"},"authoredOn":"2015-03-02T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"315b3262-bdf0-fa27-43b7-d2bee5ad8ce3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/12ff474d-b388-59a9-fc3d-c2357e37f9d6"},"authoredOn":"1986-05-10T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"315ea4d3-cdc9-dbb6-65f4-ee466aff0f34","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e01fe5f6-c8c6-4525-b51c-08ad2d79a176"},"authoredOn":"1988-08-15T20:30:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"31b19585-32fc-e7f8-28a6-c9b6deffa0d4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e76f8c48-ef59-57b8-9980-122e72a22e14"},"authoredOn":"1984-11-01T21:47:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"31cf1032-6634-b06e-a400-0276f9bad865","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/530969d8-c3ea-6fa2-b0f1-c62cc3c20092"},"authoredOn":"1987-06-24T18:56:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"31d0e10b-8247-8469-c401-4d9285ae96a1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/39f89977-605a-f5be-27e4-843f443bdf7a"},"authoredOn":"1987-10-14T06:54:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"31dc486d-f286-337b-8076-8c7c00f78850","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/9b243b0a-1bcb-03f4-71a4-5de443910c0e"},"authoredOn":"1991-08-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"324a3657-03b0-b303-7186-c858170dfaa7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3b496422-7540-9674-dc68-916cc47b22eb"},"authoredOn":"1990-05-19T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"327980e8-cdee-c862-5c44-0e4a6aa9e396","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/5dffbee7-4ef1-1a8e-405d-36f64b34f434"},"authoredOn":"2018-01-06T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"32eb764b-f0e3-6452-388c-6ea5ec6217fd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d72e5fe2-4561-76a2-78ee-5205fbdd0830"},"authoredOn":"1986-09-14T02:53:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"330989eb-6951-2180-df62-eb26c97fc0da","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b8fb3635-6ab0-79c6-7ed8-1aa08dcd6937"},"authoredOn":"1986-09-29T21:29:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"333331e1-bf47-2cba-1515-d122939f85a2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a0728a49-5677-23f7-165a-b671202c6d18"},"authoredOn":"1987-03-30T06:48:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"334b921b-11da-95cb-2999-642602c6278b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/4b4c5bd7-6a7d-a7d1-5e5e-581d7e35b26c"},"authoredOn":"2003-10-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3359725a-2dd7-cc9e-7ae3-78ba97a518df","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/02db8ffc-7249-8c86-854e-08e6864a110a"},"authoredOn":"1988-08-31T11:08:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"33a7bc26-81ec-a0aa-bb24-b79ff5a8c4bf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5e3f6b5b-a8f1-93b4-5971-b4e64af21a74"},"authoredOn":"1987-11-23T18:17:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"33acd931-a50d-8a24-47ef-cb69fb428fbf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/82046cf0-a879-61fd-9b49-f4313c454440"},"authoredOn":"1981-08-01T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"33ba9c56-1c91-d745-2d64-445e33800df7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d47ad367-cb57-0e0c-474b-cf84164dff8d"},"authoredOn":"1984-04-21T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"33fe03a7-8b75-6adb-8919-ce6421b2e366","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f06f2b09-7e0b-68ab-eee4-aeb71f965b87"},"authoredOn":"1983-09-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"341ee49b-9c43-5bae-a248-d8c7a9dcd393","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/300de0de-0063-0fc0-67b2-a35ba7836c11"},"authoredOn":"1987-09-07T18:24:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"345a460e-4157-ed71-effe-8d2083d8bbc3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e1281088-ff4b-01e7-bf07-43568e3fd65b"},"authoredOn":"1971-07-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"34632013-d0ce-291a-9911-56e6b805ad0c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5d2b7c5d-8eac-2de3-9f82-1294aab70256"},"authoredOn":"1986-07-03T19:34:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"346c6c5c-154f-8dd0-2163-5f6d86fb4752","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e3734411-56b1-01ba-4cf7-0e2dea96f9d9"},"authoredOn":"1971-06-26T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3474388e-0495-eb3f-5d03-af733c1f6307","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/bc7bfc1f-1591-f0e0-df71-edcba87aa223"},"authoredOn":"2012-12-09T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"34c25d41-9335-6bfc-2ce1-8ed703a4adf4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f244706f-cb3e-94e5-ab97-8de748d78a47"},"authoredOn":"1983-08-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"34c80f81-9c15-8f10-1cf6-13827925fdd8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"861467","display":"Meperidine Hydrochloride 50 MG Oral Tablet"}],"text":"Meperidine Hydrochloride 50 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3af3a803-bad9-34e1-c759-8e752f5a98bc"},"authoredOn":"1980-06-05T01:02:18-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":4.0,"periodUnit":"h"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"34cad2ee-4920-d759-ab16-6939d38b9ca1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/04bfa8ae-1417-da14-cb44-3b47704058fa"},"authoredOn":"1981-01-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"34dda2cb-7179-8b49-6498-268b8a4010c9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/471b00e4-ba44-76b4-55e5-6d4ea3bea57c"},"authoredOn":"1989-06-16T12:43:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"34e1e4c2-f26e-aa0a-a07b-b5fdf01f3aa0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/98e1f05a-1b22-3a15-fced-1da98785dae2"},"authoredOn":"1987-08-02T18:40:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"34e865a4-beb3-0f2b-b3a5-ce3a21373db1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-18T05:55:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"350da720-3824-cbe1-c203-c0e357c633f2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5af18daf-b161-1f8b-cc61-39cfd621df64"},"authoredOn":"1987-04-15T02:30:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3560b38f-ddb7-b65a-32cc-db76dbf14940","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4a8bc3b3-eee1-0475-75bf-d93bc8d41c6f"},"authoredOn":"1985-11-13T07:25:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"357c3c15-3690-fcb2-1802-347bb75d896f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/b99cd839-341d-deed-813b-17678e2269c4"},"authoredOn":"2018-03-27T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999995597","display":"Dr. Shiloh191 Larson43"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"35828228-4c6c-d890-ab3e-60bcf614f79d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ba52fcf1-2872-c28a-0f83-948ffbba7f27"},"authoredOn":"1985-11-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"36202624-6f28-392c-80c5-3caa4ee5ba7b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/12270de2-bbf9-bfd8-79a6-9e2677e1265e"},"authoredOn":"1989-09-05T11:55:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"36812f04-34f7-6be4-6357-5c9b8c570b94","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/19201af7-bac2-c942-a057-378d8eb832a9"},"authoredOn":"2013-02-18T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"36adfeeb-d225-d9a4-7a7a-010651678757","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/300de0de-0063-0fc0-67b2-a35ba7836c11"},"authoredOn":"1987-09-08T19:55:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"36d0beb7-2ebb-820f-4fa9-10200ff3f0a8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a554c99a-bd6f-54d6-9d24-de5ecd3f04e7"},"authoredOn":"1989-04-11T11:35:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"36e58b09-7a86-a70f-763b-f47abde45e55","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8663773a-e9e3-5a3b-71d0-088430125825"},"authoredOn":"1989-08-30T06:03:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"371a3673-a32d-cf51-5562-a48d0cd34bfd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4889a0be-9842-019f-c884-ccdc912f2fa7"},"authoredOn":"1978-01-21T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3725d752-05df-9d2a-196d-863e15529689","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/859df50d-7786-e33d-2996-3a891641ca75"},"authoredOn":"2016-02-24T13:45:24-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999933390","display":"Dr. Cherrie404 Conn188"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"376b56ed-5edc-9379-71b4-38c23ec01260","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/81e53eb5-ffea-5d33-853c-18022e4ad912"},"authoredOn":"1970-09-26T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"376ca9c2-11fa-8085-1005-b0a5646be5fe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e9126d61-103e-afe3-5aef-b758ddb8d071"},"authoredOn":"1982-09-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"376fac3e-c8ed-c36a-d2ae-84271012e6c9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f138c75b-05dc-58ec-6842-14f1e0b29905"},"authoredOn":"1988-01-04T11:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3799c767-e316-66a7-6ee9-523e4b6faea9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-09T12:37:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"379a924b-3e4b-985a-373d-19f028d405c2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b57e3916-d0a2-a18a-47e9-6246cdba56b7"},"authoredOn":"1989-04-01T14:01:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"379b4038-9d86-4a2d-5228-6f60d12291ed","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/951bf154-9e03-e6b9-e336-617ddd6f110f"},"authoredOn":"2022-03-30T14:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999933390","display":"Dr. Cherrie404 Conn188"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"37a3a54c-dfe5-6919-f377-f5f4237618ec","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"749762","display":"Seasonique 91 Day Pack"}],"text":"Seasonique 91 Day Pack"},"subject":{"reference":"Patient/a4a401d1-a46a-eb4a-8a38-760d5d79d6ec"},"encounter":{"reference":"Encounter/826a993a-07bd-a320-8a08-845ed5185b81"},"authoredOn":"2021-04-20T15:54:55-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999999698","display":"Dr. Bobbye345 Wuckert783"}}
{"resourceType":"MedicationRequest","id":"37acb49b-f93c-634e-a46e-1b59def86bf6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"748962","display":"Camila 28 Day Pack"}],"text":"Camila 28 Day Pack"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/93663acf-4ee9-8fff-e537-724885fae3ca"},"authoredOn":"2012-09-16T14:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"}}
{"resourceType":"MedicationRequest","id":"37dfb094-4f0a-4f93-4a73-3eff9f2df785","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/617be97b-d9f1-7c09-9dd8-e7c321059802"},"authoredOn":"2007-07-10T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"37f72ce4-b179-f4fb-5af0-880daebfb304","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-20T17:41:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"38760f11-fad0-ae7f-78f8-431736b6f235","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/7331f243-da97-f67b-17e6-d32ca73c13d2"},"authoredOn":"2020-01-25T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"389b6e7a-4b1c-d7e0-e92a-ae777b671f36","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7f8f1eaf-0aac-fbd8-a50d-1a7441470a1f"},"authoredOn":"1981-11-28T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"399601b3-6afe-e90d-88f0-7c7bd61cfdf7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7bf633c-a68f-a530-fc60-6150abc1cf18"},"authoredOn":"1988-10-28T04:05:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"39a43d85-3643-e7c3-b24b-ee47fde72b5f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/36709aa3-82be-8c34-c3fe-4b7271168ff1"},"authoredOn":"1988-06-01T13:28:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"39b238d5-6076-e092-7643-e5c5b5f4bc05","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0e156cf1-19e3-34f5-34da-cfe1871b2807"},"authoredOn":"1986-04-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"39fb1fcb-73c0-b27a-62d7-739fad5b66ce","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/63145e10-9d9e-771d-9403-ec94e7b12630"},"authoredOn":"1995-10-02T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3a0c48fc-77bf-e818-fb8b-c467a7a6af13","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ba87fcee-5e12-459e-78a1-291c0afdb670"},"authoredOn":"1976-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3a166211-46ce-03ad-5a7b-0d1fbe5e7862","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/be36555e-0abe-5c5a-c47e-55a47424970d"},"authoredOn":"1989-10-13T15:15:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3a1e440d-0ca8-4afa-dbbf-1357ed2fbcef","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8c47dd4c-1706-24ff-379c-fdbaa876656b"},"authoredOn":"1985-09-24T10:03:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3a24affe-8a50-6779-ee25-1653ad47d555","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-11-09T09:48:29-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"3a45502f-d6f0-36fd-761c-e8cd2c078e63","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/50d68964-cef4-eec3-9fe3-6184b4c63355"},"authoredOn":"1988-11-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3a682a2a-6843-1e76-7bdd-88e51fe00b3d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d1d1009e-0dbf-3993-5d56-1283a211e07f"},"authoredOn":"1987-03-10T02:30:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3aa76e74-86d3-d9d8-8838-cbc3dd768c2c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/c31a4354-6870-f585-9068-a6d26e389568"},"authoredOn":"2007-06-05T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999995597","display":"Dr. Shiloh191 Larson43"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"3ab5ea2b-a162-6cf7-5a33-d239fd6541d3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/254e288a-9d8c-a60f-c637-38dd5889107d"},"authoredOn":"2018-03-19T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3afca718-e6f9-f5e3-98bd-9d45e273bfaa","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1664463","display":"24 HR tacrolimus 1 MG Extended Release Oral Tablet"}],"text":"24 HR tacrolimus 1 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c3911768-27d2-34d9-b7d6-520edc65c469"},"authoredOn":"1990-11-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"3b15a0cb-b505-faff-fa7d-6e06fc64674f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f85e73ba-7b0e-caa7-9a40-b75759ff850a"},"authoredOn":"1987-11-14T09:22:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3ba76bc7-9700-ac8c-c62c-e2d5fffa36ed","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b5d7a538-9460-a6e3-2825-b094ae8b6ab8"},"authoredOn":"1986-05-31T09:04:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3bcd745e-bcf5-2d57-a479-90a6d8ebf65e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-23T22:22:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3c0b33c1-46ec-ae74-db68-0c2b410c4fc2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/541cefd7-f1b9-69d1-2a33-0dc091e2808f"},"authoredOn":"1988-03-21T16:23:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3c2dbe83-75d2-d49d-d435-2f55f24521b4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/81b7a0cb-e01e-9522-7d80-7a3f0a5e4e51"},"authoredOn":"1971-09-18T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3c5e6369-6e5c-d537-befd-81d73bfa8dbb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/74b33e69-381e-6bac-883f-30e42ed88740"},"authoredOn":"1987-03-05T04:34:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3c9fe8a2-0a2f-ad70-8cfa-ead49b8ff201","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e256ef8b-510a-cdbb-f0b9-282bd7ad157c"},"authoredOn":"1987-11-26T21:33:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3cc27f3a-86dc-1358-13d4-750fe1de1543","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/19cb10c6-b8d5-9eaa-e084-25153abbec4d"},"authoredOn":"1987-04-18T06:14:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3cc3d63f-d8a2-114b-6218-31bf81f77393","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-20T07:39:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3cd7355c-ccc1-227b-8da3-3c6dc420f003","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/104d3a3c-6a82-2da7-f0c5-40e4ae65607d"},"authoredOn":"1985-06-01T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3cf59864-1074-bece-0a56-7503fe5fbed7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cf89eeff-fb89-2ddc-1a34-41706b0fffd8"},"authoredOn":"1984-09-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3d5b7600-e259-0f5b-75bd-59ff69c4603e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c0ce36d8-4e16-67e9-86b8-6f4afc7dbc65"},"authoredOn":"1984-08-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3d604840-612f-e850-1b5c-155ad20cae2c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/20c37e5f-e4e8-6e82-cdaa-be39b6e49fa6"},"authoredOn":"1996-11-18T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3d6bbfbd-ad9b-19c4-110d-337ef54a8f33","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311989","display":"Nitrofurantoin 5 MG/ML Oral Suspension"}],"text":"Nitrofurantoin 5 MG/ML Oral Suspension"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/463ca496-be27-2fe6-1e8b-da3be27bccfb"},"authoredOn":"1982-10-29T12:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/3800b208-1af1-061e-1f2c-337ae08c1a2e","display":"Escherichia coli urinary tract infection"}]}
{"resourceType":"MedicationRequest","id":"3da97747-d92a-c5dd-5e6d-0637dcd93389","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ba52fcf1-2872-c28a-0f83-948ffbba7f27"},"authoredOn":"1985-11-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3db67ead-780d-589c-8002-9f866cae257c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/6b87cd66-850a-1f25-82ff-9d20e43f9747"},"authoredOn":"2013-09-11T14:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"}}
{"resourceType":"MedicationRequest","id":"3dbd331d-5c3b-285b-0fe1-00930522e427","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/754c85b7-b6d6-add4-746f-d19980f51183"},"authoredOn":"2023-02-04T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3e15f28c-a3f7-8c6f-70dc-6da4663fd895","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/53cfae6c-068a-6b87-7b3d-cb393680f0dd"},"authoredOn":"1986-05-28T06:56:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3e2a7828-12d2-9ef5-9dd6-a6578a2dfa51","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7d2e0052-d426-2b7f-8378-2d0dcf059ef0"},"authoredOn":"1971-05-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3e33d3c4-b62e-01c2-ec69-ecc9f0410251","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/57235505-4ec7-3c76-ef2d-11d3879eae19"},"authoredOn":"1987-12-18T16:12:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3e461cb9-3cf4-a564-4fbf-759017fb20cb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0b8427c9-f289-1ca9-5369-74c295b2cd67"},"authoredOn":"1978-06-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3e60a697-7a63-0fc4-3d53-8ba2397b816b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d6845aae-7b70-fc6a-b1d3-794f83e49fbd"},"authoredOn":"1986-12-18T18:34:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3e62c430-1642-b3cd-1459-6accd432e951","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/02431a0e-d934-755d-345d-f4d6324cfb98"},"authoredOn":"1988-03-19T04:07:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3e82aee6-dad9-ac0b-10c0-593f2a2b98a7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/980640c1-9f3e-5be2-eaf4-3001206b4ca1"},"authoredOn":"1986-02-11T17:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3e8aa099-dda4-89f7-0fca-c9056f9909c3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7337b4b4-1775-ac67-66b3-216d17832078"},"authoredOn":"1988-06-23T20:35:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3ea2f6ef-aa84-d068-0494-93adfe631c8e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/09ce47d6-066f-7633-76b8-fd78fa4addb6"},"authoredOn":"1988-01-03T02:10:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3eb04967-9860-9f8b-cd23-181fc2720b89","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-30T02:25:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3eb4566a-a438-7297-7b03-f8e0bec6a753","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ca5eddaf-8dfb-c06e-cf40-d6c670b428e6"},"authoredOn":"1987-01-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3ebca1fa-6c41-acb4-3c09-b12a2c2b01cd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a84267fc-6587-5241-ce18-9b47c38556c1"},"authoredOn":"1970-06-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3ec49369-4c8d-fc56-677e-7f368a916bdf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f138c75b-05dc-58ec-6842-14f1e0b29905"},"authoredOn":"1988-01-04T11:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3ed15ef4-8f6a-1ad4-3d10-f6c954bde382","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0a98f385-8a3c-97b2-ea8f-fe6008eb100a"},"authoredOn":"1988-09-25T02:53:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3ed8eb22-4f91-c9c2-652d-5522015ce876","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-11T06:05:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3eecd99f-a25e-5a0e-4df3-5ca48f1a8d65","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2bc49551-6496-1edf-e9cd-fbae62cdb67e"},"authoredOn":"1980-06-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3f04a6a0-24d8-c135-c4af-117f281b9883","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9318db9c-692c-b351-d472-8be543cfeb8c"},"authoredOn":"1983-06-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3f510867-4091-42cb-e751-ec52f91b32d2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"197591","display":"Diazepam 5 MG Oral Tablet"}],"text":"Diazepam 5 MG Oral Tablet"},"subject":{"reference":"Patient/3af3708d-41f1-cd80-f3dd-ec5ac76072bf"},"encounter":{"reference":"Encounter/5bda154a-78f1-25fd-b0d0-65038042a21b"},"authoredOn":"1970-07-20T13:44:40-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999907691","display":"Dr. Karisa693 D'Amore443"},"reasonReference":[{"reference":"Condition/eec69cf4-b1c4-70ee-adbb-af25c3289d24","display":"Seizure disorder"}]}
{"resourceType":"MedicationRequest","id":"3f5958b1-6693-7c4a-5f18-60310ee36141","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/65f3ad06-b39d-ddbd-c978-852966ed181a"},"authoredOn":"1986-09-17T05:44:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3f669e9d-677f-6df1-5c94-f2c1f3d7de64","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/6b80c69a-de8c-c11a-d628-242902a5e558"},"authoredOn":"2022-02-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"3f7c7fa9-2b46-c44f-8a04-ba837222da3e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/09dd8c25-1319-a5a5-f663-a729badbe70b"},"authoredOn":"1982-05-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"3feb5410-6bff-952a-50a6-3c68d92ea707","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/7bc002fa-dc52-17d6-1563-fd8901826f7d"},"encounter":{"reference":"Encounter/a556f909-8319-5a93-6e32-40da4a74d72f"},"authoredOn":"2014-02-17T10:46:59-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999998195","display":"Dr. Nicholle822 Fisher429"}}
{"resourceType":"MedicationRequest","id":"3ff356d3-377d-09ca-741a-3fe69af34c3e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-20T17:41:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4006326a-d067-040d-4158-ceee745e5962","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/50d68964-cef4-eec3-9fe3-6184b4c63355"},"authoredOn":"1988-11-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4006a04d-110a-30b7-bc59-08d1032e3bf0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1eac8dae-3fdb-92ae-2cda-7be7cb77876f"},"authoredOn":"1987-06-28T02:47:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"407ce555-a5d8-ac0a-fff3-a816e140f3b1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/a5ceee09-72ab-0737-9f7c-a5b08e0d3451"},"authoredOn":"2008-01-21T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"40a9467d-692e-d4ba-53f2-3e551262f4ac","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-13T18:57:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"40b06c56-b846-ebc0-6eec-a3c77cd9eb53","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8b19b150-acb9-4fd9-54df-5589467f7b73"},"authoredOn":"1986-04-28T18:02:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"410c0c89-d329-ddf5-692e-7fdff8c55325","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/68cd3316-2d99-793a-c6c8-c6d63a265035"},"authoredOn":"1971-07-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4118bcc9-4e42-fb54-6c17-8b65973d99e8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/22e44118-fb6f-216b-e696-f1e520bed5ba"},"authoredOn":"1986-06-24T11:47:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4143353d-707c-1828-d6e5-8b8f34778de3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad7ec66f-1e1b-74b5-c790-0067a344fb3c"},"authoredOn":"1986-03-05T14:42:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4182af28-6fd2-1326-7072-4fef62309f31","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a9c5bd01-7364-f711-a6ba-f01a5bb020ed"},"authoredOn":"1990-06-24T05:19:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"41bde7f2-de77-ace3-22b3-9855fb846a74","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bf065128-3f04-fa70-2f2a-f1399c0669d4"},"authoredOn":"1971-01-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"41d97586-2de1-570d-18c5-8f68f007f5e9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a357aad9-d1da-87d4-7afe-1c564510990e"},"authoredOn":"1986-11-21T23:54:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"42bec154-9121-27f4-c618-33c25593dbfd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/620866d9-9491-629b-cb6b-408c7477872f"},"authoredOn":"2017-01-01T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"42f4570f-afe0-df87-2211-4f695398b056","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-23T08:32:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"42fe62d4-e877-967a-2c75-1c46949717a8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313782","display":"Acetaminophen 325 MG Oral Tablet"}],"text":"Acetaminophen 325 MG Oral Tablet"},"subject":{"reference":"Patient/cbc86e51-9eca-3855-76ec-c058f72c5761"},"encounter":{"reference":"Encounter/a4131386-2be0-3746-c8a2-16278eb1f74f"},"authoredOn":"2016-03-03T01:00:06-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999999698","display":"Dr. Bobbye345 Wuckert783"},"reasonReference":[{"reference":"Condition/d4329a7e-b828-0469-5bf0-f7c1a50fd7d8","display":"Acute bronchitis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"431745d4-1721-55d0-a7eb-4d2d91ce2a9f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1cf15cc0-037e-2fca-129f-b5e11aaeb48e"},"authoredOn":"1989-08-11T16:21:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"432b6e51-6543-334f-3ace-8601e02fc713","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/39b4efca-f8e3-d3d2-9d36-e0d40713fa85"},"authoredOn":"1978-04-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"43c02a03-1395-a2c8-8131-90325d808688","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-11T16:57:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"43c78be1-4ced-46b1-5d52-979853a6496b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-08T14:36:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"43cb2316-5d94-d9db-976b-7108b7a153de","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/226ec1de-a360-cdd3-2d78-6ec5abe5e360"},"authoredOn":"1989-07-14T15:25:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"43e93aef-c122-1733-880c-1386196c65ca","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/16960634-e916-1a41-6c5f-1db216ea2712"},"authoredOn":"1987-06-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"43f1a457-77ef-ed9c-6a87-16421c3d10db","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/61d35a5f-225e-ea99-0f11-bf6ee1719226"},"authoredOn":"1971-11-20T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"43f3b6e4-9351-b66f-273f-c8f7db2eedb7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ec24c38e-9b44-d273-2a88-b98502770e14"},"authoredOn":"1984-08-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"440cf82d-f626-0ee1-2882-c6c661964e48","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-10-28T00:50:11-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e4f7b8cb-85e4-f74d-5c99-ef7465efa555","display":"Awaiting transplantation of kidney (situation)"}]}
{"resourceType":"MedicationRequest","id":"4422563f-68bb-9c1a-ca0c-ac0f8f2deb4c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3d47105c-ec7f-b52c-883d-203711d8c09d"},"authoredOn":"1987-11-11T06:00:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"44312d6c-8f12-f825-c6ec-c39959c8973f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/7085da97-a15a-c54b-1abf-ddbf78628aa9"},"authoredOn":"2008-11-18T00:16:46-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999995597","display":"Dr. Shiloh191 Larson43"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"44348168-ffdc-fc87-8492-68e7e395d6af","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2106a670-2372-dc48-d617-7f1f00a6d745"},"authoredOn":"1981-01-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"44aba586-d2f5-c11f-10d4-4a64a36dbe76","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-14T12:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"44b865dd-af60-87b1-1d65-cd2f7039bd69","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-17T01:34:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"44edb274-e989-88c0-9e3d-810b0d6b08a4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b8fb3635-6ab0-79c6-7ed8-1aa08dcd6937"},"authoredOn":"1986-10-02T04:26:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"451873ca-c0d7-7ca5-553e-8d6f68b2be04","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/04c743c3-fd07-6b4e-a288-75f9c7a88d94"},"authoredOn":"1983-02-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"451d09be-cba0-0140-9e19-e51750475bad","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/184ea392-b6d4-deec-bd36-c7985bcc3a85"},"authoredOn":"1988-09-09T19:57:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"451ed0c4-c046-e672-17e1-c98b85f0c261","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/98e1f05a-1b22-3a15-fced-1da98785dae2"},"authoredOn":"1987-08-03T20:39:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"45411464-6fd0-0772-cc0f-a72cb90814e2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/e8c11d8d-fcb2-3ff2-1791-a3167e2dba04"},"authoredOn":"2009-04-20T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999924092","display":"Dr. Asha251 Grimes165"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"455dda7d-1afb-6409-54dd-7ac1a639e078","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e854563c-6e4a-3877-f877-9b5411738527"},"authoredOn":"1985-12-07T13:25:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4599bcde-6166-0c7e-4370-c40ab3ed9761","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8f7819c3-7c93-61a3-39db-d6f401a7355b"},"authoredOn":"1989-06-04T01:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"45b3b165-4f78-d326-251b-2e79341ac6c4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-22T07:54:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"45b5b21f-6a76-b00c-504d-0993a23ead4d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f47bd74b-4e96-5a46-59dc-3847d3247326"},"authoredOn":"1985-04-01T12:46:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"45c466ba-550e-3c6a-b0d3-e4de4d9aedff","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a4eced51-1d20-82cd-233b-a70aa77c31e8"},"authoredOn":"1986-04-13T02:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"45ff735c-2ad8-a96c-a1fa-79a5ea4a9a59","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"705129","display":"Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray"}],"text":"Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/6b3dc233-dbb0-84c1-7d90-a8a2cef4f469"},"authoredOn":"1977-05-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"}}
{"resourceType":"MedicationRequest","id":"4616436c-7364-fc6d-9905-78d490a05120","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5b85af1c-31db-5884-cfa5-d8bb4ce25793"},"authoredOn":"1971-08-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4617fb00-fb14-98fe-86d9-8eb7fe190e03","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/fe4a05bb-895b-a8bd-9b57-24a9cd6a446f"},"authoredOn":"1988-08-14T17:22:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"46209973-0b16-6373-952d-3c6c04f78fe5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f65151ca-9429-27f1-27a2-9730827732c6"},"authoredOn":"1986-06-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"463c943f-cdc0-0b87-114b-d662f324c050","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/02431a0e-d934-755d-345d-f4d6324cfb98"},"authoredOn":"1988-03-20T05:29:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4647daa8-931e-3fdf-1dab-ce38b1f6c114","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1b3b12bb-403d-0eb7-2646-385d704a7b0f"},"authoredOn":"1981-07-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"466910a4-ae95-3b5b-9165-46dafc0978f5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/84c61434-7890-3f3f-086b-9f42895ca381"},"authoredOn":"1989-01-01T04:42:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"468120e7-aa64-e451-61c1-1c9efb0831e5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-05T03:33:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"46a9d1a8-9e0b-07eb-93e1-1c9465922284","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6c409738-c817-08c2-9e13-16aee5f3473e"},"authoredOn":"1987-04-21T09:00:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"46c339af-8bb0-0316-316a-40700607375e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a370d7d4-596a-61ff-41c4-963a3f023d73"},"authoredOn":"1986-08-26T14:43:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"46f3f8c6-fd80-8447-e3b4-f029e2ebdfd3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/82e589e4-20e2-4bd6-bda4-721f89de16cf"},"authoredOn":"1978-09-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4704d136-49a1-17c2-91b8-77207525a605","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/86688a05-672d-7a8b-7f87-f12d3b0ce1e8"},"authoredOn":"2022-10-04T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"4733e33f-29ba-f35e-7860-42857b35fcf2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1367439","display":"NuvaRing 0.12/0.015 MG per 24HR 21 Day Vaginal System"}],"text":"NuvaRing 0.12/0.015 MG per 24HR 21 Day Vaginal System"},"subject":{"reference":"Patient/a4a401d1-a46a-eb4a-8a38-760d5d79d6ec"},"encounter":{"reference":"Encounter/dbe6380a-fca0-c5ca-5eda-21a0691041dd"},"authoredOn":"2016-03-11T14:54:55-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999999698","display":"Dr. Bobbye345 Wuckert783"}}
{"resourceType":"MedicationRequest","id":"47534038-8427-45d1-ca98-e68592afbecc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-27T15:25:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"476fe307-35a4-edb7-9598-f49adb9e528c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/19f50b4f-83a6-1477-3195-b0669b7c66f2"},"authoredOn":"1980-08-09T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"47da90b8-86ea-a9c5-96f0-a06d76b38360","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/326aa5b6-db73-b3e3-f707-7767046f1622"},"authoredOn":"1990-12-16T02:28:56-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"47eb4e87-b1a6-66e5-1cba-38ca94a8e382","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fe22688c-0dc7-7088-d266-a97c8eb3783e"},"authoredOn":"1985-01-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"48153591-e24e-ce60-1887-b6f63fa35624","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/beb81e3b-71a2-e25a-7af4-2f9793614ea7"},"authoredOn":"1986-04-22T12:06:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4834bb70-86f7-8c47-9868-633d8fe30be5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/5ceb9efd-da97-9c8d-b0a9-0453146669de"},"authoredOn":"1996-09-08T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"48d1d78d-3852-e5bb-ffbc-bca63e79987f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/07b32657-5ef3-01f8-7f2f-4bd1b522c35a"},"authoredOn":"1989-08-08T12:27:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"48ed8c37-7e8f-553b-a33e-46658b1e2d05","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c7a3b7ab-aa7a-7f14-7040-591c55210289"},"authoredOn":"1990-05-01T12:59:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"49542605-301d-173d-05ca-a85cc35315e8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-22T19:20:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"495fa39d-d6f1-db7e-9d57-187d2d7aec5e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f5c7ad5c-6397-61c0-8978-cf9c4086d9b4"},"authoredOn":"1983-10-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"499f8efd-98a5-6e6d-4922-9a0b617b0fba","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-21T07:11:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4a342d33-cbf5-056c-f1b3-f4e559ce3947","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2071e3b1-7af3-12fb-be8f-f4410aaa12c6"},"authoredOn":"1986-01-20T18:41:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4a4c84eb-db86-f880-d150-aa1eee3781b9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5b85af1c-31db-5884-cfa5-d8bb4ce25793"},"authoredOn":"1971-08-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4a71a2ff-605c-0a34-83fd-e145cfe8ad99","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/175573ad-ef2b-ea52-0903-511d831f8010"},"authoredOn":"1990-09-01T09:09:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4a98b5ed-4d46-e6f5-8b06-0a8f06447bf6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/154c2b29-b5aa-fc20-0500-83aacf9da83f"},"authoredOn":"1980-02-09T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4aa9be28-b609-4f85-5479-3dda3d9e259e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/057feaaf-bf31-e9bc-98a5-726cbfa47ccd"},"authoredOn":"1982-06-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4ac1d748-eb7d-5536-e941-f5c0d050b8a4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2d48ae99-2ee9-04f1-5aee-181c7c2b42e1"},"authoredOn":"1986-12-04T13:19:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4ae2622f-1165-6635-0961-6e9339d54a07","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/f3d54ff9-267d-9282-ebd6-ce2157cbde40"},"authoredOn":"1993-08-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"4b411a43-b98c-77f3-cbdb-e7824124772c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/078be185-0e8e-5f5c-a7dc-d779ae805f8d"},"authoredOn":"1978-06-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4c175b35-c776-b564-da59-d25553fa8f1b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f138c75b-05dc-58ec-6842-14f1e0b29905"},"authoredOn":"1988-01-05T15:33:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4c63672d-730d-c226-ce21-b3f93e4352b7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/82754954-f2ae-6f74-65c0-1b8e7610ce26"},"authoredOn":"1975-07-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"4c97ef65-71b3-734c-c035-9450a9d4b53a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/fddc6184-76f9-a03b-56fd-c9a23fbc70f8"},"authoredOn":"1995-11-13T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"4caec7a0-fde5-1db9-17ad-672edbebc588","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/7bc002fa-dc52-17d6-1563-fd8901826f7d"},"encounter":{"reference":"Encounter/d8b23cae-16d4-686d-a3bb-72b750465d73"},"authoredOn":"2017-02-04T09:32:55-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999998195","display":"Dr. Nicholle822 Fisher429"}}
{"resourceType":"MedicationRequest","id":"4cbe9c49-abf2-1439-6926-de2cb04af194","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/7bc002fa-dc52-17d6-1563-fd8901826f7d"},"encounter":{"reference":"Encounter/eabe34a4-d7d3-4972-e9a0-70083f0e1e28"},"authoredOn":"2021-06-12T11:46:59-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999998195","display":"Dr. Nicholle822 Fisher429"},"reasonReference":[{"reference":"Condition/fd608de4-0bc0-e763-c4e2-04258a9c19aa","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"4d13a7dd-8637-fb4a-d718-d78f2695d5a7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9d84b266-cf38-63c8-bb5e-25c0e90fe06a"},"authoredOn":"1990-07-31T13:12:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4d3f8bf0-7eb9-1fc5-b24d-ef7bd57599de","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-24T10:34:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4d584562-a488-8893-333b-92eb14858150","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/511eb1ed-0d22-7db7-a6a4-1370ee5a96f5"},"authoredOn":"1989-01-10T19:38:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4d5a42bb-fcad-89c5-ac9b-e841870d8ff2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9fbe9ab9-9369-12c3-d5a2-b554eea42d01"},"authoredOn":"1984-12-08T02:50:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4d688c1f-7a91-4f3f-336b-d5087f511e70","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/317c4da0-e054-c098-7930-a3e992bff305"},"authoredOn":"1985-02-09T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4d965471-ee87-fb27-aac3-8f413532fae1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/530969d8-c3ea-6fa2-b0f1-c62cc3c20092"},"authoredOn":"1987-06-22T13:21:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4da9a6c3-c09e-0756-ba3d-f34bad2227be","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/afe9d4d4-0d61-1955-9570-07f20af00712"},"authoredOn":"1970-12-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4dcee8ff-e048-00a2-d7e0-6f440bdd6d83","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/12d1499d-0dee-b88e-99fb-de6a35db2c77"},"authoredOn":"1986-09-22T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"4dd1783d-910d-9850-e4f3-69887f4d69b7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/061bff90-096d-ada6-1ae7-46d9599b2f34"},"authoredOn":"1982-02-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4dd5ac43-ecca-42ca-8171-0cee2d2b02aa","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d6845aae-7b70-fc6a-b1d3-794f83e49fbd"},"authoredOn":"1986-12-21T00:10:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4df461a5-59ae-c829-0dd0-c8cc9c225d38","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/1a617816-6053-3d9b-dd83-88137dc1cad2"},"authoredOn":"2022-04-11T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"4e009890-8c18-6b39-969d-fcb2c39f5049","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/54611913-110c-be99-837d-11c2ee1d4dac"},"authoredOn":"1970-09-19T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4e02d669-b1a5-cfd6-476f-ae6e8919fcf0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/dad7c6b4-814f-04ac-8be2-8c543d1ba106"},"authoredOn":"1989-09-08T14:16:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4e15c494-4545-d10c-9d3f-f2cc81bc5141","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/176a5c78-d0b4-53cb-6a31-e9fd5da9afa4"},"authoredOn":"1989-08-05T10:15:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4e6351f4-4851-01bc-53b8-1ce8da672789","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/75a97d28-522f-ba4a-4c64-6d7d43e14bd2"},"authoredOn":"1981-03-07T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4e9ed7c0-e3fe-3343-7ec4-2e0fd2dc35fa","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ea3b8c5a-0b71-d059-00ec-7fe0b5402bb6"},"authoredOn":"1989-01-22T23:45:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4ec2d284-7b2b-d463-abba-8c91c3a93cdc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/3d16693e-2a09-b1e4-9fdb-08a545ed55cd"},"authoredOn":"2015-04-27T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"4ec83508-6c4f-6726-9a5c-d55f1017d1ab","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b57e3916-d0a2-a18a-47e9-6246cdba56b7"},"authoredOn":"1989-03-29T04:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4ef0c48b-b799-fb4f-1103-2209321ba438","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-17T01:00:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4efa7c81-cad5-4cec-de3e-3076d353541f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/8c5e631c-ae61-23c6-6af3-c22ccb1ada7d"},"authoredOn":"1986-07-20T00:28:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4f140c3e-c732-6bec-e707-213912c2072e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/78e879bb-1bcb-12e0-4321-a38bd17cab89"},"authoredOn":"2010-02-01T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"4f14cee3-7fcc-d17b-8ecd-d116ee92816a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/b44959cb-aaf7-050a-ab0f-b566d5b588e9"},"authoredOn":"2014-12-21T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"4f1c01e4-a799-864f-37c3-2e7e59d5a1dd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2e8e22e0-3961-a80b-223b-0a01c5297618"},"authoredOn":"1983-01-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4f299b76-3ecc-e968-7f3c-54af001611dd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/04fc8f93-3535-e324-5042-b35901ee7caf"},"authoredOn":"1988-07-25T00:30:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4f3459b6-8277-d1ce-18b6-80480a2e5fa9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/206f7446-5374-7087-5d6e-c193782a33c5"},"authoredOn":"1988-01-18T16:54:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4f43cccc-a327-53df-5422-cb8a21af1793","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0b8427c9-f289-1ca9-5369-74c295b2cd67"},"authoredOn":"1978-06-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4f57c57d-5865-b77f-f71e-46b503feca96","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/8b5e50cc-4d72-e880-3f3a-5e51f5935736"},"authoredOn":"1982-07-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"4f69d415-3676-4d36-51aa-f14aa8fdd28f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/88a06ee0-f9ce-5ab7-35c4-91aa5d55061c"},"authoredOn":"1989-01-16T18:42:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4fa282db-aacd-5b48-00f7-72e830eb1c92","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b6762ec8-da0b-8ed3-5007-1f56cd7c0fef"},"authoredOn":"1989-01-10T12:53:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4fa6f311-d5fd-3820-25e7-cad95cea5b99","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-08T09:58:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4fb38b57-e9e4-6d0c-ae87-6bc8a46a0fc2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d15e47bf-8318-caaf-e828-fb0d149ddd8a"},"authoredOn":"1989-08-02T07:10:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4fe97b3c-3b57-d39d-764a-b3526984bf5f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/904f5d11-d7d9-e0b3-b3e4-992d11f49523"},"authoredOn":"1986-06-05T03:18:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"4ff8060f-e2ab-0cf6-8ec2-67b01a68bd4f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/b44ed0af-3111-6943-cd03-4c1c08c61a19"},"authoredOn":"2012-12-08T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"501bed70-d7a0-61bc-e9d0-a2b73a076db9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7d2e0052-d426-2b7f-8378-2d0dcf059ef0"},"authoredOn":"1971-05-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"502fa444-135c-6be3-97df-eb999a1b3fd7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f55502c-5642-0f1e-f442-137b002a6691"},"authoredOn":"1979-05-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"50783466-0b41-8172-402e-f78ca8484c03","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cf1053ca-e4c4-2321-1ea1-a1d5bc008e4a"},"authoredOn":"1986-12-01T09:25:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"50bf04e9-ee10-a2c5-b581-79c0f239b0a0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e5800551-c845-7b4e-48f8-8f9be4f97b7b"},"authoredOn":"1988-08-18T23:07:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"50c96757-08be-1a70-eb4a-114f44386484","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/68cd3316-2d99-793a-c6c8-c6d63a265035"},"authoredOn":"1971-07-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"50ea098a-2473-76c6-645f-11dfa77f8cd9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-22T16:07:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"51064cee-a884-ba1d-5ff5-678b4509b821","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8b46fea0-8663-0f37-a62d-a582a1e652fe"},"authoredOn":"1984-06-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"516c7933-b57f-d0f1-6905-a3841772a316","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3d29e941-0e1f-0993-9592-f661cd11be58"},"authoredOn":"1986-03-21T04:51:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5175fcd0-ca5e-3fec-ebd8-5dc11842f4b2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/928b8e3d-0f9a-766c-98fb-c304d60f5a97"},"authoredOn":"2008-09-02T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923995","display":"Dr. Johnson679 Schmidt332"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"5186a36e-bbfa-109c-9505-06889b948f4b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/456c6466-622b-4c8d-8e72-fdffc669e8e0"},"authoredOn":"1970-11-07T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"518de7e3-d8df-57ba-1dc7-5fdb459308b1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/8c5e631c-ae61-23c6-6af3-c22ccb1ada7d"},"authoredOn":"1986-07-21T04:14:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"51bb6af1-2a5c-160f-9598-68b521393970","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e159615b-680f-2aa9-5a4a-3b7cbc101dea"},"authoredOn":"1985-08-31T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"51d5462c-2a93-41e7-9181-ddbf34fe89e2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9c64e40b-2c89-b6db-66fc-e784d7820d5f"},"authoredOn":"1990-02-09T12:43:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"51e381ff-7764-a601-2c70-32eb3af0ed59","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e59a7ad1-e076-756c-4122-d308fbcdeb76"},"authoredOn":"1987-10-17T09:10:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5206de12-22af-59af-d76b-6d324c2e5938","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/1c63885e-92a3-23e0-4384-fbe4a4e37e1c"},"authoredOn":"2003-12-29T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5211a154-2df8-1aeb-b1d6-6cff4fd41e43","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/36709aa3-82be-8c34-c3fe-4b7271168ff1"},"authoredOn":"1988-06-02T14:50:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"522555a6-cf84-9d1d-cbec-15dfb16f6c44","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/70bb4029-f259-caed-ce49-7e8793185581"},"authoredOn":"1985-10-03T19:09:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"52747789-5867-542a-3211-824e469a5607","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/75a97d28-522f-ba4a-4c64-6d7d43e14bd2"},"authoredOn":"1981-03-07T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"528f0b6e-bcaa-c3f0-59ca-5dacdc7de374","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-26T11:00:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"529221af-2e74-24c2-e781-3e1daa816aa7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/bf18f17f-837d-578b-842a-7d54cff85863"},"authoredOn":"2006-11-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"52c5c6b9-288d-b193-b693-1ef064de4ee6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/603711ca-c10b-24ee-ba2e-b9a6cc8f8704"},"authoredOn":"1980-09-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"53250991-5cde-052e-ac83-235f47f61235","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/530969d8-c3ea-6fa2-b0f1-c62cc3c20092"},"authoredOn":"1987-06-23T17:34:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"534fcdff-0c2b-6386-4afc-59390a53af46","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bac974c0-097f-95bf-28a1-6f2721af9e9f"},"authoredOn":"1970-10-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5377af6b-72e5-0219-1f6e-a876d883a358","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/46cb19b4-8bc1-87cd-2dd3-db517218f08f"},"authoredOn":"1990-02-25T05:52:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5429dc76-0e46-cee8-0c39-2a19aa3f00b3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-05T06:04:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"542de617-40fa-6b54-b481-0807f7f711f2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/3c56a6f0-ec0f-1d0f-7d2a-87e9aea3698d"},"authoredOn":"2007-10-23T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999995597","display":"Dr. Shiloh191 Larson43"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"54496b80-0fa8-9647-00ba-068aa40d9af3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/530969d8-c3ea-6fa2-b0f1-c62cc3c20092"},"authoredOn":"1987-06-24T18:56:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"54640de6-4dff-2787-73e4-b12b51009e24","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0bcee599-781e-767a-4c29-8cc966da8ee5"},"authoredOn":"1980-03-08T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"54949c34-d5eb-7f15-854d-5265615d0b2b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7691285d-14fa-7069-6de5-58b86f83374e"},"authoredOn":"1987-02-20T16:22:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"54986243-b1ad-3d20-7b1f-e65d650d893a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/254e288a-9d8c-a60f-c637-38dd5889107d"},"authoredOn":"2018-03-19T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"54a5005d-42c0-535e-f3a0-2a4d4cd0ea00","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/66a77384-edad-72ea-d3c2-5dff004dfb71"},"authoredOn":"1990-04-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"554b8bfc-8ec6-3779-1f7c-d6d200b44e7f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-19T00:52:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5576feac-70cf-0fd6-6f7b-64116d86cdcc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-23T19:16:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5581704f-86b4-841d-e407-a3e1e6ca2386","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/196a4b7a-22a1-0ef4-997f-0e7b8edef5f9"},"authoredOn":"1986-03-11T18:53:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"558659f2-4599-45a5-8cc7-866551d0a0ae","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/20e746d1-03c2-9bdb-9dbd-88ddc78b1387"},"authoredOn":"1987-01-03T05:34:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"55b383ef-2427-2b5b-d10b-e508794702b7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/a5ceee09-72ab-0737-9f7c-a5b08e0d3451"},"authoredOn":"2008-01-21T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"55d0cced-cb74-af1e-4b32-de288b06ea86","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/39523cd1-2b50-ba4e-6933-cbf4a42ad2f9"},"authoredOn":"1990-02-28T08:20:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"55f0284f-2786-76ce-0d43-d5faa763db3b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ab1ae005-4119-e04a-1fe2-0147a469549d"},"authoredOn":"1986-11-09T12:48:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"562956cd-c365-3e4d-573c-d22750ef342a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6c6bb0e0-ceb5-3d8c-27e2-1ff2458d036a"},"authoredOn":"1987-04-27T13:49:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5647f10b-7668-7bac-6592-e3f6a76296eb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/61153974-75c6-372b-e09c-b4fb070b40d9"},"authoredOn":"1981-05-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"565f537b-7182-f112-af1d-88c1e1caa675","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6351feb7-3a05-c0ef-a94e-f214aea48090"},"authoredOn":"1986-01-17T15:24:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"56805927-9ca8-1137-6126-83f95d9676dc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6893495d-0d53-cc4b-d673-e1197ef1c89b"},"authoredOn":"1989-04-30T02:50:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5719ffc4-4468-2e08-db6b-bb4f0773d074","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/b6a6171d-b924-e26b-1ae2-8cd382b27e46"},"authoredOn":"2021-01-23T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"572449dd-bb6b-1363-32e2-210f6deb36d8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e854563c-6e4a-3877-f877-9b5411738527"},"authoredOn":"1985-12-08T15:21:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5725bfad-4373-55ac-15c4-6e4aaa2449ce","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2106a670-2372-dc48-d617-7f1f00a6d745"},"authoredOn":"1981-01-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"572fff4b-e435-9892-be21-933b2d56c4f1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/48e6ad35-125d-ecae-13e6-0ccb68dcf9b1"},"authoredOn":"1990-10-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5730cd63-8279-284a-31b3-d14099bef8fd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/8c5e631c-ae61-23c6-6af3-c22ccb1ada7d"},"authoredOn":"1986-07-21T04:14:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"57703db7-f184-609e-5641-2100f626dc30","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/874982d5-4bc9-fa70-888a-827c3b02e207"},"authoredOn":"1987-04-10T04:50:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"579e9948-5296-2dc3-3ec9-019603c569d0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d1672123-53f6-c4c1-db2f-95bd32a007de"},"authoredOn":"1989-11-29T05:42:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"57b8d969-e497-7c34-0b9d-e8a223673089","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b6d9b3bf-75d0-3262-2283-d235cd258b7e"},"authoredOn":"1985-08-19T22:56:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5832e122-2738-9152-963c-00f74757c576","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c0ce36d8-4e16-67e9-86b8-6f4afc7dbc65"},"authoredOn":"1984-08-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5843beab-ce77-34db-aae7-63ba2fe85e09","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/87ea6824-0cd9-a5ba-a1d7-b4256c6d13e5"},"authoredOn":"1971-03-06T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5857770a-2258-0089-ec6b-4a82a716b300","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9fbe9ab9-9369-12c3-d5a2-b554eea42d01"},"authoredOn":"1984-12-11T10:31:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"585c4b01-03dd-dc16-a886-fbf9a1ea179e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2911d4fa-0c56-8875-bab5-3ed59f453842"},"authoredOn":"1977-11-19T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"58fe0305-9994-e848-516f-02e7f1a4b97e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-04T03:04:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"58fef570-2503-7101-74ed-7b93d73b8313","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2911d4fa-0c56-8875-bab5-3ed59f453842"},"authoredOn":"1977-11-19T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"59050f75-6620-924f-6c66-765508cfd324","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/49994b4b-b57f-de31-353c-ec4484873e7a"},"authoredOn":"1984-07-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"595246a7-7cb4-99f8-4917-95e6f909bfd0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/8437529f-337b-aef9-6023-1501c10656ba"},"authoredOn":"2007-01-15T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"59bfae36-2a36-396a-a9fd-a551c487319f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/98e1f05a-1b22-3a15-fced-1da98785dae2"},"authoredOn":"1987-07-30T13:34:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"59c41971-45b1-febe-9f0e-5abdd47326db","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ce5b42c6-7200-94ff-bbf2-a3b8fb9eff83"},"authoredOn":"1991-10-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"59e8e584-2ccf-4383-6b65-d60bc1d8fcf1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f97534ef-1347-336d-5f4f-29b5977d96c6"},"authoredOn":"1988-02-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5a00d916-19ae-5fa9-b40b-1ce447cc5c61","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ea2f4549-df34-6faa-c499-27e909d1e05d"},"authoredOn":"1988-02-19T03:13:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5a3bc48c-4f4c-0bfd-183b-671edfa79db6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/5bde2d4d-3068-9054-b1fb-a1e6a0a2d6b0"},"authoredOn":"1985-07-15T13:06:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5a3fef0a-b2a8-1e2a-1793-331393ff16ee","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8594ce9c-239b-a11a-fadc-664940386b91"},"authoredOn":"1981-01-03T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5a72fe1c-5c85-fbfe-9cf9-ac7473c03e36","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e854563c-6e4a-3877-f877-9b5411738527"},"authoredOn":"1985-12-09T17:30:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5a82dafc-969a-7c99-9713-c5706c28753a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/abbe1a1a-4181-8a9b-ff0e-cde76a2debae"},"authoredOn":"1987-01-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5a98c797-acf1-01e4-0bb5-b6d6d1509827","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/56c2517f-4180-2027-ced8-2dfa7c863d0f"},"authoredOn":"1978-05-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5b16240c-c8a1-e756-cdc6-f3ded91bccc8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3d14ec07-d167-8e78-82b0-408f046caa54"},"authoredOn":"1971-03-13T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5b44c92f-9a64-80d0-5b40-0bfc55b28744","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/996ef1fc-6beb-1d3b-050d-99d749965641"},"authoredOn":"1986-12-10T18:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5b555842-d87d-f7ce-6440-89a52d84387c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/7215c384-da46-883e-4873-10a0f5f9a749"},"authoredOn":"2019-09-17T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"5b56e58a-f93b-d8e7-3590-c1239beb8cd2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f97534ef-1347-336d-5f4f-29b5977d96c6"},"authoredOn":"1988-02-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5b74ead1-3546-5168-c8ce-ca73a5e534a7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/23b5af3e-8308-47f6-c9ba-3adcc9a50a0d"},"authoredOn":"1980-12-06T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5b8426ec-72b2-d626-c183-3ce68aeae8fc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f613df25-6c10-573d-8eb2-f00550ce35c7"},"authoredOn":"1989-07-05T07:22:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5bd6e026-4b46-0eea-78a8-d3cda55fbb54","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fc729a69-051c-c3a0-8826-1f2fd48f1998"},"authoredOn":"1970-12-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5bdc701a-5dc2-38a5-b511-9abcc64fa612","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-07T05:18:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5c0faa67-bbf1-7110-9a90-21f961902972","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cee31f43-4768-4bc3-00d5-1d8739196e18"},"authoredOn":"1985-09-27T12:14:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5c27a56f-f030-5a17-e222-be5843603439","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/34e2a584-f356-807b-a443-faa1d20e213d"},"authoredOn":"2006-01-09T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5c81385b-6378-cf70-9de5-55f25a1097dc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/895a94ae-e6bb-ea8b-527e-d52bdfefabcd"},"authoredOn":"1979-11-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5c8ed828-19bd-811c-55ed-ea5c010f0613","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e2f410cf-ca83-834f-1c05-2db1d441643f"},"authoredOn":"1987-05-22T11:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5c915bbb-a581-0c07-131d-91e17663a9eb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c544ddd4-ef20-096d-a655-ab0ce01b2cab"},"authoredOn":"1985-01-14T14:02:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5cd11af6-6aa8-6467-6b5d-d6850b41e541","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/73488f7c-a2f3-4e99-4a28-417a01ed6930"},"authoredOn":"2020-09-22T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"5ceaaa87-6078-1562-66cb-a27f7e5aeb3c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f138c75b-05dc-58ec-6842-14f1e0b29905"},"authoredOn":"1988-01-03T07:33:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5cf28995-177c-f091-dfa8-6c09d08955e3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311989","display":"Nitrofurantoin 5 MG/ML Oral Suspension"}],"text":"Nitrofurantoin 5 MG/ML Oral Suspension"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/db2357c4-3c22-43f7-2182-8770bbfd7289"},"authoredOn":"2014-11-12T21:45:24-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"},"reasonReference":[{"reference":"Condition/9f2e1f92-3b7e-cb46-db86-19117bd600aa","display":"Escherichia coli urinary tract infection"}]}
{"resourceType":"MedicationRequest","id":"5da2f705-eaf9-ee6e-9a14-548b68b11654","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/73ce4e66-4aa7-350d-4425-5069a0d7d3e2"},"authoredOn":"1985-09-16T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5dad07d4-65c3-da29-b3a8-d350df2aac5a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/902d22e4-48c9-047c-f777-5a54b5c324b1"},"authoredOn":"1987-03-14T13:32:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5df22937-3ce8-09e0-57a4-2cc4a9fe9dd4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2e8e22e0-3961-a80b-223b-0a01c5297618"},"authoredOn":"1983-01-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5dfaeae1-62a0-9856-cf30-046c59aa8170","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a16935a7-b48c-f4f8-244b-f0a4f8b8461e"},"authoredOn":"1972-01-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5e018d77-13dd-50dd-f78c-ce89db6b0771","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e1281088-ff4b-01e7-bf07-43568e3fd65b"},"authoredOn":"1971-07-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5e1319ab-391d-e706-8d4c-7686ae5aca37","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/9845a926-976b-5890-08d4-da53bddf3f20"},"authoredOn":"1985-10-16T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"5e298585-285b-4508-c97a-a60aadb97e88","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/343b0ad1-8bec-e92a-eb78-23be4f2c6fff"},"authoredOn":"1987-09-23T05:18:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5e7703ba-9876-f502-5017-0c0aa15291ed","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-02T07:16:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5e9f6c93-6e4b-2f67-5e9d-a372f9d36176","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/15edf509-e940-91e6-ba03-b9fc023d4afa"},"authoredOn":"1987-08-28T23:37:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5eafba15-9571-5b24-7483-8b4b18c040a0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/36709aa3-82be-8c34-c3fe-4b7271168ff1"},"authoredOn":"1988-05-31T12:32:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5ede517e-fcf4-3eb4-1a16-55b7e8ecde75","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/317c4da0-e054-c098-7930-a3e992bff305"},"authoredOn":"1985-02-09T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5f421f9f-4f2a-a1e0-cfaa-76fc244ba3cc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ed9be604-d6d4-a97a-fc25-b544112c3f75"},"authoredOn":"1983-04-23T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5f7310e7-0514-3bbd-df1f-80afde0aa3a3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/02537913-426d-ec2f-456e-6cc8b7a25704"},"authoredOn":"1990-02-18T22:31:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5f90303b-7371-cc79-05ee-f989802ef167","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5b38bd17-9cea-95a9-0207-2b6ffeeeb66f"},"authoredOn":"1986-07-22T14:52:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5fa2477a-e8cb-f862-9800-7165d9513640","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/524a71b0-6a52-5b88-f2f8-f6abb0521534"},"authoredOn":"1986-11-06T09:24:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"5fc0cc71-ce05-4b06-7803-91bcb7d3e852","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/37380948-34d2-53ed-4206-1b5d436f8f25"},"authoredOn":"1990-10-24T06:02:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6006c6d3-5252-b782-717a-a63980185084","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/300de0de-0063-0fc0-67b2-a35ba7836c11"},"authoredOn":"1987-09-08T19:55:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"602860b1-b11d-d240-3384-419aaff3587c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9027d918-9232-f6f4-901c-40729d07d4dd"},"authoredOn":"1980-03-15T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"606214ac-5662-189d-d4e3-1707da5b021c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/680d1696-abc3-9080-1ea3-d5d698f493ac"},"authoredOn":"1990-04-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"60807ccf-90b9-3665-13a6-22bb53a17433","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c9361eff-87eb-660a-0932-8b74945b2d4f"},"authoredOn":"1988-01-12T10:59:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"60bf4a49-de61-38e2-8055-12200c4d6ca0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/904f5d11-d7d9-e0b3-b3e4-992d11f49523"},"authoredOn":"1986-06-05T03:18:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"614e9eba-39a3-e176-9959-acf5c52dec64","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2a6b2529-6b90-c748-e1c7-75f753832701"},"authoredOn":"1989-06-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"6159ed0f-eb9f-1f25-5263-91336ffda2c5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9759a722-e802-3e6d-f3ee-96910894e65e"},"authoredOn":"1988-04-21T16:18:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"61801f17-0fb4-d94f-f5ba-8b0ddf02698a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fa24bfd1-4982-2329-50d0-97b7ced5edb7"},"authoredOn":"1987-10-23T13:28:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"61b012df-282d-2be7-d215-38a30d2449dd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f138c75b-05dc-58ec-6842-14f1e0b29905"},"authoredOn":"1988-01-03T07:33:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"61b9af88-2f3c-2e60-b3dd-179e6396ce17","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/48e6ad35-125d-ecae-13e6-0ccb68dcf9b1"},"authoredOn":"1990-10-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"61e51f7d-d667-0784-79cc-6d6fb7c6e9a3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fd43b9ab-745c-d210-1ad4-d3ce6930f4e0"},"authoredOn":"1990-06-27T08:37:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"61e7df97-7189-d55d-b2d6-d86314210cfb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b161f928-b483-d254-39e1-499f8c416fab"},"authoredOn":"1988-07-09T09:31:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"61f58aaf-38f6-3fb0-59e0-cb69c5c51c4a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/39b4efca-f8e3-d3d2-9d36-e0d40713fa85"},"authoredOn":"1978-04-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"620a38a8-82a6-b5b7-0351-1e0d5404f7cc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/957c196e-3e44-61b9-2cb2-c521c61e43f0"},"authoredOn":"1988-07-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"6251d9d2-1322-e992-74c1-a0e0a39c30b1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-08T14:36:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6296c482-bc40-8d17-7349-c91bb49f8037","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/19f50b4f-83a6-1477-3195-b0669b7c66f2"},"authoredOn":"1980-08-09T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"62a3bb44-b196-ac46-9b38-c426f76a4265","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a6a1ebb0-30ee-d7b8-9283-8ee6c7e2deec"},"authoredOn":"1986-01-05T03:42:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"62bcfe1e-c151-5b15-7942-c651bbfd8e57","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/511eb1ed-0d22-7db7-a6a4-1370ee5a96f5"},"authoredOn":"1989-01-11T22:06:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"62d46134-c7cc-7a26-24c5-7c78238e127c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-04T12:40:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"62f1b2b4-d2be-8a2c-d238-95a44c211061","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/04630c0f-5e9c-c52e-8f1e-d056f6281e9d"},"authoredOn":"1970-09-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"630eb12c-01e4-9ef7-4b73-56a6afdbfa37","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7bceafae-e37c-7bc4-6713-2fabc0d43519"},"authoredOn":"1971-11-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6323963e-cd31-ab66-1727-692f15816344","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/78f6a088-b6ec-c960-04fc-ad04f2707eb2"},"authoredOn":"2018-09-11T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"632bd86a-bc13-7ece-a422-b64f5413550a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7bf633c-a68f-a530-fc60-6150abc1cf18"},"authoredOn":"1988-10-27T02:12:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"632dd512-9912-e64b-1b14-2ab93f4b4691","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7d584e49-4f06-2a64-d497-1a98c7118c12"},"authoredOn":"1981-08-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"6331998b-4093-9c2a-de6b-5ff817dd03ad","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cf89eeff-fb89-2ddc-1a34-41706b0fffd8"},"authoredOn":"1984-09-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6401d6bf-1399-6188-7682-ad5e633a0ad5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9b916350-fe45-5f1e-f7c4-341c03781726"},"authoredOn":"1976-09-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"642b9abb-a65d-82d5-5eec-67c9ef5ba0c3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/5360923a-f812-9b28-333b-6ab9aba51c51"},"authoredOn":"2004-10-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"64a7eb5e-8eb5-56a3-f877-39df10e53373","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/220fdc78-4a69-58f9-ed50-e96c7475f719"},"authoredOn":"1987-05-13T02:36:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"64e086af-5c76-69ac-4476-5ea93c7116c4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1c21a20c-788e-1052-d488-3c9ff2b31b98"},"authoredOn":"1971-07-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"652e6cd1-e95a-90d5-b290-7d8a2ccac1da","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4446656d-16bf-e39c-9201-3f1ab31e7194"},"authoredOn":"1990-06-14T21:12:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"65370b77-e7e1-b411-4b5e-cab8630761b7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-21T18:45:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6539d890-77c7-3a44-0737-dcfd96163832","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a3922017-1040-60ee-fed6-ff00fac9958f"},"authoredOn":"1985-12-08T01:31:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"653a428f-f2be-72d4-c0b4-97f68c99af8d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/29ef6d7e-09de-b1ca-196b-3ea2f102ff21"},"authoredOn":"1986-10-09T05:35:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"656f0d83-0546-ff09-375c-6dffd9f33456","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/511eb1ed-0d22-7db7-a6a4-1370ee5a96f5"},"authoredOn":"1989-01-11T22:06:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"65784621-5b42-91fa-91e4-9f5e8b1d5b7c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-15T21:22:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"65a6265a-ab79-f670-2e2b-68af91566764","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/299f643b-18ed-7b1a-4dcb-0800339efe96"},"authoredOn":"1987-07-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"65c83afa-c25a-2001-213e-7ba4da2ba0ed","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-09T15:32:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"65fe95b3-405e-6dfe-518b-e34c886cec32","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4c280e23-6da6-6956-28f4-6272bfb638a3"},"authoredOn":"1989-03-07T11:07:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6612e905-34c9-48df-6462-50f8fac736da","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-28T21:32:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6626f6f2-63a2-4afc-1c4e-ecf1858d5de5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b7614bb8-2905-1807-2eb9-b94e2b513986"},"authoredOn":"1972-01-29T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6676f67c-c44d-7b1a-d5a3-7447f412872c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-17T10:37:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"667e1430-680b-5135-a897-dee39c57a9f1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/641cec00-201e-e10b-ac70-84044e402201"},"authoredOn":"1980-08-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"667fbb44-e873-8a3a-a1f6-b3615e8fff64","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/10815fed-3432-54c1-b955-a80783d0ae79"},"authoredOn":"1982-01-02T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"66875e20-b7a7-57ac-0863-aecce99c9587","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8ffcc256-9010-0f7b-31df-89fcde87b81d"},"authoredOn":"1989-09-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"66995b71-117e-c2ab-285b-9de599484e64","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/93d4cb1d-1cdd-411c-33a2-7c11e021d660"},"authoredOn":"1988-07-21T20:37:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"669b2143-61ac-5352-1db6-acc25a5832e5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ddc2a3cc-42bc-ad1d-bc35-9a9a9bc936c9"},"authoredOn":"1986-03-31T10:19:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"66e46d2a-bbb8-7e60-106b-0f328b2ed422","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-20T05:12:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"66e7ad5a-0461-80bc-5457-f08448e7a536","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad3dabbe-dbb1-144d-1888-82f9b42c89bc"},"authoredOn":"1980-01-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"66fbe3ba-5190-d615-486e-3cfd86ce74d1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-20T09:40:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"66fbf993-336e-b01a-b0bd-b3b33e2d0f38","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/85257ca3-c476-ee24-cce9-6df4361b18d4"},"authoredOn":"1985-12-23T16:18:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"67566a0d-52f8-eb70-307f-03463b4441a2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7bf633c-a68f-a530-fc60-6150abc1cf18"},"authoredOn":"1988-10-30T10:23:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"677421f4-1551-dad2-dc50-71b98a68adc0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3b496422-7540-9674-dc68-916cc47b22eb"},"authoredOn":"1990-05-19T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"67899057-b429-1566-9908-64174a6784ba","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/87e977d8-d0cf-82a2-bda7-4d2f2ab0e674"},"authoredOn":"1983-06-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"67eabd75-4e24-a7e9-35f7-44e98a148a8d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4b6d5065-ca02-fe22-bad7-431dbfd3ce90"},"authoredOn":"1988-09-03T13:27:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"684b223d-4f10-e073-1e1d-bc543878190b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/02431a0e-d934-755d-345d-f4d6324cfb98"},"authoredOn":"1988-03-19T04:07:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"686372eb-30bb-4f0a-bdfd-3d5c4a452f01","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bf09f876-309c-0f4d-405c-052d8bc2f65c"},"authoredOn":"1971-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"687ca5d9-51d8-b2ac-131b-6e64ba59ada6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/12e619ce-dd32-3737-71a8-0b36b4388588"},"authoredOn":"1988-11-07T18:00:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6886eb0b-f135-814f-fc3e-40612937d868","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d6845aae-7b70-fc6a-b1d3-794f83e49fbd"},"authoredOn":"1986-12-19T22:04:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"688a0472-8fcf-6eb1-4d13-e628cb6e9259","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d2e411f8-1b9e-374f-6c9d-fe1f54f7d745"},"authoredOn":"1984-08-18T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"68d376f1-12ca-b981-62ae-acb3c71f1e84","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/5bde2d4d-3068-9054-b1fb-a1e6a0a2d6b0"},"authoredOn":"1985-07-17T17:51:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"68d5be41-5420-e5aa-d696-49b536059c30","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7d2e0052-d426-2b7f-8378-2d0dcf059ef0"},"authoredOn":"1971-05-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"68eddc2c-42f2-9146-8a08-a02276d8d8a7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/da2964c5-5155-c309-5656-421e4fe9f60e"},"authoredOn":"1980-11-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"692c25b9-0ce1-8419-7c39-b61020fa7581","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/da2964c5-5155-c309-5656-421e4fe9f60e"},"authoredOn":"1980-11-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"693697dd-f2fa-661e-46b5-05d6e8efd56a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/3d16693e-2a09-b1e4-9fdb-08a545ed55cd"},"authoredOn":"2015-04-27T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"693c145a-84e2-5f11-fdb5-3264bc43cfad","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/12ff474d-b388-59a9-fc3d-c2357e37f9d6"},"authoredOn":"1986-05-10T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"69416a90-bee4-feb0-e653-6d9b3371f93e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a27150a7-8d34-baf1-c19e-d04ec5b9a912"},"authoredOn":"1990-05-10T21:31:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"694d9d94-a27b-4158-d921-f1be91ed48fd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/98e1f05a-1b22-3a15-fced-1da98785dae2"},"authoredOn":"1987-07-30T13:34:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"69544b51-f699-6162-783a-a4d27f7cd62f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-17T01:34:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"69b442b8-d3a4-3afa-a60e-774b5bb49acb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"209387","display":"Acetaminophen 325 MG Oral Tablet [Tylenol]"}],"text":"Acetaminophen 325 MG Oral Tablet [Tylenol]"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/6dbcda3a-0d7e-8561-a96c-036fc3ed5743"},"authoredOn":"2021-09-28T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"dosageInstruction":[{"sequence":1,"text":"Every four to six hours (qualifier value)","additionalInstruction":[{"coding":[{"system":"http://snomed.info/sct","code":"225757006","display":"Every four to six hours (qualifier value)"}],"text":"Every four to six hours (qualifier value)"}],"timing":{"repeat":{"frequency":4,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"69c6034f-667a-712f-3a50-525b1a2fddaa","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-18T13:50:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"69dee31f-2d8a-9e99-7ce9-63cdbb57a604","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9759a722-e802-3e6d-f3ee-96910894e65e"},"authoredOn":"1988-04-22T20:03:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6a22c99d-2ae7-d348-be96-c4610e114dab","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/f123d294-7425-d90a-ce6b-16bae7748521"},"authoredOn":"2013-12-21T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"6a52a7a5-4341-ec5e-9d23-baff051a3db0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d5436a54-796b-4344-2b12-4652dcba3aaf"},"authoredOn":"1988-07-18T17:42:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6a978a68-4c57-014e-49c7-d84b0c6f5e90","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/66a77384-edad-72ea-d3c2-5dff004dfb71"},"authoredOn":"1990-04-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"6ab5da79-66cd-8e7a-5b3f-0cdca8a90238","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/511eb1ed-0d22-7db7-a6a4-1370ee5a96f5"},"authoredOn":"1989-01-15T07:05:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6acefc1a-774e-1ae3-267c-a8759b0b63d0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"831533","display":"Errin 28 Day Pack"}],"text":"Errin 28 Day Pack"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/df074e76-919e-9a04-8dd8-44bcefcd538b"},"authoredOn":"2018-09-19T14:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"}}
{"resourceType":"MedicationRequest","id":"6b15603c-d415-6695-6743-8d72e9378c1c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0581cdb2-b230-2e8e-b958-3a57d7ebb498"},"authoredOn":"1986-10-15T12:17:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6b340193-8560-78fb-669d-cc61cec0f8b8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8fd35431-1d98-f0b7-e4ea-06613d3a9422"},"authoredOn":"1988-03-31T02:21:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6b420af7-333e-2af5-4aff-686380bf14e0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/97c65cf1-9090-4826-cb5f-17f3cf30b265"},"authoredOn":"1989-10-21T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6b4e502c-21c5-3cb1-4674-90df972cda17","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/61e0cd05-b2c5-f6c4-3fcd-4e837bdba356"},"authoredOn":"1979-07-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6b657d4f-1751-b07d-db89-b4fb6a36a8f9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/af783a30-d305-ead3-e25c-2a453a94e428"},"authoredOn":"1989-10-07T09:02:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6ba12a27-6b46-f719-d53a-6fd8e58cc7d9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-18T01:33:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6cb8973d-9a2c-740a-5d2f-b27dc6dd7517","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-06T07:00:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6cc68266-ea99-2b9f-1a6a-ffbdbc89bbb0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3467c7c1-750d-d238-10ae-47453cde0b0a"},"authoredOn":"1981-09-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6cc9aa77-e530-ceeb-8057-8075e55c48b0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d1d1009e-0dbf-3993-5d56-1283a211e07f"},"authoredOn":"1987-03-05T14:02:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6cd43176-389c-05da-4524-2f2f1421d882","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d6845aae-7b70-fc6a-b1d3-794f83e49fbd"},"authoredOn":"1986-12-18T18:34:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6d412bd5-b43a-7376-e77f-2ecee098722a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/efd68eda-8350-086f-0fac-3ee0ba1e320d"},"authoredOn":"1989-02-18T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6dcecf66-6cde-d871-78a1-5bd798026cd0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/a4a401d1-a46a-eb4a-8a38-760d5d79d6ec"},"encounter":{"reference":"Encounter/ae6eb9a6-1d5a-eb32-f420-4bfd5ebaba1b"},"authoredOn":"2012-12-11T14:54:55-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999999698","display":"Dr. Bobbye345 Wuckert783"}}
{"resourceType":"MedicationRequest","id":"6de10500-ebd3-f212-8903-662119daa284","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9481d91f-9cbc-78b7-c28b-56827a6c20f3"},"authoredOn":"1978-12-16T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6e58610b-ceeb-118b-94aa-c51f6dae1b9a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7a078dc9-3a04-8433-08ba-426517453f6e"},"authoredOn":"1987-08-10T03:29:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6e594125-26fd-e6a9-2294-3cc2474a80c2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/63217c04-c3d8-6144-9c78-3b2e97994a45"},"authoredOn":"1979-09-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6f0e45ca-7c01-446a-c6d8-f36ede3f8f26","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/511eb1ed-0d22-7db7-a6a4-1370ee5a96f5"},"authoredOn":"1989-01-15T07:05:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6f7e4873-1919-9732-7ec5-58ccb906e177","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/41d2ea35-44a9-2b7a-df42-23707eef2af4"},"authoredOn":"1979-05-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6f90417e-85a4-aab5-9636-3f0409a519ea","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c218469e-5f70-bc7b-cc1d-14bb60527c8f"},"authoredOn":"1988-03-12T08:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"6ff83324-5559-1137-4e94-8640f5280089","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad9ac519-9724-fb5e-b17b-312065a2e14b"},"authoredOn":"1981-08-08T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"70372550-776b-3337-a6c9-e68a9e7a8811","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cd12c54f-c76b-4b21-ff97-4222abc69d89"},"authoredOn":"1969-05-31T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"703a0247-3250-3b97-46ec-6c744d5aa951","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6d64ee3b-f414-47d5-bf91-c687800b9293"},"authoredOn":"1984-02-18T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7045b271-624f-a23c-ae7a-87faefbcb992","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/63f6a52f-208c-8587-9313-18ae5ecc573b"},"authoredOn":"1982-12-25T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"70ae00d4-4fa0-9931-3b50-34d2f8e17eec","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ccc50e70-bfb2-8f75-3e8c-4c6d087709ff"},"authoredOn":"1988-12-13T13:10:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"70c163bd-cf03-071c-f8c6-05f0c353e004","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9759a722-e802-3e6d-f3ee-96910894e65e"},"authoredOn":"1988-04-26T02:52:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"70c80681-f54e-00a8-7138-279d2b2496f6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d2e411f8-1b9e-374f-6c9d-fe1f54f7d745"},"authoredOn":"1984-08-18T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"70ccb53c-5f48-b919-35b4-dac687ece23a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e9126d61-103e-afe3-5aef-b758ddb8d071"},"authoredOn":"1982-09-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"70dcd412-9670-0cf7-ae75-cd1a743a93ea","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/530969d8-c3ea-6fa2-b0f1-c62cc3c20092"},"authoredOn":"1987-06-21T09:44:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"70f0b804-5271-8ef8-44b8-4f0d32e481f6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/760e8a4d-7814-841b-ed55-e5aaaab6f8f3"},"authoredOn":"1988-06-05T03:23:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"71401c85-7c29-236e-f74a-be30abd5bc91","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/904f5d11-d7d9-e0b3-b3e4-992d11f49523"},"authoredOn":"1986-06-07T10:08:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"714c5ee9-6310-4376-0be3-2d6e3fcf6bff","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c841374b-dde4-6602-fc0c-1c136e854c6f"},"authoredOn":"1983-08-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"71aec594-06ab-4715-2ab7-e506a978df62","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/874982d5-4bc9-fa70-888a-827c3b02e207"},"authoredOn":"1987-04-12T06:02:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"71d84cbc-0b26-a64a-aed8-2d1e3b8028f8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/de6c46e1-1eea-b832-7eed-15e249b38143"},"authoredOn":"1988-08-25T04:52:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"71dd316c-8e28-7516-2275-74948dce4467","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/e43ae69b-4762-fb95-0117-ac1224bac0b2"},"authoredOn":"2010-07-27T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"71f1ee45-9aa9-091c-0b26-413645224a6c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/1c63885e-92a3-23e0-4384-fbe4a4e37e1c"},"authoredOn":"2003-12-29T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"723da87c-9d05-c09b-d467-ae3b63264266","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/84ae1a94-4233-96ed-a54d-e87c6ca96287"},"authoredOn":"1990-02-03T06:39:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7254a6c7-b0ca-c62d-249f-2b03fddda7e1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-23T22:22:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7262b966-98c7-f80f-f5aa-d4fed93e78eb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-18T19:09:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"727badcc-767a-71a0-1a09-4e031bc82d49","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-08T11:00:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"72c5f19a-7a0f-37c4-ec1c-55704e2083eb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-26T14:55:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"730c1cce-4b15-34da-a576-f3cc1df7efae","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/02431a0e-d934-755d-345d-f4d6324cfb98"},"authoredOn":"1988-03-15T21:36:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"73521fe6-8f16-12ed-4d5d-6a8485cad9ba","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5023ffe0-c286-e2f8-c966-e1d09b16da29"},"authoredOn":"1990-12-09T01:20:17-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"735ee1d5-6605-4e46-d4d8-0c4c054cc8aa","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-10T04:47:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"736136df-7269-03ba-a365-530999da06bc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-28T21:32:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7378e49e-905c-b38f-46f2-aa61eede7366","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/61153974-75c6-372b-e09c-b4fb070b40d9"},"authoredOn":"1981-05-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7380b9d2-bac6-3120-b354-e1ccbf073e30","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2e376b26-c4e5-96af-d1e7-ea4808adcf29"},"authoredOn":"1990-08-18T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"738cb9b2-bed7-7f93-51d7-993241590a4b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/379e1434-8147-4892-f8c0-3641e0c5d3ff"},"authoredOn":"2021-07-07T14:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923995","display":"Dr. Johnson679 Schmidt332"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"73ee86d1-8846-6dc6-ab1f-7fa66b9278b6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-04T02:19:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"73fb3424-c58a-4671-9ef4-60adb572c48b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/20c37e5f-e4e8-6e82-cdaa-be39b6e49fa6"},"authoredOn":"1996-11-18T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"74214990-179a-c45a-11ea-3233bdb0ff36","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5d308c38-50e0-539a-f411-a6829246de71"},"authoredOn":"1990-07-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7435e1b5-604c-da26-5013-f60ee32cc1c6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e0ecaaeb-75e2-32bf-0529-0ffca8573a6c"},"authoredOn":"1972-06-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"74827edf-275a-3d6e-d56d-e35106c286db","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1043400","display":"Acetaminophen 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution"}],"text":"Acetaminophen 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/11ba7c31-1f5f-5684-915b-01ee24350c0d"},"authoredOn":"2015-04-20T01:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/7ae693a4-d462-206a-7816-2d7d3078eda8","display":"Acute bronchitis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"74b7825d-81b2-ab2a-0b20-3b4f2d741ca5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"308192","display":"Amoxicillin 500 MG Oral Tablet"}],"text":"Amoxicillin 500 MG Oral Tablet"},"subject":{"reference":"Patient/bb6a9034-2f23-2508-d29d-35efee156dc9"},"encounter":{"reference":"Encounter/7c06da55-ee8a-be57-3925-7636c1fbe57d"},"authoredOn":"2019-07-02T19:52:10-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974196","display":"Dr. Natisha940 Bradtke547"},"dosageInstruction":[{"sequence":1,"text":"Take at regular intervals. Complete the prescribed course unless otherwise directed (qualifier value)","additionalInstruction":[{"coding":[{"system":"http://snomed.info/sct","code":"418577003","display":"Take at regular intervals. Complete the prescribed course unless otherwise directed (qualifier value)"}],"text":"Take at regular intervals. Complete the prescribed course unless otherwise directed (qualifier value)"}],"timing":{"repeat":{"frequency":3,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"752d4fd7-fd16-6b52-c87f-2571f4964c43","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d6845aae-7b70-fc6a-b1d3-794f83e49fbd"},"authoredOn":"1986-12-19T22:04:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"75331a9d-e169-8ef2-25d5-7349faef5703","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a4798c34-c8b0-79d4-3776-ec557c11b469"},"authoredOn":"1974-07-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7534c623-5673-a0a8-793b-ba65645d6c42","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ef85e2bf-9f34-930a-e7d0-e316ae5aedb3"},"authoredOn":"1978-09-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"758037bc-9de6-d9ef-ae46-805c7cc92789","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/c313030c-17fe-c771-1182-b93ff0acf6e4"},"authoredOn":"1994-11-07T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"758cf0d3-2bfd-2b95-2b54-bcff6ba3591e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-01T05:38:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"759c053d-1107-6342-628b-3edb60d651fe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7bf633c-a68f-a530-fc60-6150abc1cf18"},"authoredOn":"1988-10-30T10:23:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"75e5fc54-6555-e731-b0c1-24e56f145a3e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1e0b70d1-174a-2f1b-ce4e-ccfd86b27936"},"authoredOn":"1986-12-20T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"75f1a7c2-b62c-70b6-649e-f6dc15d9cc85","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/91573545-d5df-0c70-1483-2f459c727aec"},"authoredOn":"1983-07-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"76698114-7873-8e56-f339-74520285f782","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/dec80c66-daf8-e6ef-627d-868e0e03ebf2"},"authoredOn":"1970-10-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"76830cf4-81c0-5392-592a-e4a2cd62b53a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1e89cab9-556b-677d-0484-053878851183"},"authoredOn":"1986-11-15T18:43:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7694320f-2157-7552-4e08-54810702b3fb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad3dabbe-dbb1-144d-1888-82f9b42c89bc"},"authoredOn":"1980-01-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"76de9aa7-a6ab-32ec-1f4e-1bc43c85092c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8d82f0e1-7a79-35f6-c48f-4dd5356f547f"},"authoredOn":"1971-09-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7711c886-3d1e-ced3-4178-2727ef7b0667","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-11T16:51:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"771ed759-67b0-6175-2724-3b1c55a1be60","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/abbe1a1a-4181-8a9b-ff0e-cde76a2debae"},"authoredOn":"1987-01-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"773acb22-d032-427d-d12c-e981ac25b9a3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/aa6cc40c-55e0-eb2a-c50b-bed116a81ced"},"authoredOn":"1985-06-14T20:18:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"775a6695-a9db-bf32-e421-2bdfd2cb1674","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/82754954-f2ae-6f74-65c0-1b8e7610ce26"},"authoredOn":"1975-07-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"777f4827-1d2b-5c6d-67da-46e15624e802","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313782","display":"Acetaminophen 325 MG Oral Tablet"}],"text":"Acetaminophen 325 MG Oral Tablet"},"subject":{"reference":"Patient/8e1a0a7c-e308-444b-075a-3c2b1f60f881"},"encounter":{"reference":"Encounter/f89f1000-40be-18d3-4d67-79d410362a91"},"authoredOn":"2021-12-01T11:57:01-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999907691","display":"Dr. Karisa693 D'Amore443"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"778b2461-9c5c-1153-afda-3dbb4b2a676a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bf09f876-309c-0f4d-405c-052d8bc2f65c"},"authoredOn":"1971-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"77936222-0258-de18-54af-e476f821849f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/847c1436-1f57-7683-5bc9-666ac9273bf5"},"authoredOn":"1990-06-30T10:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"77c38086-33fb-464e-09fa-8b63f13b5cf5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-28T19:50:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"77e56e6a-57df-476c-4184-a74cf4698ac2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b8fb3635-6ab0-79c6-7ed8-1aa08dcd6937"},"authoredOn":"1986-10-01T01:23:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"77f1b7d4-076e-120f-9752-9478bab40576","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/069d7ba8-1095-ae4f-41f1-e7c9a8dd14a6"},"authoredOn":"1988-08-06T11:02:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7853fc69-170e-afb7-61cf-4ca5a1558300","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/31329fdc-65bf-66a5-95c9-f86243d52152"},"authoredOn":"2012-08-07T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"785f3eee-edc1-9460-268e-8f7f4b73e170","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/57634bbf-95b9-9183-c8ac-5cc7f30b1f76"},"authoredOn":"1987-12-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"78609786-7eb0-3fcf-fc18-989870add957","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2f7f1876-8f53-fc82-d470-8403d6252131"},"authoredOn":"1989-04-02T01:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"788c07af-3e94-9754-eec8-40fffc30abc8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/56f8e782-d959-0cda-6d5e-7f71b9b6aee2"},"authoredOn":"1989-11-10T14:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"78955ed0-156a-5289-dcdc-3397232eecd4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1c979062-14f9-3170-dea6-6e263ec5ddc4"},"authoredOn":"1979-08-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"789d1817-8046-542b-deb8-89da8450090b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-11-06T07:42:57-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"78d5e581-7914-f715-82f5-93c21357d098","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/025ac45e-1977-4ee9-f881-b6d5e31e5434"},"authoredOn":"1971-09-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"78da776e-c4b7-3578-63ac-718646725064","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/67a3cc17-768a-ecb4-7d54-a301ae1b0984"},"authoredOn":"1987-11-20T15:15:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"78ef250c-b20f-fe82-dae8-8c14a96d652a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/234425d6-07a3-2fb4-48cd-f0c90996ed52"},"authoredOn":"1983-10-08T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"78ff5ca1-8569-cee8-0de8-7c2c99362a3c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7f7bb6c2-d504-33fc-4bbc-69426f2d1ec8"},"authoredOn":"1981-10-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"79118db4-5532-6703-721a-44b669e71d06","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/36709aa3-82be-8c34-c3fe-4b7271168ff1"},"authoredOn":"1988-06-02T14:50:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"793ab534-27f5-4b5f-55ad-7df59b0d89ec","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/87803bbb-84d4-ca0e-40a0-7ba024a7a6ee"},"authoredOn":"1986-08-17T03:57:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"793b7e58-cb28-4d69-64a8-26ab295b30b5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"749762","display":"Seasonique 91 Day Pack"}],"text":"Seasonique 91 Day Pack"},"subject":{"reference":"Patient/bb6a9034-2f23-2508-d29d-35efee156dc9"},"encounter":{"reference":"Encounter/097483fe-cfd2-f74d-7086-4ce69f77157f"},"authoredOn":"2021-07-10T19:52:10-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974196","display":"Dr. Natisha940 Bradtke547"}}
{"resourceType":"MedicationRequest","id":"79702432-d78b-2916-640a-3f6347f2d614","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f47bd74b-4e96-5a46-59dc-3847d3247326"},"authoredOn":"1985-03-29T06:28:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"79d07f70-86c7-fc8c-13c3-a7d8f8fc7879","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-29T00:46:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"79d0c928-a9aa-146c-405e-c33d9857336d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0b8427c9-f289-1ca9-5369-74c295b2cd67"},"authoredOn":"1978-06-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"79e07e85-14e1-652c-ab20-aabfe91a2867","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/fe051f67-71d8-ae82-fe95-f18ed8590009"},"authoredOn":"2007-10-16T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923995","display":"Dr. Johnson679 Schmidt332"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"79e48b44-f0e7-428e-6a65-3b9c40393cd6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b2ea9444-9fcf-0fd0-d9cd-6f45028e9af9"},"authoredOn":"1988-09-06T16:18:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7a00d5c0-5a7a-b1c6-4beb-36e32f41d44b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c6c6f98a-0b18-c41a-969f-8a1767454fa5"},"authoredOn":"1986-03-18T01:14:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7a201f27-c879-b1f2-34b3-c5c4b7748724","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/6dbcda3a-0d7e-8561-a96c-036fc3ed5743"},"authoredOn":"2021-09-28T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"7a52c706-d2e5-c584-dc9a-65c1725ce826","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/566a3845-208e-b78e-32e4-56b879f36fd6"},"authoredOn":"1971-12-04T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7a75a36a-0aef-68fa-6647-2a5cacaaca52","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-19T08:09:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7a869fa4-2f4d-e134-304f-32576db936f1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/57c0aeae-8cc4-8e4f-5b01-40bf150b5a3a"},"authoredOn":"1985-11-25T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7a938779-9136-4a23-d286-75984f8a86fb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/be25dfd3-79f2-4f46-a828-c2d2ded162b5"},"authoredOn":"2000-12-11T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7ab04ee6-98fe-3139-664f-26967c799a57","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2f9dedb5-c083-afdf-cc2f-075f75cbf92b"},"authoredOn":"1990-09-08T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7ab41671-f545-e905-c4cb-43bb0c2838ab","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7139b964-053a-7f01-c597-f649d561b7a1"},"authoredOn":"1985-06-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7ab7d5cb-7146-ea69-e49a-91207274348e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/56ec4720-cd35-340d-702f-d4461857c45d"},"authoredOn":"1985-12-17T09:44:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7b139e8c-c61f-6173-6af7-af58f5fe72cf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/61e0cd05-b2c5-f6c4-3fcd-4e837bdba356"},"authoredOn":"1979-07-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7b6e7ce2-f5aa-e503-4f44-68307ff77174","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3d11d073-b05e-6349-90ab-d92ed5795f86"},"authoredOn":"1986-08-09T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7b8bfba4-a4ec-40f2-99f3-7562975a99b2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/08cf0db9-d32f-5e67-4830-35efe7964434"},"authoredOn":"1978-06-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7b90f0d2-b8f0-0f9a-654b-8904534d6383","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/2e98806c-2e10-ff1d-407b-8578c53a7115"},"authoredOn":"1995-09-25T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999924092","display":"Dr. Asha251 Grimes165"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7ba4ee51-c224-2312-ff53-31e3b71cf955","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-30T02:25:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7bad1cc3-08e2-7879-46c8-8450187ef39b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/530969d8-c3ea-6fa2-b0f1-c62cc3c20092"},"authoredOn":"1987-06-22T13:21:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7bc1ac25-674f-30dd-0549-b7713d893901","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a4798c34-c8b0-79d4-3776-ec557c11b469"},"authoredOn":"1974-07-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7bc718b5-34c1-1b16-56e1-14b5fc49db98","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-24T07:47:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7bf064cd-ea5a-78a0-54d1-8bc07b4bfd48","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2eb533c4-f5d7-7dea-6681-c09d84e98676"},"authoredOn":"1989-10-10T12:07:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7c4d1fd0-4b1e-27d1-ecf0-c9d888ae880b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-19T19:47:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7c6f1df7-a4ae-8831-8ea5-78cae8071cea","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f7738769-2141-226c-ef76-a1f1d6dc1a23"},"authoredOn":"1986-05-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7c74b72a-be95-a45a-e7f6-15f3a9cebc26","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/52495cdc-ee50-c0cd-f5ed-c9d42f19d6d0"},"authoredOn":"1985-12-11T04:38:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7c90bfab-0b36-0b74-e38e-34b0b501b4d8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ce5b42c6-7200-94ff-bbf2-a3b8fb9eff83"},"authoredOn":"1991-10-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7ca87796-e9ec-3f05-f159-263e95a2aff7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-15T21:22:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7cb5a325-c4d7-f4f5-1879-7034605205ed","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/49994b4b-b57f-de31-353c-ec4484873e7a"},"authoredOn":"1984-07-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7ceba271-ee7b-a1b0-40f0-71d6f71a419b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5af68361-26b5-dc5f-aa78-62ff8134a7d0"},"authoredOn":"1990-01-20T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7d10b63d-5df3-37c4-cd78-dd6668e550d3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/680d1696-abc3-9080-1ea3-d5d698f493ac"},"authoredOn":"1990-04-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7d1f88a6-f129-b61b-2ef6-6060f6a5c585","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-21T11:51:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7d23ef81-d782-569e-de8c-0fb15568210e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ea4f2bd1-c99a-f88d-ae4f-5bbea844bf3f"},"authoredOn":"1987-05-20T19:04:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7d27a6d6-2b50-a4a7-d7ab-e686cc81a883","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-01T16:00:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7d40d7ae-604f-3839-6239-7d0ff97d7b06","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cd12c54f-c76b-4b21-ff97-4222abc69d89"},"authoredOn":"1969-05-31T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7d95d66a-f6e5-74ba-d1c6-670c1138deb2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/214dc6eb-ca71-b3c7-a3b0-334d4d5d05fe"},"authoredOn":"1988-04-06T09:51:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7dad0f1f-dba4-1975-fe9c-4992c7223da4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/874982d5-4bc9-fa70-888a-827c3b02e207"},"authoredOn":"1987-04-12T06:02:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7db96211-4005-815a-c09c-4593bfdfc6cb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/edf87e14-2fe9-be7c-865f-53ca3a349def"},"authoredOn":"1985-11-22T16:47:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7e1b5796-58ad-5d91-6967-ee1277f312c4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/04630c0f-5e9c-c52e-8f1e-d056f6281e9d"},"authoredOn":"1970-09-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7e229a97-1812-226e-797d-330c0516178f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-25T05:55:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7e30837a-b04c-6dab-2743-338a7b0e6cd7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/388c00f2-a51f-3c21-0bfb-a09ced1cd95a"},"authoredOn":"1985-03-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7e3c2a0b-463e-ade5-fb4e-ebbd6368c8e9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/48a9c62b-a992-99a4-b871-42a8200480c2"},"authoredOn":"1988-09-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7e6ea8e0-12f7-cd5d-c4b3-bb78bc101c73","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-11-02T04:25:17-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"7e869163-d370-17ff-cf67-ff3b54dfb9d9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-19T08:09:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7e86a128-1ebb-6976-2b29-08ecb8980106","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-18T05:55:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7e8c8870-2218-20dc-fd43-58eab0980331","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-20T19:03:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7e8e00dd-70cd-7354-7c2e-32c899733944","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/42475904-a62e-bd83-cb6f-e9c54e45d883"},"authoredOn":"1981-05-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7e99a37a-56e3-03a9-a7b1-fda163226c5b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1c979062-14f9-3170-dea6-6e263ec5ddc4"},"authoredOn":"1979-08-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7ea2120b-0e42-41a2-4b76-1f4f4ab50ba0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c20be672-8b7c-f189-4140-0a4b29ac240a"},"authoredOn":"1979-07-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7ea932f7-740a-495f-c121-e3d816c8e982","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e8e0abd1-ac3c-15d7-1982-754eb2d37385"},"authoredOn":"1980-04-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7eab1859-dc7d-394f-8ff0-16f96eb7f108","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/50d68964-cef4-eec3-9fe3-6184b4c63355"},"authoredOn":"1988-11-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7ebf983c-01c4-3c29-6bca-230d78bd610f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ed9be604-d6d4-a97a-fc25-b544112c3f75"},"authoredOn":"1983-04-23T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"7ed5008b-f39e-59c1-7953-64a70cf3a570","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/456c6466-622b-4c8d-8e72-fdffc669e8e0"},"authoredOn":"1970-11-07T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7edaad90-15cc-2edb-c16b-0aa4f43d2a1a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a954dd3c-d3a0-7dfe-7a81-75c29c9f6454"},"authoredOn":"1986-09-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7f0c649f-5117-e39e-3c40-5579ced362a6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/300de0de-0063-0fc0-67b2-a35ba7836c11"},"authoredOn":"1987-09-06T17:16:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7f0e902a-6c74-a191-d202-add3ecbe8a31","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6e02b10d-fab6-c7ac-eb42-98cbdac7ec02"},"authoredOn":"1986-10-27T23:48:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"7f4da252-ac9d-d7c2-f113-7685322e06df","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/d9d247e2-6e08-d51a-83f9-8b8532973b69"},"authoredOn":"2010-11-28T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"803fe92f-b485-f74e-67a9-6983d31716c8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/104d3a3c-6a82-2da7-f0c5-40e4ae65607d"},"authoredOn":"1985-06-01T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"80777453-43b4-cf09-6494-240bb61a32e4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b4b5ea98-6b91-7834-e648-9be4491a4daf"},"authoredOn":"1990-03-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"80f28e00-b797-2b92-5ed6-2c312bc4be41","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/8847d831-a793-e7fb-a195-f90a17095119"},"authoredOn":"2015-12-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8115de38-5996-fb9a-9f23-e64f49ef1290","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/65bf3e9a-383e-e9c8-cca4-9231484a2836"},"authoredOn":"1990-03-28T06:29:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"811b99eb-10ed-0ee2-9d01-4bb887036692","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-12T07:28:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8169dd1a-4d82-4d6d-7a99-9e823167b795","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f34c95b-347f-3f84-587b-7de093dde963"},"authoredOn":"1992-10-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"81d44867-19e5-3350-1945-0b80b5c99c4b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e0a759ba-8636-95df-b3ce-d9259fa61d23"},"authoredOn":"1989-04-14T14:36:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"820fc1da-05bf-d108-a93c-643bd67b305a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4889a0be-9842-019f-c884-ccdc912f2fa7"},"authoredOn":"1978-01-21T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"82cdbc94-2266-d1be-2b32-418136b65dfd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/c313030c-17fe-c771-1182-b93ff0acf6e4"},"authoredOn":"1994-11-07T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"82d9d9df-c8df-bd7f-ea16-b4eceea900d9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ef981f0b-0b02-5e38-a25a-6f5106ecea92"},"authoredOn":"1981-10-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"82ecce82-60f7-09e7-77ce-75da258e11ee","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/48a9c62b-a992-99a4-b871-42a8200480c2"},"authoredOn":"1988-09-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"831b1e30-7ec3-57dd-e8fd-c5b348323657","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/251404ff-2010-6727-38f2-328743064aa5"},"authoredOn":"1988-10-26T06:47:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"834fa17e-ca34-5a50-8d71-a2b63385f362","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/622f6967-115b-0650-376c-d1b4e12598de"},"authoredOn":"1988-03-06T02:34:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"83601de9-7ab1-2d11-4db0-9f6de04f9234","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/8c5e631c-ae61-23c6-6af3-c22ccb1ada7d"},"authoredOn":"1986-07-22T08:06:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"838a9bab-66d3-e6c2-71f5-c25b3d716016","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0311794c-b854-85d7-dd0b-dc090c318552"},"authoredOn":"1977-12-24T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"83a52cff-2dba-7891-a359-c777f99cd199","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fff73e8f-440e-bdb2-2526-399b194502c0"},"authoredOn":"1988-07-28T03:37:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"83ba5ba6-0b05-e782-424c-8faedc93814f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-11T16:57:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8419431b-d296-a673-4fb6-a981ef81aa8f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/00c7f717-4030-5582-2ed8-888ad2bc878e"},"authoredOn":"1989-10-04T06:20:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8436d66b-fde1-12e4-0aac-fcc07bad6d32","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/1a617816-6053-3d9b-dd83-88137dc1cad2"},"authoredOn":"2022-04-11T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"844ecd64-ffa6-18a3-5e23-2132b71309c7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f47bd74b-4e96-5a46-59dc-3847d3247326"},"authoredOn":"1985-03-31T10:51:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"847b1003-05ec-26e1-8351-4c72ee74229f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-24T12:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"848dd9d7-c3cf-b73f-67c3-33232eabbeb2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-26T17:57:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"84a19ed8-16ec-3bb2-8ecd-77d13e264f27","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2335013f-c7f7-960b-ff04-033e4235d5bd"},"authoredOn":"1989-12-05T11:19:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"84cff828-8ab8-f68c-108d-50a3fb75771a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5e236ce9-1b3e-1532-8e8d-75a662b44ee7"},"authoredOn":"1986-07-06T21:42:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"84da555e-d7e8-6586-b940-53c04517177e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/33d1191a-f4d0-5cbd-5f0e-eb379f90ddf4"},"authoredOn":"1987-04-05T14:50:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"84ef4e4d-8a5a-cddc-8d25-6b4f7b6880df","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9481d91f-9cbc-78b7-c28b-56827a6c20f3"},"authoredOn":"1978-12-16T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"84f550a8-a16d-1a09-3815-6fbec6f0b342","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/74886f6e-27ff-fe86-a2c7-cfc883bba4cc"},"authoredOn":"1988-02-12T21:01:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"852210cc-9c01-21ea-5482-09d41dd2b6f2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-10T16:03:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"85400829-0856-7c55-5d57-85502a56681a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/682ad75c-eefe-a37c-31ff-6ed338526a4c"},"authoredOn":"1988-05-10T20:27:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"854474e7-4beb-df1d-7d11-6191bd024e27","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/16960634-e916-1a41-6c5f-1db216ea2712"},"authoredOn":"1987-06-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"85451e33-0b0a-8f23-5d50-548cb24eaed4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313782","display":"Acetaminophen 325 MG Oral Tablet"}],"text":"Acetaminophen 325 MG Oral Tablet"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d768d048-4e5c-c815-ebfc-febb06baad7c"},"authoredOn":"1985-01-26T23:37:17-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999908392","display":"Dr. Irvin970 Emard19"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"85770857-cca7-5c14-75fc-4bfc9f5fb04c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-27T18:41:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"85945690-df7e-9b72-aa7b-a2583b582dfe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f7738769-2141-226c-ef76-a1f1d6dc1a23"},"authoredOn":"1986-05-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"85bc40f8-b69d-335e-14ee-df1639b2e947","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/62d8d424-43d9-d6d4-10b0-b0388ef8453d"},"authoredOn":"1987-06-04T00:04:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"85c24408-dcdc-737e-19d8-379ffee62006","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/904f5d11-d7d9-e0b3-b3e4-992d11f49523"},"authoredOn":"1986-06-06T07:11:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"85c6e1e3-cf5a-5491-b020-61dfbfb62f8f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ea4f2bd1-c99a-f88d-ae4f-5bbea844bf3f"},"authoredOn":"1987-05-21T23:17:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"85c730b8-1f8f-3212-23f8-4030293b4236","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b6b8dab4-4338-a331-4e10-96e40fabdee6"},"authoredOn":"1989-02-10T17:05:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"85cfee58-77e8-9eb4-9bf5-db1b890dd511","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/617be97b-d9f1-7c09-9dd8-e7c321059802"},"authoredOn":"2007-07-10T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"85e299f8-7019-64f8-e697-62e3e8316838","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/607f114c-d060-e290-154f-2fbee20c2649"},"authoredOn":"1986-02-05T12:28:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"85f0765c-b247-ac53-639a-9a9ff626faa7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1f72358c-6996-ff2b-9435-e9fab3722f5d"},"authoredOn":"1984-10-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"8646d418-255c-6dc8-a6b9-6672103e2e5d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/12a98307-6b23-ae45-53b1-35a260462401"},"authoredOn":"1982-07-31T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"8651731f-8d9b-2205-c2bd-b41e3f05f28d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/887af0a5-63d2-b23f-c5fa-1269205d288d"},"authoredOn":"1989-05-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"86790f50-e81c-9e19-031a-2cb389db579b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/f504f2ea-e611-451d-599e-de4ac92c173e"},"authoredOn":"2017-03-13T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"867b957f-b341-9823-82b1-34559997e156","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/566a3845-208e-b78e-32e4-56b879f36fd6"},"authoredOn":"1971-12-04T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"868b31d8-4ffe-a03c-0b03-877dcd0fa8f1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/317c4da0-e054-c098-7930-a3e992bff305"},"authoredOn":"1985-02-09T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"869aa9d6-81ee-0a96-735e-bc3398877613","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-23T09:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"86bdd6a3-e484-bbb9-c95d-43f60d85c7c0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f47bd74b-4e96-5a46-59dc-3847d3247326"},"authoredOn":"1985-03-31T10:51:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"86c9e024-1848-9039-be2e-f744b55dd405","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-27T18:41:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"86e5d45d-8259-23e7-c411-c640539ba466","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/750e3aaa-024c-9144-1c80-c1b07f4281f2"},"authoredOn":"1986-01-08T06:39:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"86ea1b62-2681-cdc0-cd56-4eedc1132b34","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b0356f21-8154-5fc6-c1d2-607efdc07f78"},"authoredOn":"1986-07-16T08:23:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"86f12166-8b60-7508-98d9-1c09dcca1ef7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/060d7284-14ed-bcde-d499-8577d60c7bcb"},"authoredOn":"1990-01-02T07:36:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"87aec2fc-6510-1a2e-6764-f5dc17278fa7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/154c2b29-b5aa-fc20-0500-83aacf9da83f"},"authoredOn":"1980-02-09T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"87c163a8-2ad6-6bff-e1ec-0287f4c36201","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3c0cd75f-6d54-c2d2-e239-fcc37c035777"},"authoredOn":"1989-12-02T07:57:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"882aec3f-c4d4-fa43-f193-c0ccf7311dbc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/39b4efca-f8e3-d3d2-9d36-e0d40713fa85"},"authoredOn":"1978-04-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"88741121-e9bd-de5f-fcd8-bfe00200f6c4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/56c2517f-4180-2027-ced8-2dfa7c863d0f"},"authoredOn":"1978-05-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"888a14e9-952f-23fd-d34c-d3623d716a24","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7bceafae-e37c-7bc4-6713-2fabc0d43519"},"authoredOn":"1971-11-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"88d0ec17-3c9f-6c30-eb4d-f47a8360c699","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9743b88b-8fd2-d533-b44e-bacc6192b936"},"authoredOn":"1988-11-10T20:09:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"895d0743-93fc-3363-94e1-66cda0af74ae","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"834061","display":"Penicillin V Potassium 250 MG Oral Tablet"}],"text":"Penicillin V Potassium 250 MG Oral Tablet"},"subject":{"reference":"Patient/bb6a9034-2f23-2508-d29d-35efee156dc9"},"encounter":{"reference":"Encounter/9cdaede7-ecf0-90e7-0c1a-f80ac1e238de"},"authoredOn":"2017-08-02T19:52:10-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974295","display":"Dr. Millicent213 Mertz280"},"reasonReference":[{"reference":"Condition/cc7846f2-5df5-ecbd-97a9-be5a6ff6219a","display":"Streptococcal sore throat (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8996a57d-e7e9-8186-9441-752b7917bb16","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/74e3c134-ac35-3bf4-0a46-346dd25dae2b"},"authoredOn":"1979-10-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"89ad9396-c057-ef19-fb42-d578e20b54e5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/6b77ae8e-2104-ac77-38f2-51efe15246fc"},"authoredOn":"2007-11-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"89aeb14d-1db0-4c0c-63c5-f899d35153c5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bdc0991a-ed69-f5c9-0c02-971af8b10203"},"authoredOn":"1976-07-10T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"89bdd6ed-d94c-ee3e-dc36-45851f836f44","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9fbe9ab9-9369-12c3-d5a2-b554eea42d01"},"authoredOn":"1984-12-10T07:21:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"89d568d5-173f-58d5-672d-ebdff77ed0bd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-13T09:23:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"89ff9649-dc87-1862-019e-b92a45fe4e99","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9318db9c-692c-b351-d472-8be543cfeb8c"},"authoredOn":"1983-06-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8a192826-979d-f4a1-e58a-946b47546061","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/541e6bed-3386-4aea-b229-3f3065ac546a"},"authoredOn":"1989-04-05T06:17:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8a1dc606-19a6-2597-00a1-b10593efbb02","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-07T10:42:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8a459f9a-94dd-1f13-7b5c-a738b63b0da4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2040d534-c687-67ee-e332-b2f697d326e7"},"authoredOn":"1982-01-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8a54b38a-3621-38a1-4615-72e6f061ad65","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/1bee595c-dd05-2f5f-3bc5-bee2ce3f70bf"},"authoredOn":"2016-01-02T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"8a755e51-4a2a-78fa-1d81-c208e39c3811","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-16T06:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8a79af4e-b656-e2eb-67c3-f05d04ae3367","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/48e6ad35-125d-ecae-13e6-0ccb68dcf9b1"},"authoredOn":"1990-10-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8abde4d7-ab7b-b42b-0d68-b0881b11daad","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d1d1009e-0dbf-3993-5d56-1283a211e07f"},"authoredOn":"1987-03-06T18:23:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8abe0aec-cc4e-6215-c0ea-3a09f0a166df","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/746bb38d-c336-8450-e83a-d922e3bec56e"},"authoredOn":"1989-03-10T13:11:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8ad59c39-d0f7-555e-9fc3-65a9f7aeb992","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ff351c9e-1cd7-3013-1cce-d17983528a10"},"authoredOn":"1990-09-29T08:56:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8af605be-fae9-0828-74d0-7dbcabf4a779","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6cb0f9e1-3936-d698-5d1e-dd8a8b495662"},"authoredOn":"1986-10-06T02:33:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8b07ae0f-33aa-0c2b-ad68-23737ebeff0a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/449567ce-af37-d9f6-f98a-a23570d471e6"},"authoredOn":"2009-04-13T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999924092","display":"Dr. Asha251 Grimes165"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"8b3406db-dd27-e475-efbb-e9486eb7675e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2755158a-c1d5-7656-de96-812ed71b1058"},"authoredOn":"1977-02-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8b526954-6ce3-30ca-6bdb-36579556a10f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ddc2a3cc-42bc-ad1d-bc35-9a9a9bc936c9"},"authoredOn":"1986-04-01T12:49:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8b8b273a-0c6c-c2b6-89c4-904eefd82363","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e755e154-3e48-3695-3521-5261e6fdd6d0"},"authoredOn":"1985-09-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"8b94c927-1ae2-1f7a-c5d1-48b523d9125e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-26T07:48:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8bbe1a3d-cb53-4797-3216-679ce04b8795","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9fbe9ab9-9369-12c3-d5a2-b554eea42d01"},"authoredOn":"1984-12-08T02:50:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8c417bf9-1eb3-df40-039c-dd6c4890ab0c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a827214e-bc16-28ca-50d4-e4f080a645e7"},"authoredOn":"1979-06-30T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8c6a2e11-6b25-6d46-a399-8b643a5940a0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2bc0dee8-e35e-e722-d4c5-01c58b9954df"},"authoredOn":"1988-05-04T15:26:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8c8e6b97-da7f-8fe4-0e2e-fada1ee8078d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b6626c74-ab59-ae3b-9812-1169c3266152"},"authoredOn":"1988-01-31T07:33:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8c9b098b-e709-a753-f092-e1ab06a5a219","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d942e87a-9c74-03b5-7013-38cb236546cb"},"authoredOn":"1989-03-04T07:50:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8ca1f472-e20e-fb58-da00-0b576fa490ba","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e8e0abd1-ac3c-15d7-1982-754eb2d37385"},"authoredOn":"1980-04-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8ca604d9-640d-98d8-0262-6268be8510cd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/aa6cc40c-55e0-eb2a-c50b-bed116a81ced"},"authoredOn":"1985-06-12T17:20:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8cecdf06-76aa-c8cf-efa6-b93fcb976962","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/61d35a5f-225e-ea99-0f11-bf6ee1719226"},"authoredOn":"1971-11-20T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"8cf77edf-3cd9-0e7f-5aab-d90c737da4ba","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a16935a7-b48c-f4f8-244b-f0a4f8b8461e"},"authoredOn":"1972-01-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"8d1dd8a1-73a0-3c07-e145-673ec577591d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/33424bc7-b416-ae1c-9721-7108db6159e8"},"authoredOn":"1988-04-09T13:10:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8d2a5c39-47e2-987e-eeae-263e73e1cb13","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ef85e2bf-9f34-930a-e7d0-e316ae5aedb3"},"authoredOn":"1978-09-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8d41c160-ce0e-6a82-fc89-3ee700323fa9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8cc06f19-f3e9-c57d-23d4-53a057c1dde3"},"authoredOn":"1987-11-17T12:10:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8dcbf912-0de1-3421-3a9d-4163006a000b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/42c1e9ab-d38e-71a9-d197-a36759be7433"},"authoredOn":"2011-08-02T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"8dfaeb32-47b9-2793-580a-7aa84d9e84d8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/95dd963a-5d9b-943a-bea0-ede6f2eeaf0f"},"authoredOn":"1985-11-10T04:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8e2a5233-69ea-6267-b54e-8409416cec3d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/be3dc7ac-71a8-205b-cc9c-310749c5d4c3"},"authoredOn":"1986-05-01T21:42:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8e53ebdb-6320-92a2-bfc0-bcbb6840adfd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bf065128-3f04-fa70-2f2a-f1399c0669d4"},"authoredOn":"1971-01-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8e739bbe-43cc-7a77-62bf-61ff3a220d99","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e76f8c48-ef59-57b8-9980-122e72a22e14"},"authoredOn":"1984-11-04T02:35:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8ea5d606-aa4f-d491-fd28-c548559fd248","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f47bd74b-4e96-5a46-59dc-3847d3247326"},"authoredOn":"1985-03-30T07:45:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8eb84265-4dfc-bbf5-ce3d-101a2fe4c968","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c697a0b8-6738-2cc5-5b9c-23c70f02ace6"},"authoredOn":"1989-05-03T06:41:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8ebe7658-6703-98dc-2f4e-5a9179f94c68","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4f4bf70c-b3ff-a76c-301f-12fd2dd57abe"},"authoredOn":"1986-09-29T19:17:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8ed09fbe-675e-b966-d47e-eab4b845c392","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8862841b-4bfb-1741-5956-3fa894d40129"},"authoredOn":"1990-04-25T05:42:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8ef48c83-3314-bdcb-74de-536fea87ce67","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-28T12:16:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8ef92f0f-b551-503d-b007-849e9393d804","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ef981f0b-0b02-5e38-a25a-6f5106ecea92"},"authoredOn":"1981-10-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"8f0d24db-c60f-9a9c-78e4-edac823c9b36","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7cf15bb5-8f26-dc1a-9d18-e1e489695316"},"authoredOn":"1988-05-20T07:00:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8f1377c1-d200-4f17-e19b-89f6a21e3465","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cf957340-5765-4a47-42a7-4ece82bc1a6b"},"authoredOn":"1971-12-25T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8f2fcc5e-1d4d-1f71-b8a8-4403e2cfaf7a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1664463","display":"24 HR tacrolimus 1 MG Extended Release Oral Tablet"}],"text":"24 HR tacrolimus 1 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-11-09T10:18:39-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"8f36b901-6428-100d-61d2-ff0d58920f00","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/63217c04-c3d8-6144-9c78-3b2e97994a45"},"authoredOn":"1979-09-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"8f36cc65-1744-cdd1-dbdf-da01f7c94f13","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b41405d9-16bd-6d98-9ce3-8123c8ef9bf4"},"authoredOn":"1990-02-06T08:51:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8f39174f-556d-50b8-077d-48dd1dd15746","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0d840f0a-1b12-0745-2e20-745faf116e93"},"authoredOn":"1987-05-31T21:38:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8f8fb789-6afa-28c7-cecc-525856ce4e41","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/59844801-ecd9-0d76-e242-66582cad03f8"},"authoredOn":"1985-10-19T10:34:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8fb0b473-93db-e441-610a-73e60b3c8e4b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-28T12:16:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8fb2bef7-8a76-66c4-ef36-5a6e3ccdc141","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f34c95b-347f-3f84-587b-7de093dde963"},"authoredOn":"1992-10-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"8fb2d1e0-e76e-832c-7b71-1eb3ef112984","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/41ee9a74-1f31-e081-eb58-5044c5b83a06"},"authoredOn":"1987-07-25T10:04:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"8fdf8581-d765-3560-6ffc-a4cf6043daba","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/71aa95f6-08df-9990-cb7d-eb85e1549027"},"authoredOn":"1987-03-11T09:50:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"900167ea-99ea-159b-689e-2e13669d7a70","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/34e2a584-f356-807b-a443-faa1d20e213d"},"authoredOn":"2006-01-09T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"90230cb2-a14f-1c88-6b79-a385b672db00","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e1d65e66-d9aa-b0b3-612f-910b9c76ebbc"},"authoredOn":"1976-10-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"905123ce-b0af-87e9-5344-3ba84ee656bf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a0b516d3-8c23-acf3-4e1d-fb52104a8c75"},"authoredOn":"1987-09-26T08:11:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"905683c7-d8f6-8b63-cfee-eeb0f5688227","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/40d7d2d6-7f4e-776a-b704-cd0b8de45cd0"},"authoredOn":"1971-09-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"9061ae9a-1dc7-cbc4-8960-ecf196eaf1c5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/359529a9-4805-e9c8-a976-29fbb971223e"},"authoredOn":"1989-04-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"906478b8-a3bf-014d-efd9-64d3d705fefc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/230cd571-0e61-26b9-3699-0e916520f87b"},"authoredOn":"1971-10-30T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"906b4593-ec0f-c120-f6df-18eec3df97d6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-22T00:15:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"907bd32b-ea3c-979b-1b62-e9ee951d29f7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-19T10:54:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"90879693-debe-cf8e-4339-77fabbb7eda5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/68a499da-a750-bf01-43a4-915ee1c4cdbf"},"authoredOn":"1990-02-15T19:03:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"90d392f9-ca39-71b6-7f83-e708e72d715a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-18T19:09:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9101c619-8e0a-07a1-57b1-a22a85beec1f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/3de94d96-3eea-755c-55b0-0225382491ef"},"authoredOn":"2009-07-21T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"910a9f5b-3cf1-61a9-6a99-16b388d4b624","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ec3a571a-c077-2219-d696-13317678656c"},"authoredOn":"1976-10-30T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"910abd6d-cc21-4e94-31d2-ff513866b911","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9fbe9ab9-9369-12c3-d5a2-b554eea42d01"},"authoredOn":"1984-12-09T03:46:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"91212db3-a045-2007-c5ca-fe42f34e2b44","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fe22688c-0dc7-7088-d266-a97c8eb3783e"},"authoredOn":"1985-01-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"914da8d8-bef4-1696-3058-fe2f3c66881d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/437a751e-35d0-2ece-3afe-8dbe8844860a"},"authoredOn":"1987-12-15T13:47:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9189aec1-9a46-dc7b-7383-856dbbc1aebe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/154c2b29-b5aa-fc20-0500-83aacf9da83f"},"authoredOn":"1980-02-09T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"91dbeace-9aba-ea60-987a-0c99a2f9515a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0e123c27-813e-3aa4-e737-2801645e85f5"},"authoredOn":"1988-10-23T02:49:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"91e4a28b-5d29-4bc5-bd88-4c3329b03c1a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/230cd571-0e61-26b9-3699-0e916520f87b"},"authoredOn":"1971-10-30T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"91f5a57b-ee82-15b8-7b14-e666b63f64a7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fe22688c-0dc7-7088-d266-a97c8eb3783e"},"authoredOn":"1985-01-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"91fd31d2-bfdd-d283-21bc-90ba617ec807","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/aa6cc40c-55e0-eb2a-c50b-bed116a81ced"},"authoredOn":"1985-06-14T20:18:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"91fe0b4c-3f71-5579-4d6d-e752e947fe11","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-22T07:54:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"920447c2-90c5-e382-be8c-8f0574014a76","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/fe4a05bb-895b-a8bd-9b57-24a9cd6a446f"},"authoredOn":"1988-08-14T17:22:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"92268974-f7bb-0487-7d66-6485a497fdde","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bac974c0-097f-95bf-28a1-6f2721af9e9f"},"authoredOn":"1970-10-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"92eb355c-ee84-e7cb-0078-e3f8c1a6b8f1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/61e0cd05-b2c5-f6c4-3fcd-4e837bdba356"},"authoredOn":"1979-07-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"92f6fe48-2f94-3153-8100-36cf0294ae8e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b9b6e35b-a25f-7019-181c-9f2c4450c592"},"authoredOn":"1987-02-08T02:36:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"93182755-ae18-8f0f-3332-083a0f4e23e8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5b17bb35-65c8-c022-b9ab-fdbe5850b843"},"authoredOn":"1987-07-01T05:37:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"93a83978-4511-8371-b996-6d6f11454bc4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d3cc6f84-efa9-9194-7728-72f699bb39bc"},"authoredOn":"1972-02-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"93df218a-bd39-04f1-cf23-90c8f89e3bc0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f06f2b09-7e0b-68ab-eee4-aeb71f965b87"},"authoredOn":"1983-09-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"93e2c988-e3a5-5a8b-5345-ef3a02d95b89","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1664463","display":"24 HR tacrolimus 1 MG Extended Release Oral Tablet"}],"text":"24 HR tacrolimus 1 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8a004a19-132b-9614-4ed4-c772b53e5882"},"authoredOn":"1993-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"93e7413a-790b-f5a8-674d-74e75a39110c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-05T04:29:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"940ff403-f9d3-f915-0708-c7f49971bc68","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/66d980fb-db39-bd3f-d328-51ca0ad9cb4b"},"authoredOn":"1984-12-01T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"94478f27-3249-0878-c9ab-ff36469158da","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/97c65cf1-9090-4826-cb5f-17f3cf30b265"},"authoredOn":"1989-10-21T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"94583e57-fe35-bab5-a22a-e84c46fd913d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e13efd3c-70f4-f6c7-daa7-1d2168b0384b"},"authoredOn":"1987-08-22T16:10:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"947277f4-1427-32e7-5128-5cbd05fd943a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f3353813-7dfe-2040-fc67-947bea2e6ac8"},"authoredOn":"1984-12-15T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"948e0888-63e8-ffe7-fd82-54f1a110600a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/fe4a05bb-895b-a8bd-9b57-24a9cd6a446f"},"authoredOn":"1988-08-11T09:30:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"94a17fa9-afb0-af94-6c3e-7aaaf9d29670","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e97a25fc-91e3-7db5-b353-46c298272ffb"},"authoredOn":"1987-01-21T03:35:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"94c158df-7597-95dd-7da0-d07247852061","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4d217b7f-302a-2886-bdd3-c11d7cdfbb05"},"authoredOn":"1988-10-04T12:19:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"94e320c0-07a2-a841-5ecb-c810c578ea34","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"749762","display":"Seasonique 91 Day Pack"}],"text":"Seasonique 91 Day Pack"},"subject":{"reference":"Patient/7bc002fa-dc52-17d6-1563-fd8901826f7d"},"encounter":{"reference":"Encounter/f6aae174-bcbd-9f61-d6e4-00ebf2da7773"},"authoredOn":"2016-02-10T09:32:55-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999998195","display":"Dr. Nicholle822 Fisher429"}}
{"resourceType":"MedicationRequest","id":"94f708f4-5537-a2c7-2f95-87474e55e2cc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-25T15:54:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"953ab189-060c-67f0-a6ad-a0fc3695ec84","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b6d9b3bf-75d0-3262-2283-d235cd258b7e"},"authoredOn":"1985-08-18T21:09:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"95445c7a-6d56-69eb-a56b-6a1ad7682adb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/af0e81a1-9a26-a757-d5b9-edd0e535fa22"},"authoredOn":"1986-02-08T15:05:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"95bfb1da-e0e8-d0ab-e4ec-bc1a5d88fb48","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/104d3a3c-6a82-2da7-f0c5-40e4ae65607d"},"authoredOn":"1985-06-01T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"95eb6d3a-2235-307b-0808-fb91fba74d04","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/a498060c-fb3c-a182-276e-8967534d1c9e"},"authoredOn":"2014-01-31T13:45:24-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"962c07eb-cd18-c7ac-17d0-b9e76eb37fa8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2f9dedb5-c083-afdf-cc2f-075f75cbf92b"},"authoredOn":"1990-09-08T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9638bff7-c11e-a991-f3c4-ed42585d9461","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7fafa394-7125-92f0-94ad-fb2f7b2bbcec"},"authoredOn":"1986-04-16T05:29:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9644bc5a-f38e-65a2-df8d-d6d879db3912","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/afe9d4d4-0d61-1955-9570-07f20af00712"},"authoredOn":"1970-12-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"96666cab-80dd-a59d-4d0d-511b17b8053b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ca5411a8-5075-a053-e048-0a8c7b60d500"},"authoredOn":"1986-12-13T21:19:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"96bb1ff4-034b-be2b-32d9-53bb5baca0b8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a954dd3c-d3a0-7dfe-7a81-75c29c9f6454"},"authoredOn":"1986-09-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"96d70963-8be6-0c44-5f9f-be374259bd58","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-26T14:55:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"970849b7-01e8-7c20-9f10-186c279853cb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e3734411-56b1-01ba-4cf7-0e2dea96f9d9"},"authoredOn":"1971-06-26T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"972dd9f0-03c7-1aac-6331-4cf99352e8ca","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a35e6fb0-1e23-82bd-fe7a-bc571811410d"},"authoredOn":"1989-11-18T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"973aada8-3cf5-279b-9a03-579b1c799de0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/758aae3e-fcbc-933d-d4d7-bdc62bca3d75"},"authoredOn":"1986-06-27T14:27:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"97555484-bb80-044c-ee77-9192dd3b0387","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f3353813-7dfe-2040-fc67-947bea2e6ac8"},"authoredOn":"1984-12-15T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"975777c2-7bae-9aaf-9d66-962d71540abe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/aa6cc40c-55e0-eb2a-c50b-bed116a81ced"},"authoredOn":"1985-06-12T17:20:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"979a9c67-e479-e1ce-e2d4-b0361fc6df5e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-07T05:18:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"97a54222-8ea0-5828-9756-c538285a7a3c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c5a764bd-2b1a-cb14-92be-475b6dbf2486"},"authoredOn":"1988-01-15T13:34:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"97c4a316-dae1-1acf-db53-829ef3f2484e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/874982d5-4bc9-fa70-888a-827c3b02e207"},"authoredOn":"1987-04-14T09:59:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"97d229b2-e2d0-778b-d918-93cfe984f06e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2a8fc48d-1e2e-20da-5ec8-873803d54027"},"authoredOn":"1983-11-19T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"97fe2231-9d38-007c-6735-a50722d3187d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/2c67a4c4-0c71-b6cf-cdef-a8994131c3fd"},"authoredOn":"2002-10-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"98084cc5-e5fa-8a8f-473a-998c56640267","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/42475904-a62e-bd83-cb6f-e9c54e45d883"},"authoredOn":"1981-05-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9820a7d5-035f-fdc7-efca-18985107c3db","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/baa186ba-d9ca-4621-f71d-d448cdec244e"},"authoredOn":"1984-11-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"989ada69-0df2-ca26-2831-6d9d90ce5fb6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/24d7309f-4ae9-0a26-c624-3fb0aed1e7db"},"authoredOn":"1985-04-13T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9901df85-4e17-dbdf-23fa-f904ab7a722e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2a8fc48d-1e2e-20da-5ec8-873803d54027"},"authoredOn":"1983-11-19T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"991b0951-5180-c225-6ef0-7449bec8b326","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d712f834-215a-bf04-c1d1-fea0f9326522"},"authoredOn":"1986-10-18T16:10:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9931b659-4acb-58d8-f674-b3c4e2faa6a3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/12d1499d-0dee-b88e-99fb-de6a35db2c77"},"authoredOn":"1986-09-22T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"995903b2-e59c-55a6-840f-67db5349d470","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ddc2a3cc-42bc-ad1d-bc35-9a9a9bc936c9"},"authoredOn":"1986-03-31T10:19:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9976a7b9-8b59-e052-abc9-d870adc6d6ec","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad1dc84e-5644-968f-d365-77ecc98b9561"},"authoredOn":"1971-10-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"99cadcd1-6595-7c13-788a-73df1bc5e19f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/3c892edb-555f-cccf-10c3-afac9e177f55"},"authoredOn":"2019-01-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"99deca5d-c0d5-c661-e098-c0fbfae99fb1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e854563c-6e4a-3877-f877-9b5411738527"},"authoredOn":"1985-12-07T13:25:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"99e612b9-e6a7-85bc-6342-3a465410c1e2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b8103c24-7777-8b42-6078-0e52c3e4a966"},"authoredOn":"1987-07-22T07:29:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9a0724b5-1bcf-d8ae-db82-ef68083164be","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"562251","display":"Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet"}],"text":"Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/ea291121-0697-dcf4-ebbf-ff4649268dea"},"authoredOn":"2013-12-01T22:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/983127a0-03d8-edb0-d30d-38d1d6ccf1d5","display":"Viral sinusitis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9a1c999b-c18f-8e23-784b-ccd03a115562","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/04c743c3-fd07-6b4e-a288-75f9c7a88d94"},"authoredOn":"1983-02-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9a62ecc7-a7e5-cfc0-eb04-ee40237e0898","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-21T15:19:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9ab4ace5-7679-8894-a9ac-007171641ca8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/88f680b6-e0e7-d7c0-5ac2-ca89d3c54047"},"authoredOn":"1980-09-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9abad6ec-1a44-7270-9f88-d441aab966a1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/9c39eff0-9210-dd96-dbf4-d8ae6f312fd5"},"authoredOn":"1985-07-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"9b1d77e6-84cc-95e9-39ce-f9e494dfdaf6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/576756f9-6d5f-199d-684f-4cdba7f9eeeb"},"authoredOn":"2020-03-18T14:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999933390","display":"Dr. Cherrie404 Conn188"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"9b2287ac-5c88-d2bc-b283-68bee5377b69","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/359031fd-be33-186c-68c4-2bc91247d4b8"},"authoredOn":"2018-01-13T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"9b3d499f-1800-86b7-3a61-b7c246a6e18f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b57e3916-d0a2-a18a-47e9-6246cdba56b7"},"authoredOn":"1989-03-31T11:52:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9b6b191d-7a01-3302-214b-fc32c0214da9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198405","display":"Ibuprofen 100 MG Oral Tablet"}],"text":"Ibuprofen 100 MG Oral Tablet"},"subject":{"reference":"Patient/bb6a9034-2f23-2508-d29d-35efee156dc9"},"encounter":{"reference":"Encounter/7c06da55-ee8a-be57-3925-7636c1fbe57d"},"authoredOn":"2019-07-02T19:52:10-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974196","display":"Dr. Natisha940 Bradtke547"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"9be5d1a4-fd08-630b-b991-a9b42b1e138b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f7fb6bbb-c8e9-9c41-55b2-80fe93091cd6"},"authoredOn":"1989-07-02T03:35:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9c047cb9-5717-4ae5-d35b-ba55e758b3f6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-21T20:17:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9c0bc821-90f1-ac61-ce55-cd8ddae239ea","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-04T22:04:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9c19907a-0b04-518b-8730-04f0ae68ed98","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/97aa4302-0144-8353-7f80-8ee0ef253d75"},"authoredOn":"1986-01-14T12:38:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9c3886da-d6c9-a61a-ccec-4441fb2788db","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a2cd32f3-7f55-83ed-18dd-da17268cb4b0"},"authoredOn":"1987-06-07T03:19:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9c855b8b-3e0f-ab0a-8f0b-df14b456f015","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/02431a0e-d934-755d-345d-f4d6324cfb98"},"authoredOn":"1988-03-18T03:21:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9ca2ab8d-c491-403a-1264-e3890d81ec26","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e0a19606-935e-629e-7164-5b04cf9f42e5"},"authoredOn":"1986-11-03T06:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9caf1a3a-2915-ea2b-173e-f5d18151b03b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/d61edb04-bc0e-110a-e2ef-de9c5484b524"},"authoredOn":"2008-11-11T00:16:46-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923995","display":"Dr. Johnson679 Schmidt332"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"9cb011ed-239f-0ff3-ff1c-0a69105e0ab8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-25T10:09:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9cc714ed-eb00-44e7-56cf-8281634d503e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad1dc84e-5644-968f-d365-77ecc98b9561"},"authoredOn":"1971-10-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"9cf0f7c3-0ae4-67c1-99f9-07a97fb03592","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/36f08727-b7ab-8965-9aad-652d330fe5ac"},"authoredOn":"1987-10-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9d0efa65-f578-a09f-0306-ac7636e3266c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-07T06:54:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9d2e9593-2bfa-b227-84cb-a9eb029f3f17","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/41a4cd1a-241a-b1ec-ebf3-40d2db7679fe"},"authoredOn":"1990-12-23T04:03:31-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"9da50262-b306-5964-0331-73ab3bb9a1ea","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/70530273-caad-c9fc-fb1c-6550b453d7f1"},"authoredOn":"2023-02-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"9dada97f-a892-1933-f209-9105d3ad0c72","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/217f74f6-18a1-8ee8-2930-7c3dbfe789d5"},"authoredOn":"1988-08-22T02:34:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9dc4268a-691f-145c-d8f9-0d024af5983f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fc729a69-051c-c3a0-8826-1f2fd48f1998"},"authoredOn":"1970-12-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"9e11120d-4d75-8d9b-09df-09d4a03ca675","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d47ad367-cb57-0e0c-474b-cf84164dff8d"},"authoredOn":"1984-04-21T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9e36ca7c-bcd8-db87-2159-902dff0c0247","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ec24c38e-9b44-d273-2a88-b98502770e14"},"authoredOn":"1984-08-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"9e803982-8df4-f678-da10-b60a23536308","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2aec4ce9-47e7-54cc-bff8-6c9e10b0b33b"},"authoredOn":"1988-02-09T18:01:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9ebad84f-7cf2-17b8-dca3-10bbc384d348","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-12T19:24:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9ee86421-e0d8-0032-3d7d-3d7d24411361","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-12T17:35:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9f3ad9f5-3c57-6557-225b-513eaf658de7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d6f8dcc6-63d4-0191-0964-5d172929bb72"},"authoredOn":"1985-11-03T23:43:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9f58b7aa-5a6f-f93a-37d8-f5215b75e689","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1094107","display":"Phenazopyridine hydrochloride 100 MG Oral Tablet"}],"text":"Phenazopyridine hydrochloride 100 MG Oral Tablet"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/463ca496-be27-2fe6-1e8b-da3be27bccfb"},"authoredOn":"1982-10-29T12:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/3800b208-1af1-061e-1f2c-337ae08c1a2e","display":"Escherichia coli urinary tract infection"}]}
{"resourceType":"MedicationRequest","id":"9faa9f97-7bfb-f61e-8b5b-bbe255c34734","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/fe4a05bb-895b-a8bd-9b57-24a9cd6a446f"},"authoredOn":"1988-08-13T16:23:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9fe4dcb2-7c8e-b16f-78d0-629062f996cb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ab9f22bc-bfc8-f44a-eeae-9a99f1e48d94"},"authoredOn":"1986-05-02T14:34:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9fe68257-651a-2cf2-0d95-de2a3f5c7c66","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/98e1f05a-1b22-3a15-fced-1da98785dae2"},"authoredOn":"1987-08-02T18:40:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"9ff19c2a-22db-2cc9-eca7-f9ba11a2e284","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d1d1009e-0dbf-3993-5d56-1283a211e07f"},"authoredOn":"1987-03-06T18:23:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a011e620-4eae-5866-a29b-5bf4bf80875d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ddc2a3cc-42bc-ad1d-bc35-9a9a9bc936c9"},"authoredOn":"1986-03-30T09:00:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a04f0555-c062-16df-e31f-9705cbf82a03","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/349f69da-960e-6522-87cf-59f61f0091a7"},"authoredOn":"1987-12-09T07:28:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a05be224-0b85-c4a8-5d48-19715230cc4e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b6d9b3bf-75d0-3262-2283-d235cd258b7e"},"authoredOn":"1985-08-20T23:34:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a0b2ea7d-a50d-fd3f-2e32-f9f9516690ef","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/8d865606-a904-6ce1-55ca-e2615a727c1d"},"authoredOn":"1988-10-03T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a12f51f7-527a-7c64-ab78-22b3e8fecd43","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/bc6c6b66-9b76-eaea-c66e-4bd57dc0963c"},"authoredOn":"2018-03-07T13:45:24-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999933390","display":"Dr. Cherrie404 Conn188"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"a13e4706-25a1-d84b-72b1-094aba1a277f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f88e85c6-6bcf-ed12-ae38-dc25db795c6b"},"authoredOn":"1987-04-24T11:18:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a16b7fbe-b92c-800a-7ef5-5576f2dee0fd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d3cc6f84-efa9-9194-7728-72f699bb39bc"},"authoredOn":"1972-02-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a19910ea-8d24-dd6e-a276-25b9e6811b2e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-26T01:59:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a1bb7bbc-e7ad-b45d-c255-5fb715df71a0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f7738769-2141-226c-ef76-a1f1d6dc1a23"},"authoredOn":"1986-05-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a1ddbd63-6c9a-ba4b-26d7-f58ce04454a4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b7614bb8-2905-1807-2eb9-b94e2b513986"},"authoredOn":"1972-01-29T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a1f721c3-c62d-b779-2d07-0b2de141654f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/5bde2d4d-3068-9054-b1fb-a1e6a0a2d6b0"},"authoredOn":"1985-07-16T13:40:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a23c4f06-743b-d57b-e51f-7ae975942930","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b4b5ea98-6b91-7834-e648-9be4491a4daf"},"authoredOn":"1990-03-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a24a6962-d96c-0757-e42d-0e07a1a8273e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/4f9491b5-84c4-1f5e-cb4e-809f390f52c5"},"authoredOn":"1990-10-15T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a250c268-1b97-2438-db5c-0e8b4c6bce4c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a16935a7-b48c-f4f8-244b-f0a4f8b8461e"},"authoredOn":"1972-01-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a292d831-8bea-dfd7-f1d9-e4c12cf03c55","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"562251","display":"Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet"}],"text":"Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/5667f004-10b8-4e46-0e3e-3e8c011eaa47"},"authoredOn":"2013-07-26T22:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"},"reasonReference":[{"reference":"Condition/991dbc9f-6155-74b4-8b6c-3db4e87078e4","display":"Acute bacterial sinusitis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a2f5cbc7-c487-5e47-bd60-e284b1612aac","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/680d1696-abc3-9080-1ea3-d5d698f493ac"},"authoredOn":"1990-04-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a3356322-3eb7-f570-f8a6-2a8563d6472d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/50e261fd-d506-ccde-97da-19308cd4b7ca"},"authoredOn":"1985-07-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a35aee37-6bdf-d5a4-2b44-99ce92b8ce95","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0eab0884-fe17-b7b9-a571-a6f6308690f3"},"authoredOn":"1989-02-01T08:50:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a3b77a89-c783-8983-80df-c21ebbaf0a1d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8a004a19-132b-9614-4ed4-c772b53e5882"},"authoredOn":"1993-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a3b799d3-9d9d-58f5-414e-00209694874f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-03T10:43:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a3f0ec0d-34d1-2eca-99f2-fc669d578a90","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/7bc002fa-dc52-17d6-1563-fd8901826f7d"},"encounter":{"reference":"Encounter/72487535-4be7-58db-44f6-7780245494c2"},"authoredOn":"2020-06-12T11:46:59-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999990499","display":"Dr. Lynwood354 Tromp100"},"reasonReference":[{"reference":"Condition/fd608de4-0bc0-e763-c4e2-04258a9c19aa","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a3fe7b6d-7d85-2c59-0fda-64d04f40b5e2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/661e4d2c-1e95-6484-70a3-ee0b951228db"},"authoredOn":"1977-07-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a413a278-6aec-fd63-a01f-49f519bfcbe8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e76f8c48-ef59-57b8-9980-122e72a22e14"},"authoredOn":"1984-11-02T22:30:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a4143a47-7116-2b87-bf89-5dd6ce120553","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/49ceede7-ea6d-4a9a-6257-31a778780b7e"},"authoredOn":"1984-07-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a41d93c6-d281-aee1-707d-9214ac22c8cc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-09T12:37:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a41f32bd-bfb4-f4b0-59dc-f621b9e18b74","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/19201af7-bac2-c942-a057-378d8eb832a9"},"authoredOn":"2013-02-18T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a41f9941-6b23-e9af-2590-d497393c01fe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-11-04T05:53:59-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"a42e5fbe-4cb5-db62-d123-4a0b8a7ab51b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-14T13:22:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a4605308-af1d-613b-5981-a9c9d05f8a0e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-23T08:32:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a4801b91-3fc4-04eb-4a45-b8b05868130f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3d14ec07-d167-8e78-82b0-408f046caa54"},"authoredOn":"1971-03-13T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a4825f45-1641-9d32-7eb8-24a287abd1e4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/96309b87-2891-58d4-3727-83c82d6444e3"},"authoredOn":"2007-11-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a48c7680-1f9b-5265-c450-5d13cf935e30","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8d29dfcc-6241-f40f-9eab-17978138fcc5"},"authoredOn":"1988-05-17T04:06:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a4b9401a-e912-a167-15c4-6c366c0efe88","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7d584e49-4f06-2a64-d497-1a98c7118c12"},"authoredOn":"1981-08-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a4baa785-9530-9bb3-244b-ae72216b029f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/038f458b-0eca-6ca0-8201-eaa56bfa6f28"},"authoredOn":"1990-02-12T15:53:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a4da8839-db51-13c0-6782-9b6df2cdb14a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9759a722-e802-3e6d-f3ee-96910894e65e"},"authoredOn":"1988-04-26T02:52:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a4ed2d4c-8cd3-ca13-e718-75b40ae557e2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5b85af1c-31db-5884-cfa5-d8bb4ce25793"},"authoredOn":"1971-08-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a4f38a19-c0d0-3bc0-8e00-386e2ff10d35","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fa4fa3be-8891-0f8b-1b52-a5b5a99ca35d"},"authoredOn":"1989-01-19T21:44:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a550baa4-464f-c38b-dbf0-0db4c017fe10","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-06T01:54:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a568de54-ca0a-746d-2e48-0a56f69ed245","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c3911768-27d2-34d9-b7d6-520edc65c469"},"authoredOn":"1990-11-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a57650d7-26f8-63e1-841a-05df7b81204a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/aa6cc40c-55e0-eb2a-c50b-bed116a81ced"},"authoredOn":"1985-06-13T18:48:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a595a22a-0a3f-93fb-9f89-b20cbc07731f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b1884875-2ee5-9d7d-7a60-1eb1d95c1a97"},"authoredOn":"1973-06-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a5ad9a8e-da39-b6d4-ee5c-d6121249c98d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c940f8fa-e5f1-873b-d6da-bedaaddae131"},"authoredOn":"1988-01-25T00:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a5e877c9-08a6-3154-69f2-7d709fd18360","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ed6ca109-21b3-3664-71eb-7b730e23a8bd"},"authoredOn":"1988-03-24T19:24:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a61e9f97-197f-d1ca-a579-216de807d87a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/fe4a05bb-895b-a8bd-9b57-24a9cd6a446f"},"authoredOn":"1988-08-12T12:49:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a628996d-05eb-e730-ce9e-29bdada30875","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-16T16:51:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a63d72d5-1484-b6b2-f8db-545bbd47f119","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"834102","display":"Penicillin V Potassium 500 MG Oral Tablet"}],"text":"Penicillin V Potassium 500 MG Oral Tablet"},"subject":{"reference":"Patient/a4a401d1-a46a-eb4a-8a38-760d5d79d6ec"},"encounter":{"reference":"Encounter/d6f85826-5072-4002-39be-385a0e149a47"},"authoredOn":"2015-03-24T02:54:55-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999999698","display":"Dr. Bobbye345 Wuckert783"},"reasonReference":[{"reference":"Condition/026da40a-8d33-5b03-15e3-7d0c3e9ec7c1","display":"Streptococcal sore throat (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a64e30b8-f368-e63b-2e93-a8d22f0484a6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9759a722-e802-3e6d-f3ee-96910894e65e"},"authoredOn":"1988-04-23T20:45:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a6582e9b-20f4-2f12-f5c1-32096bfcfab2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d1b8d47e-3c09-e3e1-01b9-0ac46828f03a"},"authoredOn":"1988-06-11T09:41:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a67a459c-7f0c-4ede-ece1-f360a2d1a5f6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/234425d6-07a3-2fb4-48cd-f0c90996ed52"},"authoredOn":"1983-10-08T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a6abd426-149d-8a7e-4f65-c7f4fd0d5a94","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/43d6ab2c-e4c9-df8c-0feb-5e5e58023a06"},"authoredOn":"1990-01-05T10:20:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a6be1f5a-867f-868d-bc4b-dc6966db9943","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8a004a19-132b-9614-4ed4-c772b53e5882"},"authoredOn":"1993-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a6ce0073-ed77-180b-32c5-54b16a8ecb66","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7709085c-11c8-0f0d-adc1-bb64b252ab92"},"authoredOn":"1988-10-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a6d9f35c-9a00-e2ea-c727-44eaa48a78a2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/e696a90b-13e6-7c09-be62-0a5ff4238233"},"authoredOn":"2016-03-07T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a6f92628-a12d-449d-9a69-5cfcf389c9d3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/874982d5-4bc9-fa70-888a-827c3b02e207"},"authoredOn":"1987-04-13T08:46:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a70fa6c3-d61f-9a3d-faa7-cb8c8b5775ae","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7bf633c-a68f-a530-fc60-6150abc1cf18"},"authoredOn":"1988-10-29T07:49:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a73e98a5-fc94-7a7e-4ce2-0f8ab279a094","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-06T05:08:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a7895e87-0bea-c3b0-72af-276f444bc12c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/66a77384-edad-72ea-d3c2-5dff004dfb71"},"authoredOn":"1990-04-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a78d10f9-d39b-1710-4be4-0f1745cf9a38","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1b3b12bb-403d-0eb7-2646-385d704a7b0f"},"authoredOn":"1981-07-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a79c0fe9-c29d-77e2-26a6-33d2f1bdd4fe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/03699278-1388-f7b2-544b-b02277d2ec5f"},"authoredOn":"1987-10-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a7dd801c-b274-55c3-b1a9-8fc95c97826d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ef839846-3f79-a086-13f0-c67c0d145bf0"},"authoredOn":"1989-05-06T10:04:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a7ec70e8-d1f3-826e-67d0-3b5375984b49","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d1d1009e-0dbf-3993-5d56-1283a211e07f"},"authoredOn":"1987-03-10T02:30:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a7fe54f6-d561-732a-7434-ededa27f82ca","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0c5e3425-9a4e-9e20-b181-1e4c8cb60b7c"},"authoredOn":"1989-05-12T17:20:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a834886a-ca3e-c7af-752a-7b6eec08891a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/e696a90b-13e6-7c09-be62-0a5ff4238233"},"authoredOn":"2016-03-07T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a840e20d-0008-980b-29b7-677704b3e1d7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/42c1e9ab-d38e-71a9-d197-a36759be7433"},"authoredOn":"2011-08-02T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"a895ffb4-e24a-07b5-9583-c416190dab01","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b1884875-2ee5-9d7d-7a60-1eb1d95c1a97"},"authoredOn":"1973-06-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a89a63b8-f00e-fa1d-e944-bf31bb6e4f1f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1c979062-14f9-3170-dea6-6e263ec5ddc4"},"authoredOn":"1979-08-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a8de7b7c-0554-4417-2130-cec3d4c1daa9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-06T20:42:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a8eb6617-b274-a153-2d5c-866b9bc35e9c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-07T06:54:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a9014a2f-7652-67e4-1f5f-da53f3fab044","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e8e0abd1-ac3c-15d7-1982-754eb2d37385"},"authoredOn":"1980-04-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a90cb6ef-a71f-481b-66af-4229a5833379","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/078be185-0e8e-5f5c-a7dc-d779ae805f8d"},"authoredOn":"1978-06-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a91070f3-2a57-a3b9-664d-4ab5e2b00321","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/2cfba02c-0d6e-73b1-bbd8-b0920d3f631f"},"authoredOn":"2013-12-14T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a996b0ca-e4f0-ac1c-b947-c7dc01035ba8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/7bc002fa-dc52-17d6-1563-fd8901826f7d"},"encounter":{"reference":"Encounter/999c5de7-da6d-92e8-e151-2cbf2250e0f4"},"authoredOn":"2022-06-12T11:46:59-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999998195","display":"Dr. Nicholle822 Fisher429"},"reasonReference":[{"reference":"Condition/fd608de4-0bc0-e763-c4e2-04258a9c19aa","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"a9b01c6a-42db-7b51-66d6-e6eeda352c4c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/de2e9c9f-4425-f51b-e32c-ff3657730d41"},"authoredOn":"1986-09-23T12:14:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a9ce09f5-4b90-a4a3-c1b1-7e5ddfa7b5df","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b57e3916-d0a2-a18a-47e9-6246cdba56b7"},"authoredOn":"1989-03-30T08:29:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"a9e49611-5b92-f8b9-16ea-32d88c7c5183","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-02T07:16:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"aa232d92-d2cc-3c79-25a9-5f31b4b9750b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/abe5843a-8210-e623-20c8-eccdab9e708e"},"authoredOn":"2009-11-21T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"aa312cc2-c3f7-333f-7ee9-7c0b433f0b64","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b6d9b3bf-75d0-3262-2283-d235cd258b7e"},"authoredOn":"1985-08-20T23:34:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"aa57aec7-3c02-d405-571d-ee7cada2f2fb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/970c4039-4240-1555-d498-75fe16bb73d9"},"authoredOn":"1987-07-19T03:54:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"aa68d322-dea3-1351-d2f0-e0c639db94fa","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/36709aa3-82be-8c34-c3fe-4b7271168ff1"},"authoredOn":"1988-05-31T12:32:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"aa7e9ec2-81d0-91b1-016a-2fc8cc88b650","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ab9f22bc-bfc8-f44a-eeae-9a99f1e48d94"},"authoredOn":"1986-05-03T18:35:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"aa9bbbe4-61f1-be3a-94a8-510735f909e3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-11T06:05:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"aad5f5d8-3ff9-57fb-9985-e2219af8c743","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5cb8aaf6-4203-134e-4374-e4e0aa14e52f"},"authoredOn":"1989-08-19T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"aaee9e08-c1a7-ec1c-6c5d-0d7236903c82","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f138c75b-05dc-58ec-6842-14f1e0b29905"},"authoredOn":"1988-01-06T19:20:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ab1de445-e619-8e5f-2bfd-c46e7f0bb8c4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/02431a0e-d934-755d-345d-f4d6324cfb98"},"authoredOn":"1988-03-17T00:55:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ab2bc86d-0cc6-d2f7-5637-e9aa757ab83f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ddc2a3cc-42bc-ad1d-bc35-9a9a9bc936c9"},"authoredOn":"1986-03-30T09:00:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ab440454-63db-2df5-e878-2c0f8164e687","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9fbe9ab9-9369-12c3-d5a2-b554eea42d01"},"authoredOn":"1984-12-12T14:53:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ab6d2454-9318-66ef-d0ff-d0549d8fc933","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/86f85f2b-9611-bcfe-ed3e-d4637fe89f1e"},"authoredOn":"1987-03-20T20:05:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ab8d1d4e-c12f-c923-1bad-9f5ce2f138ab","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/a0956aef-fc0c-c070-170e-7ebb3fd3c9da"},"authoredOn":"2017-03-01T13:45:24-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999933390","display":"Dr. Cherrie404 Conn188"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"abe46f16-1aa8-6f5f-4351-96c9f34033f3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7f8f1eaf-0aac-fbd8-a50d-1a7441470a1f"},"authoredOn":"1981-11-28T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"abf9eb5f-d028-1555-c381-2d7d653c64ef","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-27T15:25:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ac20fbb2-d051-c74a-8085-f24183183087","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/950049e3-b310-87e7-3184-e72d185d1813"},"authoredOn":"1979-06-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ac2b568b-10a6-ef4e-6fb4-0fcbdb159d2c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2c9ee0d4-ac42-c72b-eadd-0d40d36ed27c"},"authoredOn":"1988-02-15T23:51:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ac39b1e1-fa2d-f946-f2d8-fe7ce9d9d349","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a57fdf46-e363-f784-1242-b060038a0beb"},"authoredOn":"1988-09-28T06:27:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ac406e51-9f74-f86a-1cbb-4e43db07aa48","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/37477504-6bbb-4b35-981b-15f1ec51902b"},"authoredOn":"1993-11-01T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ac47b50a-1f0b-058d-3378-c27f1d5478fa","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bdc0991a-ed69-f5c9-0c02-971af8b10203"},"authoredOn":"1976-07-10T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ac8f2adb-dc71-7100-fcc4-7e0a181e0f63","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/63145e10-9d9e-771d-9403-ec94e7b12630"},"authoredOn":"1995-10-02T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ac98141c-16e7-da8a-bd3b-39b35eafb7de","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/388c00f2-a51f-3c21-0bfb-a09ced1cd95a"},"authoredOn":"1985-03-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"acdede4b-0977-5dca-f03c-c7bfd639196d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f138c75b-05dc-58ec-6842-14f1e0b29905"},"authoredOn":"1988-01-07T23:13:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"acf8685c-fe61-8e9d-6521-e25175e8c2dc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7139b964-053a-7f01-c597-f649d561b7a1"},"authoredOn":"1985-06-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"acfd1bee-3dea-26fe-29b3-a2f8504f7f30","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/53a47462-cbaf-ef55-5537-4e2ea10cfc75"},"authoredOn":"1988-07-15T15:41:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ad21ef23-fcc6-403e-2588-3fdf794d0f9e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/cc461327-6962-c37a-58a3-477327c38d27"},"authoredOn":"1991-10-21T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ad2766cb-0530-659d-3dcc-8ebaaf6fa0b4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/34217a07-8aac-e5a7-a302-3c47ed46c7a6"},"authoredOn":"1994-08-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ad55ebb1-125d-4858-82fd-ef3c68cf0b61","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-15T14:51:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"adf9be2b-00bb-349c-3ec9-a7171efd647e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4889a0be-9842-019f-c884-ccdc912f2fa7"},"authoredOn":"1978-01-21T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ae61ac09-8361-6acb-026c-6e808595ea3d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1f72358c-6996-ff2b-9435-e9fab3722f5d"},"authoredOn":"1984-10-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ae67a38f-ac8d-c189-80e4-b4e6f0a4bed3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/58fea874-6bb8-e0a5-eae6-6dad82a0b07e"},"authoredOn":"2012-02-13T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"aea356b9-69e3-bbfd-bb48-6f7a3be372ff","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f65151ca-9429-27f1-27a2-9730827732c6"},"authoredOn":"1986-06-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"aeac878f-d56a-5a63-3495-882f1e9b35fd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d6845aae-7b70-fc6a-b1d3-794f83e49fbd"},"authoredOn":"1986-12-21T00:10:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"aef7d0c8-8019-da4e-d17a-04cfbff5b379","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/90360b5a-5d3a-54af-e0ff-92c55d2fed51"},"authoredOn":"1978-07-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"af04afd3-11e7-6edb-db98-13bab953393a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e377e2ee-23af-0ec2-5f9f-4bbcb185a722"},"authoredOn":"1986-08-01T00:15:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"af51df43-e749-49af-3b4a-60cd4ede8832","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1970a439-6a26-78fd-529d-7e578fb88435"},"authoredOn":"1983-12-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"af70e438-4d68-8d33-b5c4-6aac5eedc0b0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b55ca44e-2d6c-f6f2-4a10-bc031c7e6244"},"authoredOn":"1986-10-12T09:05:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"af868a87-dfb0-fc8c-e3d4-a378c818cb9a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3f87cda2-e0e4-9335-fe19-bd1ee5ab1caf"},"authoredOn":"1990-03-09T17:25:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"af9c390a-9297-087c-2321-8798bf5a7f28","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c0ce36d8-4e16-67e9-86b8-6f4afc7dbc65"},"authoredOn":"1984-08-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"afa5db42-a0da-d0df-70b0-fac91221610a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c544ddd4-ef20-096d-a655-ab0ce01b2cab"},"authoredOn":"1985-01-12T09:04:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"afba72eb-e86d-e831-b985-cbcaa7d6c48f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/78f6a088-b6ec-c960-04fc-ad04f2707eb2"},"authoredOn":"2018-09-11T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"afbc827e-7a93-5bcb-ed9b-23453eafa367","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cdb473bb-30dd-3078-a357-15d4e519f276"},"authoredOn":"1987-07-31T17:39:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"afcb47bf-a579-91f2-d06d-90bd9c359694","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bdecd21e-6c56-2442-a0b5-d5e725c049c8"},"authoredOn":"1987-08-06T23:53:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"aff77324-0719-549f-1cf7-a670c0b5550c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b57e3916-d0a2-a18a-47e9-6246cdba56b7"},"authoredOn":"1989-04-01T14:01:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b0788186-277c-7271-a663-a155f8d48646","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/87ea6824-0cd9-a5ba-a1d7-b4256c6d13e5"},"authoredOn":"1971-03-06T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b0a23615-7d20-bf59-338c-3e00cacf34f2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad3dabbe-dbb1-144d-1888-82f9b42c89bc"},"authoredOn":"1980-01-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b0a73dbd-1584-63cf-b9f0-a3dd41ba183a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/511eb1ed-0d22-7db7-a6a4-1370ee5a96f5"},"authoredOn":"1989-01-13T01:33:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b0af6419-0760-5376-c6d3-9c2c535f23c1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c6bb5ab9-9e09-a3ca-6c27-c6b8912ad0b1"},"authoredOn":"1988-03-15T12:13:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b0cc3ad0-a085-a71e-1a49-a340e88147d2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/21a51094-9989-a914-2783-feba62e6bbad"},"authoredOn":"1986-03-24T07:04:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b0dbf7de-f45a-4361-71d5-937375e986cb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f06f2b09-7e0b-68ab-eee4-aeb71f965b87"},"authoredOn":"1983-09-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b0f616ee-ba61-4477-8582-d62b83e9979b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bac974c0-097f-95bf-28a1-6f2721af9e9f"},"authoredOn":"1970-10-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b128d9dd-bf6f-c657-7200-31b46a294867","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6d64ee3b-f414-47d5-bf91-c687800b9293"},"authoredOn":"1984-02-18T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b131e12d-1045-ffd4-0d62-cb816f8a30d8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-11-03T05:00:01-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"b14dcf47-16d2-44e8-af18-45bbdb9e7309","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-17T17:38:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b1a1e688-8753-7402-b563-cd8dc608754a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/3c56a6f0-ec0f-1d0f-7d2a-87e9aea3698d"},"authoredOn":"2007-10-23T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999995597","display":"Dr. Shiloh191 Larson43"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"b1af8dd5-2a10-d6bb-9dd9-44552fe76c88","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/14ebde3a-d387-1325-8363-926628c9adf5"},"authoredOn":"2013-08-13T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"b24781df-e0c5-c011-e8dd-bb97a346ab86","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-20T09:40:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b25af3f6-59b6-5a85-e25f-1325fde3b18c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/887af0a5-63d2-b23f-c5fa-1269205d288d"},"authoredOn":"1989-05-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b282543d-f7b6-d188-65db-0c63df7c3c1b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-20T05:12:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b28c2cfa-aaf1-378e-905f-6117a0104fec","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2a8fc48d-1e2e-20da-5ec8-873803d54027"},"authoredOn":"1983-11-19T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b2b4d4d9-09b6-8dc6-01a8-7dda3708ac9f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-27T22:21:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b2d76495-d282-3fdb-fa2b-203f57a6a7d5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-26T01:59:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b2db3320-3588-e90d-73cc-4e5f07581ff6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0c3a25fd-a572-9f57-57ad-1702cd899a4a"},"authoredOn":"1989-02-04T11:04:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b32c966d-b58d-9235-5cd7-52227ef02a5a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d1d1009e-0dbf-3993-5d56-1283a211e07f"},"authoredOn":"1987-03-07T22:07:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b3460acb-ab1d-3837-4c2a-1469fc846a8d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/9211600f-7526-11ad-d970-a2a430d698cc"},"authoredOn":"2020-03-30T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b362d558-9ce7-45c4-9404-85f28b9488af","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/61153974-75c6-372b-e09c-b4fb070b40d9"},"authoredOn":"1981-05-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b381abe6-ced7-28d3-a078-eeea006299d2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-08T11:00:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b38ba36e-87af-9e92-c8be-bc5a57db68a2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ff79edd8-fa90-51b0-cac4-d1abcd4a0f6d"},"authoredOn":"1989-03-01T05:34:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b3d698e7-9eaf-a0a7-f02c-81139054fcfe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/19493569-d56d-7e42-c937-214f05cb21e9"},"authoredOn":"2011-02-07T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b3e84ef5-f905-ad51-d8a1-263e9155997b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-14T20:01:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b3edad6b-9a41-7c81-8bf0-61155f7d330c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/98e1f05a-1b22-3a15-fced-1da98785dae2"},"authoredOn":"1987-08-01T17:23:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b40c2b6a-5653-d135-c692-96b7ab45f3c5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cf89eeff-fb89-2ddc-1a34-41706b0fffd8"},"authoredOn":"1984-09-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b42e0527-3ce0-f6b6-8b11-69b10b413053","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8d3e5f0c-a5de-25a7-4207-ba0d12e7f98f"},"authoredOn":"1970-11-28T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b441e5f5-2aaa-8a18-c2fc-8f7391aefa53","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/24d7309f-4ae9-0a26-c624-3fb0aed1e7db"},"authoredOn":"1985-04-13T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b45182fd-1024-ae2c-3923-c2bcb5864db1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7f5b7f1d-321e-917e-1038-1c98397addd2"},"authoredOn":"1986-12-28T01:01:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b45656c7-e295-6751-3144-dbf695d60d07","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/641cec00-201e-e10b-ac70-84044e402201"},"authoredOn":"1980-08-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b4695044-f52b-fbf4-b460-9779052ef296","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2650abb7-64a6-00df-5d23-08fc22c7dfb6"},"authoredOn":"1988-06-30T00:52:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b4b0e646-836b-fc85-51e3-816fe028af63","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7139b964-053a-7f01-c597-f649d561b7a1"},"authoredOn":"1985-06-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b4e63914-f095-670e-261c-944faccba3f8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/35bc8e39-e9f6-655d-45ac-2cb9fc321dfb"},"authoredOn":"1988-05-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b51efbe9-4db5-fc00-3a9e-20e0d55c15ae","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310325","display":"ferrous sulfate 325 MG Oral Tablet"}],"text":"ferrous sulfate 325 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/36580a9a-0a37-6552-2c90-20efba827a0b"},"authoredOn":"1957-06-16T01:15:44-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"}}
{"resourceType":"MedicationRequest","id":"b53c0b2e-0aa6-fe22-fed5-eb98562169ff","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f5c7ad5c-6397-61c0-8978-cf9c4086d9b4"},"authoredOn":"1983-10-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b5b78f8d-f8dc-c767-8a83-c0ded6378102","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1b3b12bb-403d-0eb7-2646-385d704a7b0f"},"authoredOn":"1981-07-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b5f635fa-4fd3-a7f0-5b6d-52cb48ba9ca8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0218f8b1-1f94-68da-024c-9bdef1f1fbfb"},"authoredOn":"1990-02-22T02:30:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b60ad82f-b8aa-68a5-2ad7-f2e0d74ca55d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e854563c-6e4a-3877-f877-9b5411738527"},"authoredOn":"1985-12-09T17:30:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b63383f8-626a-f4f9-d15f-931c8b579c53","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/84098622-da37-647d-4e75-62cca0eff97f"},"authoredOn":"2002-12-23T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b6372328-fb74-bae5-fc26-4d7a16a5ac26","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/37477504-6bbb-4b35-981b-15f1ec51902b"},"authoredOn":"1993-11-01T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b66213d4-c0e8-65d1-f076-b6d13e367d78","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b4b5ea98-6b91-7834-e648-9be4491a4daf"},"authoredOn":"1990-03-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b6704bfc-cbd2-6377-085f-efe9b082d088","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/58fea874-6bb8-e0a5-eae6-6dad82a0b07e"},"authoredOn":"2012-02-13T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b682c10b-65fa-297a-07ad-0cbfacc7b55e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6d606c67-0ae8-4d7a-a14b-fa628206c951"},"authoredOn":"1988-02-06T14:31:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b6b073ee-4d8c-ca79-259c-808b59de31e6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/12a98307-6b23-ae45-53b1-35a260462401"},"authoredOn":"1982-07-31T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b6f71d25-0166-fee6-64bc-648798a77d51","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1664463","display":"24 HR tacrolimus 1 MG Extended Release Oral Tablet"}],"text":"24 HR tacrolimus 1 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f34c95b-347f-3f84-587b-7de093dde963"},"authoredOn":"1992-10-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"b7555b1f-2af1-fb85-96ed-b14eeb61340d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/545a6d8d-eae5-2c88-395b-791c93336fb3"},"authoredOn":"1987-09-20T02:48:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b78c833a-07e6-14d7-7fc1-9fdd9596ce2f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/984fb35a-418d-c90b-4e7c-7a3220f4a179"},"authoredOn":"1989-07-11T12:38:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b795a5a1-99ad-7f6e-9e1e-869a49844e4c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cf957340-5765-4a47-42a7-4ece82bc1a6b"},"authoredOn":"1971-12-25T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b79a42b3-7cd0-8055-36e5-911ae6ceef0d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/a0ad98cc-3e9d-470a-d6b6-36447f629bdd"},"authoredOn":"1987-09-28T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b79ddba2-1993-6aca-ab1c-c0bb439e414a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/88f680b6-e0e7-d7c0-5ac2-ca89d3c54047"},"authoredOn":"1980-09-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b82168ec-71a0-6e16-491f-a96ac7fe4ffd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2a31266d-f8dd-19cc-16bf-8a3a0b5a6fc2"},"authoredOn":"1987-03-02T01:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b852486b-fdc9-5ca0-aa81-8d2259ad15bd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/19493569-d56d-7e42-c937-214f05cb21e9"},"authoredOn":"2011-02-07T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b862f76a-6560-ff31-bfda-6af05f35666c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/85ee11d6-f223-cd51-7988-708cc483f232"},"authoredOn":"1989-07-30T03:51:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b88065b0-66b5-f9ee-916a-2732b7e6e48f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"978950","display":"Natazia 28 Day Pack"}],"text":"Natazia 28 Day Pack"},"subject":{"reference":"Patient/a4a401d1-a46a-eb4a-8a38-760d5d79d6ec"},"encounter":{"reference":"Encounter/9da16fa0-4a1f-9643-12ca-5a67311e7b4e"},"authoredOn":"2020-02-19T14:54:55-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999999698","display":"Dr. Bobbye345 Wuckert783"}}
{"resourceType":"MedicationRequest","id":"b8b88ce1-4cc6-1d50-8baf-5bcb7876504f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3d14ec07-d167-8e78-82b0-408f046caa54"},"authoredOn":"1971-03-13T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b8fa24ba-16a6-da44-637c-4b2e8b34bc58","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6de05aa5-4cfc-9293-ad90-c5bab52a904a"},"authoredOn":"1989-02-07T13:17:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b905964b-6bea-fbd7-cc44-abc4de9bd03f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/eb96a570-8079-912c-1f48-a497a6470b26"},"authoredOn":"1992-10-26T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"b91ee147-c2bc-0bc0-f87d-ee6f8b33d2cc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-01T20:01:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b92319cf-a495-dbfe-6b60-cf461405f16c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/173abf34-adc3-19f3-d8ef-abf16ede8c89"},"authoredOn":"2022-01-29T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b96b2d44-3fdc-33ca-f3ef-9b3c85fbbdb2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6388514b-89c8-96b8-2646-e305b8312897"},"authoredOn":"1989-01-13T15:32:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b97abec9-6205-ab5d-b20c-5237374df086","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-25T12:37:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"b989aaf2-4eb6-7bcd-35cc-9fea4f786101","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e1d65e66-d9aa-b0b3-612f-910b9c76ebbc"},"authoredOn":"1976-10-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ba0b16da-9279-d9b4-6caf-09014e201be8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6a47de66-4ae1-e2a4-9b14-36671b63b81f"},"authoredOn":"1986-08-23T11:20:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ba135e27-b914-c71d-fdca-bbe17b2090d0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/772c8659-ba16-d1c4-4e77-b1bbd9b6eb75"},"authoredOn":"2007-10-09T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923995","display":"Dr. Johnson679 Schmidt332"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"ba17eb9b-a857-7c60-2487-42f4953993ec","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/fe051f67-71d8-ae82-fe95-f18ed8590009"},"authoredOn":"2007-10-16T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923995","display":"Dr. Johnson679 Schmidt332"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"ba1fe479-2902-ba51-d31b-66401ba54ed5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/895a94ae-e6bb-ea8b-527e-d52bdfefabcd"},"authoredOn":"1979-11-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ba9c4452-51f0-50e2-9b75-52d7c6a8eaf6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e0ecaaeb-75e2-32bf-0529-0ffca8573a6c"},"authoredOn":"1972-06-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"bacd2e71-987a-b851-ff88-212dd0178bea","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/df96293d-d0d9-5e91-84bd-b27ce608b379"},"authoredOn":"1985-11-07T01:59:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bafaacf7-b891-bc6f-e0f8-5ce729accba2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9b2f646e-df81-421d-1d07-821007a2e020"},"authoredOn":"1989-06-10T07:52:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bb6abd48-a8f2-2a5f-8016-720cc67e16f1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-22T19:20:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bb890b04-743d-c437-7616-407596c1ef64","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a62f59db-b656-dbb4-d0b3-7a1d61dabda6"},"authoredOn":"1986-11-28T05:56:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bbea58a2-7ebd-17c5-aa9a-6ed7cc8a11b6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7f8f1eaf-0aac-fbd8-a50d-1a7441470a1f"},"authoredOn":"1981-11-28T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bc1e26df-7dc3-d866-fa00-5a3d99a68ccb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"705129","display":"Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray"}],"text":"Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f34c95b-347f-3f84-587b-7de093dde963"},"authoredOn":"1992-10-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"}}
{"resourceType":"MedicationRequest","id":"bc250be2-c27e-afb2-dcd1-799d676429ef","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/017170c6-d467-d131-6ce1-066366055a42"},"authoredOn":"1986-10-21T19:00:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bc4e5858-2726-c6ab-d328-fd8606a7b752","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-29T00:46:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bc613830-be8a-1140-621d-607d67da32e2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2e376b26-c4e5-96af-d1e7-ea4808adcf29"},"authoredOn":"1990-08-18T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bc61cdad-ffd1-4298-b303-0641304de3cc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9a07af63-51f2-a9d7-8c27-7e213700f916"},"authoredOn":"1988-07-31T06:53:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bc82daa0-30f3-4acb-cbea-770c2b44ee30","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e13baf95-986a-6cdc-feed-a7ac3ddbb5ff"},"authoredOn":"1987-05-19T08:27:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bc89e20d-5836-de98-f0b1-246298e3adc2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/04630c0f-5e9c-c52e-8f1e-d056f6281e9d"},"authoredOn":"1970-09-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"bc9248b9-6a00-672a-150d-fbccb3a0d16f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c4a22965-b86f-99fb-7d84-ec78957ec55c"},"authoredOn":"1985-12-20T13:22:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bcb75336-0ad2-b5c8-1193-69af929f81b0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-23T03:42:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bcd3056b-800c-0125-51dd-7484b001a453","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-04T02:19:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bcd54988-d18e-9cf9-cc0c-732fe1d7a5d3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/31329fdc-65bf-66a5-95c9-f86243d52152"},"authoredOn":"2012-08-07T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"bcd9f50a-640d-b4ae-4478-598c01320835","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-18T01:33:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bcecf3b6-32ef-2b1d-f9a4-a47a2ca94d9b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c3d45d96-3eda-fe67-4a34-e97e647b9eb7"},"authoredOn":"1989-09-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"bcf59af4-1989-39d7-7d38-ecaf20d494ad","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bf5d9bd9-cd30-9d37-e763-535771f35ad2"},"authoredOn":"1988-06-26T22:49:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bd0f8a58-4aa1-89ef-5a99-d223e9ae0102","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-24T10:34:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bd4654c8-f986-53fc-4337-4d707b52692e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/094eff01-4e5a-0f7b-3d35-ff06c046ef3a"},"authoredOn":"1982-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bd4ca547-c6d9-8847-07c8-ca9a5da1fa1b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/63f6a52f-208c-8587-9313-18ae5ecc573b"},"authoredOn":"1982-12-25T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"bd513b34-82f1-2c47-6002-3282e7798760","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9d655b17-7ad9-d080-39d8-fd7848030a60"},"authoredOn":"1986-07-25T18:43:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bd7b8899-2440-0394-cba6-deb0962d128b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/98e1f05a-1b22-3a15-fced-1da98785dae2"},"authoredOn":"1987-08-03T20:39:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bd83e87c-f13d-7998-009c-6624d07bb215","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/57c0aeae-8cc4-8e4f-5b01-40bf150b5a3a"},"authoredOn":"1985-11-25T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"be2e61a5-732b-9a45-3e97-6884b25cff7d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2d5bb62f-9600-b487-cbc7-ed35f866a45e"},"authoredOn":"1986-01-27T01:15:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"be62ebee-18ff-bfc1-81e7-a17deddaa851","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/97f1f5d7-6dbb-72a8-4d61-ade7bcc5b9e5"},"authoredOn":"1987-04-08T18:39:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bea718af-187a-16d6-6b7f-50f3ec3193c7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2a6b2529-6b90-c748-e1c7-75f753832701"},"authoredOn":"1989-06-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"beb66eb4-eaed-508d-6e40-b1b01740064e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/586df9e3-5ce1-43b1-01ac-7fb954db4e63"},"authoredOn":"1989-01-07T10:12:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bef6db3c-51e2-0aa2-0916-bb9d5926391d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-27T09:49:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bf53edf4-616e-bc8b-24c8-3374dd672b7b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/98e1f05a-1b22-3a15-fced-1da98785dae2"},"authoredOn":"1987-07-31T14:57:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bf83ff93-cfba-966b-b0e9-494072b2788d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/511eb1ed-0d22-7db7-a6a4-1370ee5a96f5"},"authoredOn":"1989-01-13T01:33:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bf8dada3-a9b4-f60f-2a06-d6f4995b9fcf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9b2ac79d-d591-b387-9aef-f072f424c4eb"},"authoredOn":"1987-07-04T08:28:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bfc2a06b-740c-e2ff-df60-09776fbd7b68","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-05T04:29:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bfd2786d-299c-12d5-7ada-a5e2cd0b449f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f138c75b-05dc-58ec-6842-14f1e0b29905"},"authoredOn":"1988-01-05T15:33:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"bffa4718-c5f6-92cd-079a-0a4a53f459b2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2bcbde85-50ed-9e59-f7d6-fae74741bdeb"},"authoredOn":"1990-04-28T09:08:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c00645af-f8be-2ccc-6057-bd90a89f59d0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c3911768-27d2-34d9-b7d6-520edc65c469"},"authoredOn":"1990-11-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c01b9ea7-f7e9-35ee-9e52-6c554f47e0c1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ee23c66c-577e-9e4c-4dfc-82136b01ab86"},"authoredOn":"1988-08-09T14:55:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c02c2c84-28d0-e605-e7f8-10925e329043","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/826e339a-fe94-2eca-202d-99b1b9901512"},"authoredOn":"1985-09-21T07:24:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c07f12ea-ef27-789c-b386-f7fc36909f68","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c073e339-1e53-4199-70ca-ff6808c4e031"},"authoredOn":"1971-06-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c0834f82-9dbe-305b-abb4-d79ee136d6ad","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/92bc64d7-b189-cde0-a10a-d836dd2f6040"},"authoredOn":"1989-11-01T04:49:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c091e37f-03f0-85fa-5f5f-7795dbcce854","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/67547824-ea47-e31f-11dc-ce73b9b4ceb8"},"authoredOn":"1990-05-30T05:39:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c095ad70-538b-6e30-33ca-380006c3c6f1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7f268b77-6ad9-a989-60f4-ede62d6e8706"},"authoredOn":"1986-06-30T16:53:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c0974751-5f5d-f2f2-8188-d4935eddc551","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9759a722-e802-3e6d-f3ee-96910894e65e"},"authoredOn":"1988-04-21T16:18:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c0987a2c-449e-0e8b-defb-1eb530add12e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f65151ca-9429-27f1-27a2-9730827732c6"},"authoredOn":"1986-06-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c0b9d5a2-2e15-73cb-f263-ed9e1b7da5c7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-14T20:01:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c0c689f8-1e42-b7ca-0304-16cc38620fa2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/eeec9c58-8546-ad91-0e23-3986685f9f22"},"authoredOn":"1989-03-16T20:42:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c10306ac-7e5c-febc-2c52-aaf963978793","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ec3a571a-c077-2219-d696-13317678656c"},"authoredOn":"1976-10-30T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c1272103-93c7-0305-e2bb-042718e5a62f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e854563c-6e4a-3877-f877-9b5411738527"},"authoredOn":"1985-12-08T15:21:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c142f55c-a28c-eac4-5f69-d2dbf5e9062d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f47bd74b-4e96-5a46-59dc-3847d3247326"},"authoredOn":"1985-03-29T06:28:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c145fd90-6f0f-2162-30be-9d626a00e745","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/412fc8a4-7f8c-ed84-353a-2ccc010797ee"},"authoredOn":"1986-11-12T15:53:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c154616d-7a44-35df-5843-a613c8244697","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/874982d5-4bc9-fa70-888a-827c3b02e207"},"authoredOn":"1987-04-11T05:29:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c155b824-00ca-ef30-c685-51b39743950a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/e8c11d8d-fcb2-3ff2-1791-a3167e2dba04"},"authoredOn":"2009-04-20T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999924092","display":"Dr. Asha251 Grimes165"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c163ca7d-d482-67f7-caca-d2f6ec9a22e0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d1d1009e-0dbf-3993-5d56-1283a211e07f"},"authoredOn":"1987-03-07T22:07:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c170b109-9153-50f9-c2ec-198b09534c2e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"849574","display":"Naproxen sodium 220 MG Oral Tablet"}],"text":"Naproxen sodium 220 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/af5789a3-afe3-1348-ffc5-85ad27b563df"},"authoredOn":"2018-10-18T02:16:29-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"c193a0dc-f0a8-6ccd-9627-53a8c7645be3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9b2d2ed8-9d6a-04a6-e959-bf3ce4b504aa"},"authoredOn":"1988-12-07T05:33:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c19b0415-9a69-bb21-b7a1-1502fe6599cb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5af68361-26b5-dc5f-aa78-62ff8134a7d0"},"authoredOn":"1990-01-20T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c19deaaa-c0fc-3dc5-a3f4-f918f437cd79","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3bd36936-adf5-0cdc-168d-2621e1c22820"},"authoredOn":"1988-03-09T05:22:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c1ffea07-00b1-e487-9ca2-63f853a753eb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c841374b-dde4-6602-fc0c-1c136e854c6f"},"authoredOn":"1983-08-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c21bce8d-21da-4866-f843-e7cc154cdc99","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4b7070eb-5fb6-fb76-8d68-2e539cff23ce"},"authoredOn":"1990-10-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c22eca72-52d9-2f85-923e-4a95ef16f586","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-09T15:32:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c2558b22-6c54-58f9-7098-55083a26e4c9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/da2964c5-5155-c309-5656-421e4fe9f60e"},"authoredOn":"1980-11-22T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c25bf28c-2e31-d7ae-c609-476a6a19ebef","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/5bde2d4d-3068-9054-b1fb-a1e6a0a2d6b0"},"authoredOn":"1985-07-18T20:35:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c27d28e9-b7b7-9dba-569b-5ea1ee092668","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3793ad5e-553e-024a-7f2d-ce956aab8fac"},"authoredOn":"1986-01-02T01:25:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c2ac98ce-56de-a29d-435e-10052ae3aa4b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1d73dfda-6dc0-293b-a3bc-43b7fa9f4b8a"},"authoredOn":"1987-12-03T02:39:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c2b13c35-5e64-2fe3-725b-1a5b52934799","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3d5ed14f-867e-a2a9-9378-332e9e55d20c"},"authoredOn":"1989-10-01T02:25:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c2b5353a-7781-7674-3ace-2de1aa16c4ee","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/162da8f8-8073-de7e-4835-996c3db2cd06"},"authoredOn":"2011-12-03T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c2f146e6-51fb-60da-cfdd-142fcf31d1e1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/63f6a52f-208c-8587-9313-18ae5ecc573b"},"authoredOn":"1982-12-25T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c32bcc41-3d22-9412-eba9-a0cd63cc31df","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/095821a4-3ecd-ab51-bbe0-c48ce35678f5"},"authoredOn":"1987-02-14T08:43:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c369271a-99f7-eb2d-6070-c557e2b020b6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5cb8aaf6-4203-134e-4374-e4e0aa14e52f"},"authoredOn":"1989-08-19T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c3afa8d8-b242-ee8f-c26a-20fc62ba4c1e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ba87fcee-5e12-459e-78a1-291c0afdb670"},"authoredOn":"1976-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c3b23f14-25c5-b51a-8d6e-e4d5f18c6c10","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/95f1ab77-b752-0d8f-298e-804cab2f8456"},"authoredOn":"1982-05-01T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c3c6a2bb-8c5a-1b60-bbbf-d99cc99c4805","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a3adfda5-6941-6662-0c46-c23cff52f14d"},"authoredOn":"1987-09-04T06:45:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c40fbcfd-a90c-41ac-11a3-34e06b76b887","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/56c2517f-4180-2027-ced8-2dfa7c863d0f"},"authoredOn":"1978-05-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c463ecc3-a490-3d81-8ef2-0aed872e0beb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/56dabda7-f779-de4a-ed97-a8b55dec69d8"},"authoredOn":"1997-09-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c46ed69d-0dd3-fc82-e575-1ee20cfff482","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198405","display":"Ibuprofen 100 MG Oral Tablet"}],"text":"Ibuprofen 100 MG Oral Tablet"},"subject":{"reference":"Patient/63ee2253-bdd5-da55-2ad2-b4984d0ad700"},"encounter":{"reference":"Encounter/8af5af9d-0858-c7f7-46aa-35194b8014b9"},"authoredOn":"2017-01-03T10:33:07-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999886895","display":"Dr. Hazel720 Schultz619"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"c4a6eb07-d098-58cc-6703-48f507d5b379","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9318db9c-692c-b351-d472-8be543cfeb8c"},"authoredOn":"1983-06-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c4f0c532-2d02-d196-832a-abcbe692a508","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ea629ebf-098a-f989-1a90-6c67a0550c4e"},"authoredOn":"1986-10-31T03:31:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c4f2a3b3-bd22-a963-ae1f-3295ad9e227c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a4cd12e4-98f7-22d0-5037-ab22fe80610a"},"authoredOn":"1990-12-01T23:44:46-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"c4f53237-3d07-c4d4-90bc-088d85673544","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/9886a52b-ef10-353f-93e9-661fe7bd64e3"},"authoredOn":"2016-12-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c5789222-01f6-12b0-c618-d8c21c109360","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2dbec3c4-98ee-1d38-365b-dfbe489d12cd"},"authoredOn":"1987-11-08T02:09:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c5804b72-77e7-d4df-d3f9-fccdac0dcff9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/73488f7c-a2f3-4e99-4a28-417a01ed6930"},"authoredOn":"2020-09-22T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"c589d038-d56e-4170-2be7-bb7446626de1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/fddc6184-76f9-a03b-56fd-c9a23fbc70f8"},"authoredOn":"1995-11-13T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c618bce5-96e2-4124-cf75-5adbc4585461","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/19f20906-a2d1-dd97-6e60-754f24268ad0"},"authoredOn":"1990-08-09T21:32:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c6392a36-98a4-8556-98aa-75da50018c39","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/91476ae4-6ce4-b542-fa1d-51048f1f3e8b"},"authoredOn":"1986-06-15T02:03:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c63d245b-7405-dffc-382e-29769a87d06f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b8fb3635-6ab0-79c6-7ed8-1aa08dcd6937"},"authoredOn":"1986-10-02T04:26:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c63eaa5d-4b22-51b9-58c3-f1adef60d317","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"209387","display":"Acetaminophen 325 MG Oral Tablet [Tylenol]"}],"text":"Acetaminophen 325 MG Oral Tablet [Tylenol]"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/4364d0d1-6f8d-e8be-8024-9404b2d2a5fa"},"authoredOn":"2020-10-04T16:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999995597","display":"Dr. Shiloh191 Larson43"},"dosageInstruction":[{"sequence":1,"text":"Every four to six hours (qualifier value)","additionalInstruction":[{"coding":[{"system":"http://snomed.info/sct","code":"225757006","display":"Every four to six hours (qualifier value)"}],"text":"Every four to six hours (qualifier value)"}],"timing":{"repeat":{"frequency":4,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c64d4ddf-7fb7-7703-c6fd-93253c595ff8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ec3a571a-c077-2219-d696-13317678656c"},"authoredOn":"1976-10-30T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c693e92d-de44-ca5a-878a-1afcd897f04b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-17T10:37:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c6d55565-b31e-ffd5-b1ad-e0f2e283ea86","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1f7df196-f4a0-da07-3646-6c21182479b0"},"authoredOn":"1988-01-28T04:12:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c728c9aa-24c0-1222-d10c-307551e6bb5d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/19f50b4f-83a6-1477-3195-b0669b7c66f2"},"authoredOn":"1980-08-09T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c7362b82-6763-00ef-29ac-9d12318aa8a3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b4f6ccaa-2abe-40ad-023d-fd29475de084"},"authoredOn":"1986-03-02T11:36:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c753736f-dc65-a559-b77f-e6f438dfc841","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/dec80c66-daf8-e6ef-627d-868e0e03ebf2"},"authoredOn":"1970-10-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c77f4e42-cb8d-865d-0690-b0a265f2273e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/88f680b6-e0e7-d7c0-5ac2-ca89d3c54047"},"authoredOn":"1980-09-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c7946e2a-8563-95cc-66ec-9df030280b0f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/388af599-5dff-6e59-2166-0c4e121a0972"},"authoredOn":"1987-02-17T12:29:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c7c5c46e-63a5-f726-86b6-2605e9e5c3ee","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/36709aa3-82be-8c34-c3fe-4b7271168ff1"},"authoredOn":"1988-06-01T13:28:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c83021d5-e9f1-fced-4b6a-3e25fc121392","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ffc7118b-b744-da7a-d7fc-d3f6ab6a0350"},"authoredOn":"1990-06-08T14:39:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c835baeb-bbec-eacb-575f-f57db7453c4e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f5c7ad5c-6397-61c0-8978-cf9c4086d9b4"},"authoredOn":"1983-10-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c8813191-6b9c-6f9c-02a3-1ea1e1892d3e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3467c7c1-750d-d238-10ae-47453cde0b0a"},"authoredOn":"1981-09-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c8d31ad0-97ff-1636-fcf8-21967296ee51","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/798187ef-ec6d-e274-5e54-4e060b90e10d"},"authoredOn":"2015-08-25T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"c8df2f74-1f9b-6829-1193-864dedf04cd0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/efd68eda-8350-086f-0fac-3ee0ba1e320d"},"authoredOn":"1989-02-18T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"c90f4a8c-e711-9a65-e7df-7e8b70642eac","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-11-07T08:17:13-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"c90fd0a0-fa15-456b-18e6-e37cdbb1eaa4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9b916350-fe45-5f1e-f7c4-341c03781726"},"authoredOn":"1976-09-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c970f9f0-d744-507e-0b12-6b6e2a964583","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e755e154-3e48-3695-3521-5261e6fdd6d0"},"authoredOn":"1985-09-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"c99ec303-acca-f9ce-e0cb-c4232564774a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f55502c-5642-0f1e-f442-137b002a6691"},"authoredOn":"1979-05-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ca1026eb-224c-3a6a-0d98-65ea5e2c463e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5412173e-50cb-1119-e67c-c3db00a037e6"},"authoredOn":"1987-10-20T11:18:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ca40b2bd-fe1f-f7b2-38db-67f71479e45c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-25T10:09:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ca8006e2-ab8b-4b02-ad70-36cc3f9f923a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8594ce9c-239b-a11a-fadc-664940386b91"},"authoredOn":"1981-01-03T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cb52961a-4cb8-f3f5-5db3-682336a83796","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/40d7d2d6-7f4e-776a-b704-cd0b8de45cd0"},"authoredOn":"1971-09-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cb798d3d-7878-bea6-48ac-8198f7b0e68d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/82e589e4-20e2-4bd6-bda4-721f89de16cf"},"authoredOn":"1978-09-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cba90b0d-f071-0496-bf91-b430dbdd5e81","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a9e58034-a488-5c1f-917c-ac646183be23"},"authoredOn":"1987-05-16T05:09:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cbb6f639-95c6-0ada-5e40-e93b421ddbb6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e81c079a-4240-4eb8-d138-a9f00a04419b"},"authoredOn":"1989-08-27T02:25:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cbc35fb9-817d-dab5-3384-fa1fdbdba93d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/e43ae69b-4762-fb95-0117-ac1224bac0b2"},"authoredOn":"2010-07-27T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"cbc88cf7-b7dd-17db-121a-a1b1d263db6e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-24T03:33:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cbf514d2-cf06-5ae8-a385-270219621a08","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ebac9a16-c0ee-8ed1-7487-95483885b476"},"authoredOn":"1989-12-08T13:40:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cc03a676-0825-7e18-c1f9-e7ee52e76c05","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1094107","display":"Phenazopyridine hydrochloride 100 MG Oral Tablet"}],"text":"Phenazopyridine hydrochloride 100 MG Oral Tablet"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/db2357c4-3c22-43f7-2182-8770bbfd7289"},"authoredOn":"2014-11-12T21:45:24-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"},"reasonReference":[{"reference":"Condition/9f2e1f92-3b7e-cb46-db86-19117bd600aa","display":"Escherichia coli urinary tract infection"}]}
{"resourceType":"MedicationRequest","id":"cc194f34-2fda-55f7-1323-f44db2d23d07","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-13T09:23:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cc52877f-733c-0697-2d24-69ae6dedc432","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/02431a0e-d934-755d-345d-f4d6324cfb98"},"authoredOn":"1988-03-17T00:55:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cc65a401-17c1-cdd4-bbdd-accc9ed29b09","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5d308c38-50e0-539a-f411-a6829246de71"},"authoredOn":"1990-07-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cc683d7d-aff0-ad3e-c577-7f9750ceeb3f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/70659784-0556-fbdf-81cb-957fd514bd71"},"authoredOn":"1997-11-24T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"cc766a8f-15f1-3350-abb1-d2ae956b8cfd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c20be672-8b7c-f189-4140-0a4b29ac240a"},"authoredOn":"1979-07-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cd268afa-169d-9bde-5e98-8c2db7ea745b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6ce8e0c9-3274-9ddd-a977-23de15d04e86"},"authoredOn":"1990-04-22T03:23:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cd2be5fb-08f7-54c9-f36f-49bddcc12c8b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fd11a283-742d-9d9e-e2fb-64b73e212991"},"authoredOn":"1990-03-31T09:08:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cd372088-2f4a-8a88-91cf-6fbb683ec480","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-24T07:47:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cd3a10a5-f65f-cbfa-4a0e-00ce60a9527e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/74e3c134-ac35-3bf4-0a46-346dd25dae2b"},"authoredOn":"1979-10-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"cd4204d0-249c-bde1-82a6-fd97c9f2a7cc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"849574","display":"Naproxen sodium 220 MG Oral Tablet"}],"text":"Naproxen sodium 220 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/a50250d3-22f2-3f20-f030-a6a63b4d8cea"},"authoredOn":"2006-05-13T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/98308690-1c80-5d2f-f04c-7c825f4ceecc","display":"Osteoarthritis of knee"}]}
{"resourceType":"MedicationRequest","id":"cd609394-f749-4913-3407-fea83f60aa52","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-10T15:57:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cd6d6e93-0744-f65b-8838-9dd7eb6e1927","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a35e6fb0-1e23-82bd-fe7a-bc571811410d"},"authoredOn":"1989-11-18T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"cdaf6b2d-efea-4337-6939-afec83b185de","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d1d1009e-0dbf-3993-5d56-1283a211e07f"},"authoredOn":"1987-03-08T23:50:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cdcbe54d-beda-6c71-b1ac-e1eae78a7eef","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/904f5d11-d7d9-e0b3-b3e4-992d11f49523"},"authoredOn":"1986-06-07T10:08:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cdd443fd-2640-0f7a-7d9a-e85b2973b22d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/222b3db9-b658-f4d0-4ec1-780a907f8306"},"authoredOn":"1985-12-26T19:18:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ce2476a5-f4ba-2466-00b8-139ebbcc3c98","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-29T14:20:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ce700014-df5a-42d1-5602-ffe5194d9fbc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/aa6cc40c-55e0-eb2a-c50b-bed116a81ced"},"authoredOn":"1985-06-13T18:48:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ce9404ae-ed41-5103-9e78-3048f1b5b41a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5d308c38-50e0-539a-f411-a6829246de71"},"authoredOn":"1990-07-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"cec20a70-7e92-c10c-466d-844a56556c03","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-27T22:21:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cf53c55d-b0a6-ba19-8f90-a6917ffec069","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9955b848-d0df-0756-aa21-d96e090ec811"},"authoredOn":"1986-10-02T22:56:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cf5e1215-d215-db8f-f5ab-8ac1740a8616","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bd9b06ac-0873-15c9-e7d1-84356c2de89e"},"authoredOn":"1987-05-10T00:32:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cf6c2698-5037-b146-2f34-2eb2d559a472","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0239b16e-8b3d-ee0c-7f9f-29618f32e59c"},"authoredOn":"1986-09-20T09:37:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cf9d368d-442e-c18f-c7cb-5b630e142f87","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2dda2b15-afe6-63cd-571d-00cd00b9990e"},"authoredOn":"1990-10-21T03:16:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"cfe14bf1-f50c-7296-add8-55a4466c895c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/68cd511a-269c-b687-a52a-a6784ff731a4"},"authoredOn":"1980-10-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d08293a3-c035-64b2-a7df-20e55b56a692","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9759a722-e802-3e6d-f3ee-96910894e65e"},"authoredOn":"1988-04-23T20:45:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d0acb6a6-3668-0056-dafe-bca16ef96af9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-17T01:00:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d0c56023-d9c1-b4b3-c3e1-74ebd1931722","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/41d2ea35-44a9-2b7a-df42-23707eef2af4"},"authoredOn":"1979-05-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d0ec712f-4771-cb87-72a7-276fa11d3af4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/83187dff-758d-d9ad-95ac-d55584b5ae16"},"authoredOn":"1990-09-23T03:12:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d1127e5e-d815-63db-1edd-dada600e4ab9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/cc461327-6962-c37a-58a3-477327c38d27"},"authoredOn":"1991-10-21T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"d126db13-a476-5d52-631a-102ad23497e5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-03T10:43:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d1be415d-9766-35a3-86b3-d4e816cdb5cf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/0d3f79d5-ee2c-af5f-18bb-0cde9480457f"},"authoredOn":"2014-08-19T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"d20516bf-0cb2-7104-ed40-3c57fabcb5b6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ddc2a3cc-42bc-ad1d-bc35-9a9a9bc936c9"},"authoredOn":"1986-04-01T12:49:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d21dc894-cdea-a80a-4df8-f3ed7021fe2a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-10T04:47:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d242d1c7-7ed3-23ed-56a9-39e961219262","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1043400","display":"Acetaminophen 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution"}],"text":"Acetaminophen 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution"},"subject":{"reference":"Patient/bb6a9034-2f23-2508-d29d-35efee156dc9"},"encounter":{"reference":"Encounter/b6ad7dca-8a36-6eb4-f091-d286f9663f45"},"authoredOn":"2021-10-27T14:52:10-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974295","display":"Dr. Millicent213 Mertz280"},"reasonReference":[{"reference":"Condition/494e6a66-860e-91bc-4acf-516a1f6337f9","display":"Acute bronchitis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d28fbc3a-5854-c166-27c9-886b846b95b9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f138c75b-05dc-58ec-6842-14f1e0b29905"},"authoredOn":"1988-01-06T19:20:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d29c2541-7f33-0092-67a9-3a9eb7cd0390","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-09T13:57:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d2d34c67-13ea-bf7e-6dd3-2c05109c5ff6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fb2ce4eb-4218-6367-cf0a-9f4941b76ae9"},"authoredOn":"1987-08-03T20:35:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d2f908a1-5116-3fae-ff37-a24ba6791a04","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-21T11:51:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d300a197-ea71-c04a-1f74-2ffad5f297d3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/fe4a05bb-895b-a8bd-9b57-24a9cd6a446f"},"authoredOn":"1988-08-12T12:49:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d31b390a-df50-c5a2-4f85-a20de6acc92f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1da034a6-272c-a248-4852-fcf83492b805"},"authoredOn":"1987-03-27T03:16:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d3305a30-d5fa-c893-3295-bbda094dc412","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/57634bbf-95b9-9183-c8ac-5cc7f30b1f76"},"authoredOn":"1987-12-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d38cf8ae-e07e-5640-3b52-e16fa6067c86","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-12T17:30:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d39c5f10-c14c-eec3-5461-62360d15c176","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/9740459b-0423-19ac-9b06-d69c2ea95382"},"authoredOn":"2014-02-12T13:45:24-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999933390","display":"Dr. Cherrie404 Conn188"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"d3a513ee-fe69-6d1e-718e-2ed3a809ddb5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e1d65e66-d9aa-b0b3-612f-910b9c76ebbc"},"authoredOn":"1976-10-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d45a524a-6feb-50b4-8a39-5663355ec55e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d681ddd9-1fa8-e1b0-e6f2-b25e0a65b6af"},"authoredOn":"1985-05-02T22:19:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d4796de7-9049-61a7-6796-c09262314832","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/148ac0ea-a254-7d24-34cd-c149191ab613"},"authoredOn":"2019-09-14T14:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"}}
{"resourceType":"MedicationRequest","id":"d49e0ede-ef08-4adf-f271-0c7bcc0169a0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/adb3d130-8739-4eec-5a0e-a9aa59a49e1f"},"authoredOn":"1988-12-16T15:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d4a23fe7-0422-5ee5-94e4-168475796479","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e5fd3539-e5c0-7c5d-e638-0df191617243"},"authoredOn":"1987-01-23T09:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d4e95e23-8980-65d9-9058-3623a4741c2c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/506795e8-845d-669e-99e8-f3a05b9ea8d0"},"authoredOn":"1985-11-19T13:48:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d4ea6645-8246-9192-216a-807ca34c861b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/34ae8c0b-1271-6f7e-1d9a-c9e239be41c2"},"authoredOn":"1992-08-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"d4f26e53-b004-6a92-6bc9-54b222f526d6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/1757eb91-63f9-5a92-ef9b-1afa1a17cef2"},"authoredOn":"1987-10-12T17:35:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d5108c3c-7267-c053-f651-17e1241fef44","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2755158a-c1d5-7656-de96-812ed71b1058"},"authoredOn":"1977-02-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d58a098f-1dc1-f564-3e47-8b88ca36fd0e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/31a317f9-5cac-3f7e-9912-2eea37327966"},"authoredOn":"1985-10-06T22:25:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d5a00fe1-1b4d-3e4a-e914-b2e0fb4ac35e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8bc36efc-e924-f254-7376-a0e5e3e96e67"},"authoredOn":"1986-06-21T09:25:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d5c6c188-4f3e-792b-2a3b-5889674886ad","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ca5eddaf-8dfb-c06e-cf40-d6c670b428e6"},"authoredOn":"1987-01-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d5e22a06-aa96-cb98-a703-467da5df8cee","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e9126d61-103e-afe3-5aef-b758ddb8d071"},"authoredOn":"1982-09-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d5ff2800-8c34-22a7-6056-ba85c612dc20","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/96309b87-2891-58d4-3727-83c82d6444e3"},"authoredOn":"2007-11-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d61c7349-eed7-ee3e-3540-816f181cd831","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e3bed295-2fb9-aa1e-76f4-3f86cf783a5c"},"authoredOn":"1989-12-27T02:59:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d622f6fb-29f6-daff-2166-986d4b074655","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ff6b1a6f-d01b-148a-684b-330294f7b947"},"authoredOn":"1987-05-25T15:36:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d624ac74-b51c-9a36-be64-9d93df5da4ca","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/cbcea78a-b03b-76a4-ced4-3a3a9785be47"},"authoredOn":"1989-10-09T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"d64f30b2-a302-2030-9eff-0aba568236f9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0b40bf17-392b-5221-2f8f-93faddef1aaa"},"authoredOn":"1987-12-12T10:36:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d651d19e-586e-ea63-b422-01b644ba24f1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/1854cfee-25a9-be78-3e58-610628bc7129"},"authoredOn":"2008-11-15T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d69fbc6d-d5a2-4829-1411-f4e030be8e8b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e755e154-3e48-3695-3521-5261e6fdd6d0"},"authoredOn":"1985-09-07T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d6ad1773-a092-7ba7-e263-8621fc1bce05","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/42475904-a62e-bd83-cb6f-e9c54e45d883"},"authoredOn":"1981-05-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d6e99e9a-6b02-c07a-e7ca-ea9434aa97c9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/904f5d11-d7d9-e0b3-b3e4-992d11f49523"},"authoredOn":"1986-06-06T07:11:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d71094df-cad4-e540-a6f2-84719196cc9b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/87e977d8-d0cf-82a2-bda7-4d2f2ab0e674"},"authoredOn":"1983-06-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d74707fb-7ba0-4026-7b11-2356fd5d15eb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/234425d6-07a3-2fb4-48cd-f0c90996ed52"},"authoredOn":"1983-10-08T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d75c83dd-72fa-1c7e-56fb-30d32f5aa85a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bdc0991a-ed69-f5c9-0c02-971af8b10203"},"authoredOn":"1976-07-10T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"d7c58929-a0d2-9334-c9df-14556459faae","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1094107","display":"Phenazopyridine hydrochloride 100 MG Oral Tablet"}],"text":"Phenazopyridine hydrochloride 100 MG Oral Tablet"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/aea4a38b-9860-8edb-cef8-79e5da15e7f4"},"authoredOn":"2018-01-31T13:45:24-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"},"reasonReference":[{"reference":"Condition/9f2e1f92-3b7e-cb46-db86-19117bd600aa","display":"Escherichia coli urinary tract infection"}]}
{"resourceType":"MedicationRequest","id":"d80bdbd3-a410-cbfe-68ff-3116328716ce","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c544ddd4-ef20-096d-a655-ab0ce01b2cab"},"authoredOn":"1985-01-13T11:17:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d8940970-4a13-3a1c-7c5c-3a9e94ed6750","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/74e3c134-ac35-3bf4-0a46-346dd25dae2b"},"authoredOn":"1979-10-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d896d797-2728-a58e-c361-3dc2f94264a1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-18T13:50:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d8b8c831-364f-3290-1cbd-6446599f869b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-20T19:03:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d903c94a-447b-cf4d-4f7b-ff2a4472c085","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a480e772-74e0-0483-5e58-ffcc8ab7336f"},"authoredOn":"1990-11-25T01:12:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d91def5f-561e-2a22-b53d-e6972a28876e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8d82f0e1-7a79-35f6-c48f-4dd5356f547f"},"authoredOn":"1971-09-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d923095d-bdbf-bd89-66c3-8c1dfad5368e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/ddebadfa-544a-36c0-f50a-9e5ce9b94723"},"authoredOn":"1995-09-09T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"d9697b4d-016a-309e-3762-08e626213477","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c3911768-27d2-34d9-b7d6-520edc65c469"},"authoredOn":"1990-11-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d97d4f93-a164-40ee-5bcd-6557710b655d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a827214e-bc16-28ca-50d4-e4f080a645e7"},"authoredOn":"1979-06-30T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"d99dc91c-d1b7-6b05-0cf3-3f0130619e00","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f6de2653-81be-e82e-0ef2-4f0526b67f17"},"authoredOn":"1986-08-20T07:49:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d9b9567d-5bda-4502-cba7-9c2ed5e1fd70","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0311794c-b854-85d7-dd0b-dc090c318552"},"authoredOn":"1977-12-24T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d9d4543e-ec8c-8087-7c1a-dc63fc7e9cda","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8d8f5b99-ce58-87fc-ca8e-d2c606a1d693"},"authoredOn":"1986-03-14T22:41:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"d9edaf93-cb71-41e8-80ed-abccbb7ed286","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7709085c-11c8-0f0d-adc1-bb64b252ab92"},"authoredOn":"1988-10-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"d9fd7e21-89a6-bb9f-6903-5c5ea90d0e7d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/e76f8c48-ef59-57b8-9980-122e72a22e14"},"authoredOn":"1984-11-05T03:37:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"da15e330-eaf0-a129-55e1-0ce3f216641f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5d4f61fa-5cd3-8eb5-2aa1-79c119fcda9a"},"authoredOn":"1990-10-27T08:15:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"da4cdde2-a400-ff5c-58c2-2b884ddf05a4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/57634bbf-95b9-9183-c8ac-5cc7f30b1f76"},"authoredOn":"1987-12-26T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dacb25c6-717a-8c0f-78a6-dcf81f99e686","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313782","display":"Acetaminophen 325 MG Oral Tablet"}],"text":"Acetaminophen 325 MG Oral Tablet"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/a175b1f8-f9ed-ee45-a25f-a43291e426e1"},"authoredOn":"1980-09-07T00:08:43-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/a74e11f3-980b-4eef-2ad9-1fc36d952530","display":"Acute bronchitis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dad4168a-fcef-4c5e-06e4-87ca7f036d06","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/abbe1a1a-4181-8a9b-ff0e-cde76a2debae"},"authoredOn":"1987-01-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dad6a065-99da-844d-db1c-0c1d8c3afb3c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4319ba8d-5e1a-3f58-9edc-6ea6318f39c9"},"authoredOn":"1986-05-25T03:44:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dae33f15-1aec-e552-166f-425b66c4d70b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"866412","display":"24 HR metoprolol succinate 100 MG Extended Release Oral Tablet"}],"text":"24 HR metoprolol succinate 100 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f34c95b-347f-3f84-587b-7de093dde963"},"authoredOn":"1992-10-24T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"}}
{"resourceType":"MedicationRequest","id":"dafd3d8b-e6c7-eeb8-d0a0-af4f5ed40ef7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d1ad6852-7059-8ef8-b710-4cc34d57381f"},"authoredOn":"1985-12-14T07:02:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"db09a8ce-d698-cf62-dfec-ad97b623ae8d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/78e879bb-1bcb-12e0-4321-a38bd17cab89"},"authoredOn":"2010-02-01T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"db15620c-7173-e004-40cc-203dab5eac54","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e0ecaaeb-75e2-32bf-0529-0ffca8573a6c"},"authoredOn":"1972-06-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"db39e8c3-bd9f-4c4b-0ab6-f21df8f42699","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/248210ad-87ae-66a8-a756-393f140752a7"},"authoredOn":"1995-05-22T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999992990","display":"Dr. Estell607 Barton704"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"dbb3462c-de31-c142-1019-8d7e4806f869","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e06a5917-9f46-3891-e40a-8917335e408a"},"authoredOn":"1990-09-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dbc5198b-ce43-c120-2b63-1990ff66f9c5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ab9f22bc-bfc8-f44a-eeae-9a99f1e48d94"},"authoredOn":"1986-05-04T19:13:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dbf3b937-ef01-d7df-1d18-cb0316802514","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/0e4ba84e-0afc-0850-85ad-23a64c17cd6c"},"authoredOn":"2016-08-30T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"dbfef2ee-c467-d775-c39b-ee792b28a9c0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/50e261fd-d506-ccde-97da-19308cd4b7ca"},"authoredOn":"1985-07-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dc0df89f-113f-c15a-66aa-48925faa87d9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/da66d08f-1aaa-fe80-45ee-f6c90b7337f1"},"authoredOn":"1988-04-12T15:31:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dc187f6e-9060-716b-2e54-be35e564cc3a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1edab468-a695-f52a-cfaa-da186d2a25c7"},"authoredOn":"1990-07-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"dc1f2065-6571-21c6-09ff-f2a0af9fdf6a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9759a722-e802-3e6d-f3ee-96910894e65e"},"authoredOn":"1988-04-22T20:03:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dc24c8e5-1c6b-12ea-635c-b8775907da05","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-17T17:38:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dc2fea4d-9727-e306-3e4e-2d072b787607","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c544ddd4-ef20-096d-a655-ab0ce01b2cab"},"authoredOn":"1985-01-13T11:17:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dc9d2809-b728-9f1b-e219-7d553eb9cc6e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7546e2cc-bd65-f234-f334-8babc46bf2ae"},"authoredOn":"1986-02-21T01:37:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dca44c73-edb0-cb76-32a1-b8659f466fbc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/464fa24e-a654-d19f-bf62-c78daa09708a"},"authoredOn":"2001-12-17T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"dcd1240b-0386-c4d1-a676-fbf0de4b3833","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8a4709db-e864-7b05-5285-f19f8817c147"},"authoredOn":"1985-09-30T15:38:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dd6ed8df-9156-9fe0-7094-3fe2b2258c8b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0ad1b3e4-60fa-1772-975c-18ff8f356d9f"},"authoredOn":"1988-07-12T12:13:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dd9a4660-2c67-2506-c649-9cd1bfb21852","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/76ce794d-ea01-e87d-2fff-892d2b609cbe"},"authoredOn":"1989-01-26T02:09:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dd9afab8-5f9a-a62c-791d-ece3cae99684","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a7045325-23db-55de-2dc1-20f8f828352a"},"authoredOn":"1988-02-03T11:04:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ddb4807e-e5de-8d00-d5d8-4de5f44dfe5b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/00d2903a-e2d6-20e6-df87-52bb6477f24f"},"authoredOn":"1989-12-16T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ddd877b7-7467-e19e-4433-a1b850686d61","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-05T16:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dddac2fd-58ff-3a49-2661-e02e16d2c295","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/02431a0e-d934-755d-345d-f4d6324cfb98"},"authoredOn":"1988-03-20T05:29:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"de275030-141d-ca03-fdd3-6e3d06cea39a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5783a21a-dee1-2c88-c93b-b89c740fd209"},"authoredOn":"1990-07-25T06:20:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"de731ecd-9b7b-4bbf-5ab0-57b780f780cb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b57e3916-d0a2-a18a-47e9-6246cdba56b7"},"authoredOn":"1989-03-31T11:52:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"de8e929d-da55-31ad-d23c-9a21ac86d557","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/721fa30c-7711-c850-8faa-9066eabb0cb7"},"authoredOn":"1988-12-04T02:16:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"de91eac2-4672-7009-572b-384a3bae9e05","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-21T20:17:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dec54655-42b8-5178-a89d-a6eaa7c6f3ee","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-11-08T08:52:49-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"dedf7fc7-84d3-10b6-1752-aae635abbf4c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1523b699-afa5-5120-b0be-7da8e512f6bc"},"authoredOn":"1990-08-06T18:45:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"df14ee4f-af46-d180-d2cd-42abf5b9d411","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ae72af58-fd26-6776-b565-c6cc426bd594"},"authoredOn":"1986-07-13T05:35:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"df45e3f3-9475-5071-1522-a0ec6cd12619","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0a4aceee-f368-3837-fde1-ddcc6bcca3c3"},"authoredOn":"1990-09-26T06:37:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"df5ab29c-dc2a-0f00-dc6c-b0981b3f7de4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/359529a9-4805-e9c8-a976-29fbb971223e"},"authoredOn":"1989-04-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dfac0f77-ddcc-dcd9-0da0-f6ab1ca54253","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/81e53eb5-ffea-5d33-853c-18022e4ad912"},"authoredOn":"1970-09-26T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"dfc655b3-7cd9-c28e-0f63-ced52c101183","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/54611913-110c-be99-837d-11c2ee1d4dac"},"authoredOn":"1970-09-19T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dfd7b25f-06bd-b168-36e1-8e21c82e9214","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad1dc84e-5644-968f-d365-77ecc98b9561"},"authoredOn":"1971-10-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"dfea4cdc-c0ca-b2c4-32c4-2d611ec56e2c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2755158a-c1d5-7656-de96-812ed71b1058"},"authoredOn":"1977-02-12T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e01ab4db-a156-602e-9f66-cdb5815aa65a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9ff43790-954b-f4ba-4cfa-9cc3b1667ada"},"authoredOn":"1989-03-13T17:09:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e01bf767-1c28-092b-17df-93054c9ef829","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/16721467-00f3-06a3-77d2-1959f0e81392"},"authoredOn":"1998-11-30T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e0787a65-9914-a37a-569e-218de089df43","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6db51d6b-e4ed-7361-0124-4d3518d541e1"},"authoredOn":"1988-05-14T00:15:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e09b7544-c3b5-b16b-4513-97b12d0fd257","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/b67e1ed9-e31c-cca0-71e9-02a5e47a0e86"},"authoredOn":"2005-01-03T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e0d3eb64-0827-00bd-d3c1-d56cee2b4712","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1043400","display":"Acetaminophen 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution"}],"text":"Acetaminophen 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/2ec50ae0-c782-b188-7729-f60d15287cca"},"authoredOn":"2021-07-14T14:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"},"reasonReference":[{"reference":"Condition/238ddba1-c9bc-2ea2-8d7d-5238d140dd13","display":"Acute bronchitis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e0daa904-b9da-3fa2-2e28-a8f4cf7f2c3f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/566a3845-208e-b78e-32e4-56b879f36fd6"},"authoredOn":"1971-12-04T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e0f14d1f-e168-0b6a-df14-be69c2ba8142","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/63f23b73-1623-966a-ea00-876590af06a5"},"authoredOn":"1987-11-24T12:27:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e0f2a661-a1bd-436d-f862-c390d5f7ccb6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e6750199-c8cf-8929-3c97-e87e5b45e85a"},"authoredOn":"1987-06-10T05:45:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e11b3968-d074-0332-e4fe-a27ae357952d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-10-30T02:05:27-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"e123849e-7bf0-0805-251c-6575db62ecfd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ebc9ac84-055c-ccc9-d132-c882ed0c94f5"},"authoredOn":"1988-11-04T15:29:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e1378623-533e-60ec-f37a-94ef0872d389","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/22e321b3-c461-6881-fc27-f8d582172834"},"authoredOn":"1988-04-28T07:47:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e14f7748-adcd-2bcd-7163-4a354b1b8834","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ea4f2bd1-c99a-f88d-ae4f-5bbea844bf3f"},"authoredOn":"1987-05-20T19:04:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e1c9e0c9-b31f-8545-911f-bb1ef03cf34e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7bceafae-e37c-7bc4-6713-2fabc0d43519"},"authoredOn":"1971-11-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e20c503f-930c-b269-839f-e9b733483642","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3010af54-0dd9-0d5b-4c82-5599ace816ff"},"authoredOn":"1988-12-19T18:12:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e212bf1a-34c7-093c-57ec-a324d5a5fd55","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/43d42def-fc22-eeb6-3ce7-47cf8613392e"},"authoredOn":"1988-10-01T10:05:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e21bdee8-1bcc-4901-dd70-ac905f591089","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4f0b4625-f84f-3137-4094-0ce465057d22"},"authoredOn":"1990-08-26T02:24:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e248df37-f37d-b3b7-9bc3-836c562edaf2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/aa807c3e-896b-ddab-eb4d-f26cf481a176"},"authoredOn":"1990-01-31T04:32:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e255a704-3e3f-b4d7-64ea-158aef991176","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7ffeff66-2f87-bd97-5651-d3a82909df3a"},"authoredOn":"1971-02-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e25a056b-c463-c798-9978-3a4498e03612","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/cf957340-5765-4a47-42a7-4ece82bc1a6b"},"authoredOn":"1971-12-25T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e2dd090f-c1ef-092d-fe2f-0a193968048b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a827214e-bc16-28ca-50d4-e4f080a645e7"},"authoredOn":"1979-06-30T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e2e600b7-432a-64fc-fdb7-03923665a3c3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/23b5af3e-8308-47f6-c9ba-3adcc9a50a0d"},"authoredOn":"1980-12-06T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e2ef7e19-55e7-4dee-82b2-38862094390b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-20T07:39:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e32f5601-9569-a091-a207-e486474a2406","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f3764db9-fe9c-da95-2022-00eddb6d29d9"},"authoredOn":"1986-12-07T16:12:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e36f9923-9d42-c05f-eee0-11ddc1f162fa","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ea4f2bd1-c99a-f88d-ae4f-5bbea844bf3f"},"authoredOn":"1987-05-19T14:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e373b4a9-2ee3-3c0b-b518-31bf2bf16acc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/641cec00-201e-e10b-ac70-84044e402201"},"authoredOn":"1980-08-02T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e3886dad-964b-122e-5e00-64a0512f676a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/53ee38fc-c961-fee0-2ecf-c60c6b31482c"},"authoredOn":"1974-06-29T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e3b14b58-2ea4-b7f7-917a-e4f67dade1af","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c3d45d96-3eda-fe67-4a34-e97e647b9eb7"},"authoredOn":"1989-09-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e3d15d7c-8e06-7efb-5419-04c29e19f7a5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/80652af2-1433-73d2-50ca-3686197c00a9"},"authoredOn":"1987-10-11T03:21:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e3ddb85c-112f-ea60-0d46-01004e959c0d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5aac140a-fa93-f364-e5e5-568d1ac81df2"},"authoredOn":"1985-10-31T21:14:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e4273604-0c42-e3a6-3655-7eca6dfd572d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/73ce4e66-4aa7-350d-4425-5069a0d7d3e2"},"authoredOn":"1985-09-16T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e435ffe2-8d0b-a24b-afb3-d38552840005","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/10815fed-3432-54c1-b955-a80783d0ae79"},"authoredOn":"1982-01-02T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e4379b9e-6195-43ae-4ad4-663aa1f817ff","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c1e25292-4a68-dc42-3020-67d94d70c3c2"},"authoredOn":"1988-01-06T05:25:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e44068d0-ad61-ba20-413d-1ece8690b4fa","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/f244706f-cb3e-94e5-ab97-8de748d78a47"},"authoredOn":"1983-08-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e4d58aae-0769-fa3c-0fcf-0dee2f649910","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c5fef4f0-e4b1-da8c-dcf2-de91f0705b85"},"authoredOn":"1985-09-27T09:49:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e5110218-810d-a360-1cbe-5362b13dfd22","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b491663b-6d9f-624c-fc97-f6387653d932"},"authoredOn":"1988-07-06T06:44:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e55f198b-2d0b-b83b-b61a-5a0241ed2959","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c7d26c2e-9a8d-106b-8161-f263984aec68"},"authoredOn":"1985-10-22T12:44:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e58be633-c776-2971-2dca-251ea506d4c8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5356c11b-ee5c-ede5-96d6-18b0704cd4fc"},"authoredOn":"1987-09-01T02:54:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e5cb3c19-e1a6-4c34-3cde-922f7f64fd53","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2001499","display":"Vitamin B12 5 MG/ML Injectable Solution"}],"text":"Vitamin B12 5 MG/ML Injectable Solution"},"subject":{"reference":"Patient/8e1a0a7c-e308-444b-075a-3c2b1f60f881"},"encounter":{"reference":"Encounter/63886790-e50e-64c7-cd45-b144b273bdc2"},"authoredOn":"1988-06-29T13:46:29-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999999896","display":"Dr. Ahmed109 Feil794"}}
{"resourceType":"MedicationRequest","id":"e5dcfefd-20f3-3c8b-9c7d-767f9ec9910a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/86d672c8-3119-04be-9d14-73c7cfb4a6e6"},"authoredOn":"1989-05-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e5f19186-6eb5-d1f6-3837-0d92a3863129","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ed720c15-610a-e299-df4f-a57c4b9df1bb"},"authoredOn":"1989-07-22T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e615968a-efb5-e3fe-516c-82221f35b6d9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6f55502c-5642-0f1e-f442-137b002a6691"},"authoredOn":"1979-05-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e622146b-9d0e-bd3c-6ac2-82d3bbe967be","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/82046cf0-a879-61fd-9b49-f4313c454440"},"authoredOn":"1981-08-01T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e63602f5-9dfe-0451-b4ab-f51ffd6e7e50","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-10T15:57:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e65d5a9e-6cbb-7c66-df81-157f9a1dc7a1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/28d2dcb9-8d04-110e-4683-0a3548a9b163"},"authoredOn":"1986-02-24T05:22:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e6627628-e0d9-d036-5d46-d1a2446cb829","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/ad5388d1-8388-b7ba-dbd9-405587643943"},"authoredOn":"2009-01-26T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e6d514af-8328-c14e-7803-4e4d0c31d596","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ad589382-acac-fd0e-212f-095d7aa538e3"},"authoredOn":"1990-06-02T08:30:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e6ffefff-24f7-7fe0-ea17-490a1cb57219","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/14ebde3a-d387-1325-8363-926628c9adf5"},"authoredOn":"2013-08-13T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"e72fa8e7-b554-cd99-40d6-c4f85f11641d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/4f9491b5-84c4-1f5e-cb4e-809f390f52c5"},"authoredOn":"1990-10-15T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e79bf907-a37b-bd19-6d30-628763b6f15e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b4f368b3-c6b0-bb03-193d-39c8832dbf25"},"authoredOn":"1987-11-29T23:59:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e7b33f2b-c641-18f0-9676-55c92e6dc4c8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-03T19:35:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e7b4fa32-7a10-a011-2038-5476e7a9ff57","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bf065128-3f04-fa70-2f2a-f1399c0669d4"},"authoredOn":"1971-01-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e7de2564-b9e8-0d38-9f45-63288250b8e2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/5760afc0-fc0e-794a-0d2f-ed4fcb81d8ca"},"authoredOn":"2005-11-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e80cb487-f779-ea99-4c4f-7f2a79f2fcb0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/c31a4354-6870-f585-9068-a6d26e389568"},"authoredOn":"2007-06-05T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999995597","display":"Dr. Shiloh191 Larson43"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"e820e254-9cd7-a43e-737c-655644c481af","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/b101308a-0066-f30b-148d-d770cfb26443"},"authoredOn":"2017-09-05T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"e876c7e4-6072-acda-53c8-bd076d4d1552","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8b46fea0-8663-0f37-a62d-a582a1e652fe"},"authoredOn":"1984-06-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e8c11a12-185e-1a7e-0084-56b64cf1e1ce","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9027d918-9232-f6f4-901c-40729d07d4dd"},"authoredOn":"1980-03-15T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e8df7263-5274-7e93-2920-d759b22555d2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9fbe9ab9-9369-12c3-d5a2-b554eea42d01"},"authoredOn":"1984-12-11T10:31:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e8e6e93c-feeb-0b79-a01d-2ed97e0ea6f3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/50e261fd-d506-ccde-97da-19308cd4b7ca"},"authoredOn":"1985-07-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e8f696bc-c9a8-f497-da8e-df0128babd11","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/6bd77e0a-d5d7-37d3-c808-b0942a0788d2"},"authoredOn":"2001-10-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e8f936a6-6a21-d574-0a48-62cdbb14aed3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-16T00:20:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e9025ace-251b-9cb0-1478-5b65412b3feb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/895a94ae-e6bb-ea8b-527e-d52bdfefabcd"},"authoredOn":"1979-11-10T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e90594ec-b591-a569-9bf2-eabc74cfc1a5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/39ec36e9-4924-05eb-02a9-854713329d2c"},"authoredOn":"1988-03-18T14:20:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e93a80f8-dea4-6526-f47e-d937165e65b7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/35bc8e39-e9f6-655d-45ac-2cb9fc321dfb"},"authoredOn":"1988-05-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e9658326-5235-6840-1985-1e55ca64b6c6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9d72935b-726c-e298-bf1c-d1aa2eb592b3"},"authoredOn":"1985-10-28T18:51:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e9a7a12a-e787-e434-caf4-1f16abf4fb27","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8a004a19-132b-9614-4ed4-c772b53e5882"},"authoredOn":"1993-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"e9aaa3fa-a513-9d58-530b-78315b861cdb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/874982d5-4bc9-fa70-888a-827c3b02e207"},"authoredOn":"1987-04-14T09:59:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"e9d9827a-d674-0c5f-0331-48d8c2c3028d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f47bd74b-4e96-5a46-59dc-3847d3247326"},"authoredOn":"1985-04-01T12:46:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ea246c9b-0271-4656-ca77-ce2c4bc98d1e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/b67e1ed9-e31c-cca0-71e9-02a5e47a0e86"},"authoredOn":"2005-01-03T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ea319cc3-6793-baa4-3576-f542fd895ded","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-01T05:38:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ea371a79-d6d2-4eec-bd4f-129fc9d14f5d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/5bde2d4d-3068-9054-b1fb-a1e6a0a2d6b0"},"authoredOn":"1985-07-16T13:40:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ea401ccb-dbf9-3a65-6d6e-b5b6b78bf13f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/603711ca-c10b-24ee-ba2e-b9a6cc8f8704"},"authoredOn":"1980-09-27T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ea5a6980-f633-c1bb-64a8-d36accc7a2b1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/025ac45e-1977-4ee9-f881-b6d5e31e5434"},"authoredOn":"1971-09-11T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ea622ef1-a2ee-5f95-4836-144ef7cd6441","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a53543ff-b352-53ec-24d5-0b9093dea284"},"authoredOn":"1987-09-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ea70cd02-17cb-9d88-e97c-4c5b2774bd9d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6d64ee3b-f414-47d5-bf91-c687800b9293"},"authoredOn":"1984-02-18T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ea7a61b7-b532-6aae-a760-64611bc3b130","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/595dc965-1102-b51c-3cea-7fa686414dc7"},"authoredOn":"1986-02-17T23:18:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eab5d85e-645d-0335-3f11-81fac6d9c8f0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/456c6466-622b-4c8d-8e72-fdffc669e8e0"},"authoredOn":"1970-11-07T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eab7d808-2cca-d94a-3195-b1953808fb56","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3d291b56-d41a-32b4-708a-f0d1ed9fb7f9"},"authoredOn":"1986-11-04T03:04:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eae11dce-12c4-a4d9-3be3-ed6703bb51e0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c544ddd4-ef20-096d-a655-ab0ce01b2cab"},"authoredOn":"1985-01-12T09:04:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eaf1d7e3-3baf-e769-631b-5622c5f2fe6f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1094107","display":"Phenazopyridine hydrochloride 100 MG Oral Tablet"}],"text":"Phenazopyridine hydrochloride 100 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/59515b7e-3f42-7649-be31-d1c27c71aff8"},"authoredOn":"1986-06-18T19:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/d2be1b9a-1465-4ee9-c053-402bf7676e27","display":"Escherichia coli urinary tract infection"}]}
{"resourceType":"MedicationRequest","id":"eb02094a-4fae-68c4-6bc7-ca3039468ec2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-10T16:03:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eb2c99b2-2805-2c7e-13df-fb0ac9caf66c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b6d9b3bf-75d0-3262-2283-d235cd258b7e"},"authoredOn":"1985-08-19T22:56:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eb373b3f-402f-c915-4112-ddb258321076","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/84098622-da37-647d-4e75-62cca0eff97f"},"authoredOn":"2002-12-23T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"eb5c485a-cb8a-c099-046c-41f27b467f38","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4aacef0e-3736-80f7-61ed-ec0192635d09"},"authoredOn":"1985-11-16T10:46:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eb7dbf41-1f21-76d3-a74c-0327e63285c2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/efd68eda-8350-086f-0fac-3ee0ba1e320d"},"authoredOn":"1989-02-18T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eb8a8916-c462-d85f-18e0-d4204eb1b592","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/061bff90-096d-ada6-1ae7-46d9599b2f34"},"authoredOn":"1982-02-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eb8c3313-6124-f09b-5a34-d58ab4097579","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/35bc8e39-e9f6-655d-45ac-2cb9fc321dfb"},"authoredOn":"1988-05-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ebb862ca-687b-8992-8c8d-e9848f6c87f8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5ea2402c-df72-0891-5976-a90ee264fcda"},"authoredOn":"1988-08-28T08:31:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ebbfa6fe-c1b6-8509-c963-b66dbb655933","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/661e4d2c-1e95-6484-70a3-ee0b951228db"},"authoredOn":"1977-07-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ec381b36-96c2-c989-098b-6642533a918c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/511eb1ed-0d22-7db7-a6a4-1370ee5a96f5"},"authoredOn":"1989-01-10T19:38:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ed0391b1-69c6-4c5a-6161-4b8fed219032","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d815bdd9-da63-6ded-ed97-cae7ae5e2d15"},"authoredOn":"1986-02-25T00:56:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ed4df7be-1df7-0e0b-b32b-c2093067d590","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/506977b5-9761-f21c-6aad-0d6c34b76ca6"},"authoredOn":"1989-12-30T05:21:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ed6429f3-409c-57b2-d840-c33cb126a244","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b6d9b3bf-75d0-3262-2283-d235cd258b7e"},"authoredOn":"1985-08-18T21:09:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"edac3606-3545-cd72-b43e-28e4a91de63a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/73f0269c-bb03-766c-52e0-48cb714e9f24"},"authoredOn":"2021-04-05T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ede8387f-263c-3fea-1eaa-4a7c9db5904f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9439bc8e-fc9c-35f2-e181-f4ac5e369b06"},"authoredOn":"1990-05-27T02:41:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"edf275e6-caca-e55c-0695-52cac5a6972e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/de8b10e0-e01b-795d-0219-797a07dd21bc"},"authoredOn":"1988-02-15T15:43:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ee6a8089-c135-5c91-4467-5ea9124db571","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0766f9fd-a6e9-c138-5ebd-15670bedb6ee"},"authoredOn":"1987-04-02T10:45:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ee755c32-7590-a92e-4f65-676a8971aa0f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/682a6208-ee03-aca7-d794-c27b20527574"},"authoredOn":"1986-01-19T19:47:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eea9919e-6621-f2f5-2a57-592469a9eca1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/950049e3-b310-87e7-3184-e72d185d1813"},"authoredOn":"1979-06-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"eeaff459-6002-f8c6-3fbe-63938cfa40ba","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/54611913-110c-be99-837d-11c2ee1d4dac"},"authoredOn":"1970-09-19T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"eeb9cf6d-754d-2911-384a-bb4285d66818","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/86a2740f-4a92-49a4-e570-3a59cde034f7"},"authoredOn":"1987-06-13T09:27:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"eec4593b-5a90-d055-776b-fcd37dd2536b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/48a9c62b-a992-99a4-b871-42a8200480c2"},"authoredOn":"1988-09-17T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ef576dca-f058-4853-0a05-bc55eb7552a5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"904419","display":"Alendronic acid 10 MG Oral Tablet"}],"text":"Alendronic acid 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/7aff346c-e48f-25b3-2b9f-4317747ed542"},"authoredOn":"2010-11-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999947499","display":"Dr. Roland928 Hirthe744"},"reasonReference":[{"reference":"Condition/9d82ec90-2f01-eef3-5674-6fdc43211b7c","display":"Osteoporosis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ef579458-1108-708e-2ba3-1ed628349628","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/52550c26-47e7-c210-c894-c4964e184117"},"authoredOn":"1989-01-04T07:32:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ef61cd49-2f98-c54b-d403-3dae09f07a5f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3467c7c1-750d-d238-10ae-47453cde0b0a"},"authoredOn":"1981-09-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ef80ada5-7523-f551-32cf-57397763b433","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/41d2ea35-44a9-2b7a-df42-23707eef2af4"},"authoredOn":"1979-05-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ef85760a-5a18-7ab6-c5e2-335927f78e59","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0bcee599-781e-767a-4c29-8cc966da8ee5"},"authoredOn":"1980-03-08T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ef9b23c1-2bcf-722c-1f0d-8fbbaee02c4f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/86688a05-672d-7a8b-7f87-f12d3b0ce1e8"},"authoredOn":"2022-10-04T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"efa1085b-fd93-ae7e-dad2-c6131cd08cf7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"209387","display":"Acetaminophen 325 MG Oral Tablet [Tylenol]"}],"text":"Acetaminophen 325 MG Oral Tablet [Tylenol]"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/86688a05-672d-7a8b-7f87-f12d3b0ce1e8"},"authoredOn":"2022-10-04T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"dosageInstruction":[{"sequence":1,"text":"Every four to six hours (qualifier value)","additionalInstruction":[{"coding":[{"system":"http://snomed.info/sct","code":"225757006","display":"Every four to six hours (qualifier value)"}],"text":"Every four to six hours (qualifier value)"}],"timing":{"repeat":{"frequency":4,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"efcf0264-4804-8545-7c19-34091e41228a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/4c929bba-5ec8-4787-a097-704b90607f77"},"authoredOn":"1987-03-08T06:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"efe6aee8-fe84-9076-2b2a-bc362202b8f2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2bc49551-6496-1edf-e9cd-fbae62cdb67e"},"authoredOn":"1980-06-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f01d2862-007e-c453-911d-38684ba119e8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e06a5917-9f46-3891-e40a-8917335e408a"},"authoredOn":"1990-09-15T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f022ee56-b6a9-2c08-4125-c39e65e112b0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6c20a7a6-0af8-417e-838f-b064e708a8e2"},"authoredOn":"1987-04-30T16:52:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f02f7f3e-ba9f-a097-f6be-114704bb31b5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3da59ce5-cae0-b4d9-0b02-bc6c71825c8f"},"authoredOn":"1988-12-22T20:35:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f04683fe-6e92-aa56-33b2-ec1f6e78f084","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5c189dd8-9405-c099-383e-19d04ea17529"},"authoredOn":"1987-08-16T09:45:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f056e8ae-5d35-f958-cffd-9a65864138fb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/0e4ba84e-0afc-0850-85ad-23a64c17cd6c"},"authoredOn":"2016-08-30T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"f05f5682-8a70-44fd-e6dd-d867b8ee37e9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ab9f22bc-bfc8-f44a-eeae-9a99f1e48d94"},"authoredOn":"1986-05-01T13:09:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f0723f70-10cc-aee0-5538-0fb00e6b14e3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bf09f876-309c-0f4d-405c-052d8bc2f65c"},"authoredOn":"1971-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f0791e2d-4f72-46d1-2734-5af1419ac9c7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/a0ad98cc-3e9d-470a-d6b6-36447f629bdd"},"authoredOn":"1987-09-28T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f0854972-e985-63e4-b25a-7b24a9207391","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/43f8ba93-4d29-5382-a6b6-048788addf66"},"authoredOn":"1989-05-09T14:03:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f088bc4c-a9cd-8d8a-8f5e-6fa5716bb8b7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/01ed1572-71b6-3787-d30a-952295a96665"},"authoredOn":"1986-07-13T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f0bd6130-7de1-e6ef-1043-6118f1349722","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c0961a92-18e3-574c-f62b-9e5deb760f85"},"authoredOn":"1988-06-20T17:46:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f0f262f8-e55e-c7dd-3066-92b1cb8a9308","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d9987f68-18c9-7feb-e112-6f8067df7df6"},"authoredOn":"1988-12-05T16:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f11adfb4-a0db-c04d-b89f-96d0edc72f07","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/b8fb3635-6ab0-79c6-7ed8-1aa08dcd6937"},"authoredOn":"1986-10-01T01:23:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f11d4b21-e15e-cfd6-56cf-abb65ffbdba9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/094eff01-4e5a-0f7b-3d35-ff06c046ef3a"},"authoredOn":"1982-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f14bd5ef-1b88-503d-a7f5-0daa40558f67","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/08068762-996f-0aaa-8b0c-bddda0a41d1f"},"authoredOn":"1986-06-18T05:46:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f1b723d3-d84e-4610-5425-b47721ca66e4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1970a439-6a26-78fd-529d-7e578fb88435"},"authoredOn":"1983-12-17T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f1bc938a-3f5e-2980-2fec-fbd9a0dcbe2a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ef981f0b-0b02-5e38-a25a-6f5106ecea92"},"authoredOn":"1981-10-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f1fb66f1-59c6-1ed3-9a4d-df21a63220f0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/061bff90-096d-ada6-1ae7-46d9599b2f34"},"authoredOn":"1982-02-27T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f2202212-493e-8225-1856-df2c3f8f4572","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fedbfeb8-2f02-f89c-25d4-95ebbbf001b2"},"authoredOn":"1990-01-28T01:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f2284dd2-05cb-5286-223f-0ff431c7fab4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/70659784-0556-fbdf-81cb-957fd514bd71"},"authoredOn":"1997-11-24T13:37:35-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f29a3f51-579e-36af-3372-3e873f43aaf4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/78cbcee4-5c37-aa56-ac25-1b9244646fb2"},"authoredOn":"1990-11-01T03:36:00-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/e51afbc9-5223-082d-7661-93d642a99497","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationRequest","id":"f2a13dd1-e814-7e1b-ae26-3dcc81bc2345","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e28dfc70-9d63-8fe6-99a6-98049329caad"},"authoredOn":"1986-03-27T10:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f2b8c4de-e02a-dda3-8eff-9e32dbda5ced","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8690d98a-628b-94dc-e4ab-cc67244a04c7"},"authoredOn":"1971-04-24T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f2cd5e1d-a751-826f-04a9-8f2b514058cf","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9c1df8db-3bcc-d043-a696-833e59d83d0c"},"authoredOn":"1990-03-06T14:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f2e3310c-1d72-628a-a43f-a75ef75d02ef","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/00d2903a-e2d6-20e6-df87-52bb6477f24f"},"authoredOn":"1989-12-16T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f39388e2-63c3-f183-eeb1-c2974221685a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/03191e66-8f6f-80b2-2dae-cfb1ae296dec"},"authoredOn":"1987-08-25T20:06:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f3adc2c0-7034-78a2-fd05-f5f320ab6c7d","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314231","display":"Simvastatin 10 MG Oral Tablet"}],"text":"Simvastatin 10 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/4a571225-697e-9582-60ee-2152fea593ab"},"authoredOn":"1998-09-20T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/45c2ced0-6dd7-c704-0b63-deb567cc7d0a","display":"Hyperlipidemia"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f3b6a1f6-782a-cb0d-7bd2-91dd5e01b2f5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-16T00:20:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f3f59871-7bbd-2746-0030-2cbd2306fb8e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-19T10:54:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f416c428-f81c-0ad2-ea7f-4f043ecf4fd4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/3eeb2645-b2a6-b62f-2cae-946a6ae99f0b"},"authoredOn":"1989-02-19T18:00:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f42b1acf-c047-6595-8a1a-4dda88694efa","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ea4f2bd1-c99a-f88d-ae4f-5bbea844bf3f"},"authoredOn":"1987-05-19T14:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f453670d-46ec-fa86-96fc-4fc1d2b3f683","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/02431a0e-d934-755d-345d-f4d6324cfb98"},"authoredOn":"1988-03-18T03:21:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f47bc202-3e26-74c6-2c47-822814630289","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ac022cd7-3596-1277-a63c-ee44cca6a97f"},"authoredOn":"1986-01-30T04:59:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f47c4851-dd54-1e24-53dd-6d6390660011","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/b7614bb8-2905-1807-2eb9-b94e2b513986"},"authoredOn":"1972-01-29T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f4cb41b2-334b-7ddf-1308-1c41207f590b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8ffcc256-9010-0f7b-31df-89fcde87b81d"},"authoredOn":"1989-09-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f4ed90e1-c7c1-dc87-ee3c-58be4a0311f7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/57e00db9-f4fa-f050-ca55-2c8dd02a50aa"},"authoredOn":"1990-03-25T02:35:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f4f9900a-5122-7736-9ddc-62d82ca530d2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f01e4802-1b45-ac72-b1aa-284ee87ae277"},"authoredOn":"1988-09-24T23:41:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f53a6c36-22a7-7357-8bb5-45d77e26be5e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/00d2903a-e2d6-20e6-df87-52bb6477f24f"},"authoredOn":"1989-12-16T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f5453c9d-1056-fa1a-8e09-b5f471bef1c0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/61c22675-b271-65ba-1565-382a2edfdaed"},"authoredOn":"1988-06-14T12:01:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f54b3153-f30b-08f8-3a98-1e26a9e306e6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c20be672-8b7c-f189-4140-0a4b29ac240a"},"authoredOn":"1979-07-28T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f5d0cf3f-ead8-0607-4037-55b693fc2717","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/82046cf0-a879-61fd-9b49-f4313c454440"},"authoredOn":"1981-08-01T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f5f46644-5a33-a793-1d46-d8fce10cf419","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a34a2a78-e173-51d1-81c3-3af655a04eb3"},"authoredOn":"1988-11-17T03:00:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f609a9d2-cb5c-e91f-ecb2-57ad1a500ff6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/fc729a69-051c-c3a0-8826-1f2fd48f1998"},"authoredOn":"1970-12-05T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f642a585-dea7-f130-4223-fff73325eac6","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9759a722-e802-3e6d-f3ee-96910894e65e"},"authoredOn":"1988-04-24T23:38:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f64cb83f-babf-85ea-205e-b3b1665f18ff","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198405","display":"Ibuprofen 100 MG Oral Tablet"}],"text":"Ibuprofen 100 MG Oral Tablet"},"subject":{"reference":"Patient/63ee2253-bdd5-da55-2ad2-b4984d0ad700"},"encounter":{"reference":"Encounter/c7be7941-aae1-4776-d4e2-4f960b96a1e6"},"authoredOn":"2018-03-27T12:19:13-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999886895","display":"Dr. Hazel720 Schultz619"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"f660bc28-07a2-f52a-84cc-a76851727441","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/64d8ea9c-a3d2-719c-8d30-46927fb41da5"},"authoredOn":"1986-10-24T21:18:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f6782ea9-e73e-612e-7b26-4c8ff23b07ee","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a35e6fb0-1e23-82bd-fe7a-bc571811410d"},"authoredOn":"1989-11-18T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f69d2335-b791-3ec7-a510-c39adb4545bd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/f7e1266c-820d-ecde-cdce-2eee40a9f95a"},"authoredOn":"1985-02-19T04:28:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f6b5a67b-fead-49df-cf6b-5beb1ee41426","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ef85e2bf-9f34-930a-e7d0-e316ae5aedb3"},"authoredOn":"1978-09-16T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f6c2ca05-8fb0-afd9-b3dd-c00a74dce8b9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310965","display":"Ibuprofen 200 MG Oral Tablet"}],"text":"Ibuprofen 200 MG Oral Tablet"},"subject":{"reference":"Patient/cbc86e51-9eca-3855-76ec-c058f72c5761"},"encounter":{"reference":"Encounter/d3905e96-2662-b092-eded-660d362d6f9a"},"authoredOn":"2018-08-11T01:39:41-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999909499","display":"Dr. Jamal145 Casper496"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"f709220c-ff7e-ec88-9acc-54a16144b71f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ce5b42c6-7200-94ff-bbf2-a3b8fb9eff83"},"authoredOn":"1991-10-12T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f7188404-c795-e2f5-6ac2-d12af0019372","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/61d35a5f-225e-ea99-0f11-bf6ee1719226"},"authoredOn":"1971-11-20T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f742dc71-adc0-9a23-34bd-2fbf12b269b5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/81e53eb5-ffea-5d33-853c-18022e4ad912"},"authoredOn":"1970-09-26T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f79c766d-fc7f-53e8-b213-369b43a1e328","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a7d14270-1daf-e9be-c1b1-605033af406f"},"authoredOn":"1988-10-07T15:47:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f7afb590-2e87-568d-48ff-115054ffef22","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1e0b70d1-174a-2f1b-ce4e-ccfd86b27936"},"authoredOn":"1986-12-20T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f7c51dba-1076-a840-c18c-15fae5eb1560","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/75a97d28-522f-ba4a-4c64-6d7d43e14bd2"},"authoredOn":"1981-03-07T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f7cd5026-b452-3c8f-0b81-272333b3a6e5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/02431a0e-d934-755d-345d-f4d6324cfb98"},"authoredOn":"1988-03-15T21:36:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f804ee49-27e4-6740-c50a-b267c406dbef","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/dec80c66-daf8-e6ef-627d-868e0e03ebf2"},"authoredOn":"1970-10-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f82c1164-5e9f-b6a8-9fb3-37abb4da6118","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/9e132d3f-c07c-0516-c097-124e96a9bcc6"},"authoredOn":"1987-01-18T01:26:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f83597f5-adca-3161-b8a0-e5c87c4e2a11","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/c83974bd-92ad-4458-ca72-d17574617ad1"},"authoredOn":"2008-07-15T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"f83fb5ac-23a9-2771-0973-879fa1b3ccfb","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/2040d534-c687-67ee-e332-b2f697d326e7"},"authoredOn":"1982-01-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f846b290-f513-1c80-e768-676074fe5986","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/98bb9adc-b1aa-52b2-6a57-a94cf799b78b"},"authoredOn":"2016-08-29T18:40:36-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999993295","display":"Dr. Barrett790 Wolf938"}}
{"resourceType":"MedicationRequest","id":"f854c0fe-9eae-91db-4183-a3c8f5ebd0c5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d4255942-185e-b2da-d93a-2eda1424526b"},"authoredOn":"1988-11-01T11:37:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f86baddd-a725-8952-68f5-2a34cd4b6dce","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d44287bf-0fd1-3142-862b-b34f00f2b680"},"authoredOn":"1987-05-06T22:01:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f886d568-ca60-6ac2-a664-ccf0b3f399ae","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a956b355-ad4d-dfa7-8cdf-4165a35043c8"},"authoredOn":"1987-12-06T04:53:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f8c1cfee-381a-3bf5-2982-c79e004a8ca9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/bc71dafb-6f98-241e-98fa-4cd4cf57811f"},"authoredOn":"1989-04-08T08:21:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f8de28b1-dfd2-50f4-df25-1688ed6a3754","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c04e8b41-12dd-8c8e-5cbf-fb19f5044a33"},"authoredOn":"1988-04-03T06:28:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f8e21eee-971e-10f7-3163-8513a872e9fe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"849574","display":"Naproxen sodium 220 MG Oral Tablet"}],"text":"Naproxen sodium 220 MG Oral Tablet"},"subject":{"reference":"Patient/a4a401d1-a46a-eb4a-8a38-760d5d79d6ec"},"encounter":{"reference":"Encounter/b9535feb-c2b7-4c79-4a1a-c28ba3c5c9b0"},"authoredOn":"2021-07-07T16:05:27-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999909499","display":"Dr. Jamal145 Casper496"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"f9362271-3c83-edb7-b03d-90c028440dbe","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/68cd511a-269c-b687-a52a-a6784ff731a4"},"authoredOn":"1980-10-04T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f93a7e99-58f8-e47c-2a5a-a611c96acdba","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351137","display":"albuterol 0.21 MG/ML Inhalation Solution"}],"text":"albuterol 0.21 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/c83974bd-92ad-4458-ca72-d17574617ad1"},"authoredOn":"2008-07-15T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999945097","display":"Dr. Jasper743 Champlin946"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"f9550bd9-b285-543b-cae1-f995df13ef7e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8d3e5f0c-a5de-25a7-4207-ba0d12e7f98f"},"authoredOn":"1970-11-28T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f95f3fff-1993-c7de-bed8-3463f6c7b61c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/03699278-1388-f7b2-544b-b02277d2ec5f"},"authoredOn":"1987-10-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"f9a65fcc-9954-a6a4-b425-87a200e2a091","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/94959e12-0937-a865-1d60-9d55b5013cd6"},"authoredOn":"1987-02-23T18:57:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f9c610fa-615e-e8a4-b555-15e33be6fde9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/c544ddd4-ef20-096d-a655-ab0ce01b2cab"},"authoredOn":"1985-01-14T14:02:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f9dad4cc-0d39-4ba7-4a8a-3b1790511a67","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/dc7f830e-1443-bbc4-07f7-e3dc7c3837ed"},"authoredOn":"1986-08-23T03:42:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"f9fcedbd-a9de-bc28-5044-1deefc76773e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/28cf79ff-23e1-8d0a-4d8c-8330480331b2"},"authoredOn":"1990-07-22T03:03:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fa226d1d-e935-deb9-7f61-b74707cea94b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-02T17:42:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fa5430dc-2b07-d213-9a5e-fc970009c6ff","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ab9f22bc-bfc8-f44a-eeae-9a99f1e48d94"},"authoredOn":"1986-05-01T13:09:20-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fa9280ae-9f87-480a-c4d7-7a1749ef494b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/04bfa8ae-1417-da14-cb44-3b47704058fa"},"authoredOn":"1981-01-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fa9c715f-507e-8c89-9b52-676a60662d7a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a84267fc-6587-5241-ce18-9b47c38556c1"},"authoredOn":"1970-06-06T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"faa6d33d-3285-d05b-b543-89e67818b4b0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1870230","display":"NDA020800 0.3 ML Epinephrine 1 MG/ML Auto-Injector"}],"text":"NDA020800 0.3 ML Epinephrine 1 MG/ML Auto-Injector"},"subject":{"reference":"Patient/cbc86e51-9eca-3855-76ec-c058f72c5761"},"encounter":{"reference":"Encounter/068032dd-088c-4108-4da9-25b25847f4e3"},"authoredOn":"1996-12-27T05:00:32-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999999698","display":"Dr. Bobbye345 Wuckert783"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"fab2ab17-1b56-7932-cb69-0ba8baeb65b8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/87ea6824-0cd9-a5ba-a1d7-b4256c6d13e5"},"authoredOn":"1971-03-06T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"faeaf7f6-c638-6ed1-8395-fd4eccb9b432","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/0311794c-b854-85d7-dd0b-dc090c318552"},"authoredOn":"1977-12-24T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fb2ecd4f-e603-1769-622d-3b0209a39b8c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/5cb8aaf6-4203-134e-4374-e4e0aa14e52f"},"authoredOn":"1989-08-19T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fb6bfc74-9c4f-a9a8-c95e-545303eac4c4","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ba87fcee-5e12-459e-78a1-291c0afdb670"},"authoredOn":"1976-10-23T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fb88d068-e966-a584-b290-002cb1649ab2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"351109","display":"budesonide 0.25 MG/ML Inhalation Suspension"}],"text":"budesonide 0.25 MG/ML Inhalation Suspension"},"subject":{"reference":"Patient/fb7c882a-f897-e7c5-67e0-825e7fd55d15"},"encounter":{"reference":"Encounter/772c8659-ba16-d1c4-4e77-b1bbd9b6eb75"},"authoredOn":"2007-10-09T01:16:46-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923995","display":"Dr. Johnson679 Schmidt332"},"reasonReference":[{"reference":"Condition/6d9e5499-8c79-badc-de5f-2884df2e7141","display":"Childhood asthma"}],"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"fba78143-ce75-af4a-055b-5ca3c2459e5c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/9fbe9ab9-9369-12c3-d5a2-b554eea42d01"},"authoredOn":"1984-12-12T14:53:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fbd3f9a2-71e0-e522-3b83-7a0018b1454c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206905","display":"Ibuprofen 400 MG Oral Tablet [Ibu]"}],"text":"Ibuprofen 400 MG Oral Tablet [Ibu]"},"subject":{"reference":"Patient/ca15b832-01e4-41dd-6a52-97bd3e5510cb"},"encounter":{"reference":"Encounter/3439e7a6-f51a-e487-fddc-08efc4494627"},"authoredOn":"2021-03-24T14:45:24-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999933390","display":"Dr. Cherrie404 Conn188"},"dosageInstruction":[{"sequence":1,"text":"Take as needed.","asNeededBoolean":true}]}
{"resourceType":"MedicationRequest","id":"fc2417f1-d3b3-2efa-7f4b-0be6f18696d2","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/d7da3067-3825-83bc-add1-b47ff571fd6f"},"authoredOn":"1982-08-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fc6625c1-4b32-11e9-d9a0-7cdf5380cf4b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/bfd53f35-a90e-76b0-6a05-2eb5f354d24a"},"authoredOn":"1988-07-05T06:04:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fc8da9ef-a436-d6a9-8afa-7b23847080a1","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/c11752a7-8834-16b9-89da-10c630986d5c"},"authoredOn":"1986-09-26T15:22:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fc9adfe3-0e78-e02e-6445-1a39b0e9c15f","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310798","display":"Hydrochlorothiazide 25 MG Oral Tablet"}],"text":"Hydrochlorothiazide 25 MG Oral Tablet"},"subject":{"reference":"Patient/6a4160eb-a793-2f86-2302-378626f46cce"},"encounter":{"reference":"Encounter/9211600f-7526-11ad-d970-a2a430d698cc"},"authoredOn":"2020-03-30T14:37:35-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999934299","display":"Dr. Joaquín233 Duarte203"},"reasonReference":[{"reference":"Condition/f0e7c8e7-93f6-aa19-a716-b6b1a34f83fb","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"fcf60b66-797b-90bb-0542-310a54fb521b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"562251","display":"Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet"}],"text":"Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet"},"subject":{"reference":"Patient/a5cb8ce9-cec6-6b23-0990-cbaf753578a4"},"encounter":{"reference":"Encounter/ccf7c5ce-4559-de62-0292-81ed65976d98"},"authoredOn":"2017-08-15T05:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/830ab3cb-900a-8453-0f37-7a662e7dfe66","display":"Viral sinusitis (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fd17f7f7-0a20-ac54-2b67-31005552a6fc","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/0392dfae-b7b9-80cd-16bd-77ee104b960c"},"authoredOn":"1985-11-03T19:35:20-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fd2abb6c-bc82-c1f3-d357-06eec26b6cb7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/db78b870-03a8-cfe0-a5ea-9aaf608b2499"},"authoredOn":"1987-05-28T17:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fd397b90-d576-f987-d141-0f312cb35f9a","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/6349324c-7534-9c1a-7bc5-0f19d34c602a"},"authoredOn":"1989-11-26T02:24:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fd3cd1b9-e3e9-57df-4287-1f9c42fb2fb7","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/300de0de-0063-0fc0-67b2-a35ba7836c11"},"authoredOn":"1987-09-07T18:24:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fd3fccc3-57aa-f3c2-126b-bc69501f79f5","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/8c5e631c-ae61-23c6-6af3-c22ccb1ada7d"},"authoredOn":"1986-07-22T08:06:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fd60bd52-a336-ab43-ed1a-71c656630611","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/87e977d8-d0cf-82a2-bda7-4d2f2ab0e674"},"authoredOn":"1983-06-25T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"fdc146b5-1d9d-7e93-a151-52e277157979","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/3d11d073-b05e-6349-90ab-d92ed5795f86"},"authoredOn":"1986-08-09T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fe10a69c-485f-02f2-883c-735cae91b9d8","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e1281088-ff4b-01e7-bf07-43568e3fd65b"},"authoredOn":"1971-07-03T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fe4989ef-acfc-3df2-67b9-8fc56f7edc99","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/ea4f2bd1-c99a-f88d-ae4f-5bbea844bf3f"},"authoredOn":"1987-05-21T23:17:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fe783307-c23d-a63c-ba16-d398e5f845e9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/129c6ac7-8d06-89de-ad63-0204a93e76c3"},"encounter":{"reference":"Encounter/d1d1009e-0dbf-3993-5d56-1283a211e07f"},"authoredOn":"1987-03-05T14:02:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974592","display":"Dr. Liane379 Kunze215"},"reasonReference":[{"reference":"Condition/864227c1-ef70-0af7-711a-32e2d6bdbf1d","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"fe8aeeaf-f855-9852-8782-8744528bd091","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/e159615b-680f-2aa9-5a4a-3b7cbc101dea"},"authoredOn":"1985-08-31T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999969790","display":"Dr. Dennis979 Effertz744"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ff1fe52c-2da3-7d10-e421-73ac863edf6e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/aacf0177-e1a7-f1e1-57f7-b0b453f28874"},"authoredOn":"1986-11-18T20:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ff2742e1-fb5b-48f0-0b13-196098a02067","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/66d980fb-db39-bd3f-d328-51ca0ad9cb4b"},"authoredOn":"1984-12-01T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ff31c71f-d3ae-eea9-8a49-f12636a8886e","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"106892","display":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"}],"text":"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/04bfa8ae-1417-da14-cb44-3b47704058fa"},"authoredOn":"1981-01-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ff411012-2fe4-c327-2bef-1b42a67cd90c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/ba52fcf1-2872-c28a-0f83-948ffbba7f27"},"authoredOn":"1985-11-30T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ff7d85e8-8fd0-0c56-6c28-68b3e6b453fd","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/7f7bb6c2-d504-33fc-4bbc-69426f2d1ec8"},"authoredOn":"1981-10-31T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ff8bbb12-c6b2-6c2c-7551-1838fb7119f9","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/a0eb985d-9394-425b-c938-9802b281cbcd"},"authoredOn":"1989-09-02T09:33:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ff924eb8-7a7c-3839-d9f5-3e28700e7270","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/056f19ac-c462-6b04-2f48-f535679c8333"},"authoredOn":"1988-01-21T20:37:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ffa01ca4-9364-3d1c-af62-cb9e5466e3c3","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/057feaaf-bf31-e9bc-98a5-726cbfa47ccd"},"authoredOn":"1982-06-05T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
{"resourceType":"MedicationRequest","id":"ffb49cff-ab1b-809a-e0cc-a000775b4438","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/68f126b9-d0aa-d12b-be88-b1cec302c916"},"authoredOn":"1988-07-03T04:21:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974493","display":"Dr. Chelsey293 Simonis280"},"reasonReference":[{"reference":"Condition/473532b1-a3de-d071-8f1e-e3e518b40aac","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ffd3a59d-74f6-c4d3-143c-53cf25f16b5b","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/1edab468-a695-f52a-cfaa-da186d2a25c7"},"authoredOn":"1990-07-14T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999923391","display":"Dr. Millie392 Eichmann909"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ffd6fd44-ef80-04f6-ff0b-c4dd733b1ae0","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"860975","display":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"}],"text":"24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/12a98307-6b23-ae45-53b1-35a260462401"},"authoredOn":"1982-07-31T23:58:16-04:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/5e29e62c-0751-c36e-7308-ccd940301135","display":"Diabetes mellitus type 2 (disorder)"}]}
{"resourceType":"MedicationRequest","id":"ffe02c1f-44f2-831c-41b8-806e533c080c","meta":{"profile":["http://hl7.org/fhir/us/core/StructureDefinition/us-core-medicationrequest"]},"status":"stopped","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"community","display":"Community"}],"text":"Community"}],"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"314076","display":"lisinopril 10 MG Oral Tablet"}],"text":"lisinopril 10 MG Oral Tablet"},"subject":{"reference":"Patient/79a66c97-6131-3213-f3c9-4606946ab056"},"encounter":{"reference":"Encounter/8690d98a-628b-94dc-e4ab-cc67244a04c7"},"authoredOn":"1971-04-24T22:58:16-05:00","requester":{"reference":"Practitioner?identifier=http://hl7.org/fhir/sid/us-npi|9999974394","display":"Dr. Olevia458 Hermiston71"},"reasonReference":[{"reference":"Condition/b343d81b-e061-10cb-8292-8ff6ba4dfbf8","display":"Essential hypertension (disorder)"}],"dosageInstruction":[{"sequence":1,"timing":{"repeat":{"frequency":1,"period":1.0,"periodUnit":"d"}},"asNeededBoolean":false,"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.0}}]}]}
